Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009466	s-valpr	umol/l (umol/l)	5811	30303	0.06%
3009466	s-valpr	— (—)	2295	5876	100.00%	Distribution not available
3009466	s-valpr	umol/l____ (umol/l)	157	549	0.00%
3009466	s-valpr	UMOL/L (umol/l)	73	282	0.00%
3009466	s-valpr	µmol/l (umol/l)	65	146	0.00%
3009466	s-valpr	µmol/L (umol/l)	62	253	0.00%
3009466	s-valpr	% (—)	32	33	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

KRA_PSY_EATING, excluding more controls

195

43.00

323.01

6.4

4.0

377.81

339.95

umol/l

0.83

163

Mental and behavioural disorders due to sedatives or hypnotics

374

404

10.43

318.74

7.1

6.2

370.18

380.11

umol/l

0.43

329

358

Extrapyramidal and movement disorders

879

2185

4.16

314.66

6.7

4.7

382.77

349.74

umol/l

8.65

808

1861

Acute alcohol intoxication

656

1310

5.21

309.59

6.7

4.9

364.38

356.25

umol/l

0.59

587

1129

Epilepsy

2667

1195

26.14

307.65

4.4

6.5

368.63

361.88

umol/l

0.75

2390

1025

Hypothyroidism, levothyroxine purchases

467

177

15.18

307.65

7.2

3.0

393.71

398.44

umol/l

0.14

416

148

Focal epilepsy, strict definition

1615

735

26.22

307.65

3.8

6.3

363.30

358.95

umol/l

0.32

1434

630

Persons encountering health services in other circumstances

1026

2301

4.56

307.65

7.1

4.7

373.45

364.28

umol/l

1.09

902

2007

Focal epilepsy

1838

814

27.18

307.65

4.1

6.2

368.68

357.75

umol/l

1.18

1639

701

Generalized epilepsy, strict definition

226

34.37

307.65

4.7

6.9

393.18

374.59

umol/l

0.50

211

Hypothyroidism (congenital or acquired)

471

181

14.96

307.65

7.2

3.0

392.28

398.87

umol/l

0.21

420

151

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1875

3740

3.46

307.65

5.7

5.5

361.06

371.14

umol/l

1.92

1675

3272

Neurotic, stress-related and somatoform disorders

2337

3550

4.69

307.65

6.2

5.4

369.32

370.72

umol/l

0.15

2083

3130

1737

3177

5.09

307.65

6.7

5.1

368.35

359.50

umol/l

1.37

1542

2748

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

912

902

11.27

307.65

6.9

5.8

384.62

370.35

umol/l

1.38

808

802

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1366

318

46.34

307.65

6.8

2.7

379.02

360.22

umol/l

1.28

1214

274

Nonorganic sleeping disorders, excluding more controls

567

262

22.74

307.65

6.7

2.8

377.03

353.87

umol/l

1.47

509

230

Manic episode

463

95.53

307.65

8.9

6.5

408.16

357.30

umol/l

2.51

423

Concussion

960

1419

5.37

307.65

5.6

6.9

363.79

384.54

umol/l

3.11

858

1222

Hyperkinetic disorders, excluding more controls

314

110

27.78

307.65

4.9

3.3

359.27

357.10

umol/l

0.05

280

101

Alcohol abuse, main dg, excluding more controls

454

220

21.91

307.65

7.1

2.8

366.90

339.53

umol/l

1.50

409

185

Selective serotonin reuptake inhibitors

2204

2137

5.51

307.65

6.0

4.7

366.17

364.12

umol/l

0.19

1936

1853

Implicit bacterial Sepsis

944

1864

4.48

307.65

5.7

4.8

352.63

350.02

umol/l

0.19

833

1590

Anxiety disorders, excluding more controls

2181

954

15.19

307.65

6.2

2.8

368.51

354.49

umol/l

1.90

1942

797

Condition for Implicit Sepsis (Organ dysfunction codes)

1789

3632

3.49

307.65

5.6

5.5

359.27

368.37

umol/l

1.59

1594

3172

Bacterial Sepsis

1010

2114

4.06

307.65

5.6

4.9

354.09

352.50

umol/l

0.11

894

1815

Pneumonia, organism unspecified

1894

4046

3.28

307.65

6.4

5.2

372.62

365.84

umol/l

1.04

1695

3549

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2002

4359

3.12

307.65

6.4

5.2

373.32

366.38

umol/l

1.12

1797

3827

Persistent mood disorders

530

587

9.49

307.65

6.5

4.5

361.16

353.58

umol/l

0.44

471

513

Depression medications

662

207

16.59

307.65

6.4

3.2

373.67

399.70

umol/l

1.45

586

175

Substance abuse, excluding more controls

2009

818

21.74

307.65

6.8

2.8

368.03

344.90

umol/l

3.81

1778

674

Mental and behavioural disorders due to psychoactive substance use

2037

3207

6.11

307.65

6.8

5.0

368.24

362.62

umol/l

0.76

1803

2789

All pneumoniae

2031

4375

3.08

307.65

6.4

5.2

374.45

366.48

umol/l

1.40

1823

3836

Acute and transient psychotic disorders

980

439

27.09

307.65

8.4

4.5

390.88

345.37

umol/l

8.04

896

384

Other specified and unspecified personality disorders

544

422

14.72

307.65

7.3

5.9

376.99

366.07

umol/l

0.63

491

377

Mental retardation

322

241

16.25

307.65

6.6

5.8

419.22

376.72

umol/l

3.47

303

222

Schizophrenia

1535

631

30.18

307.65

8.3

4.3

388.57

355.38

umol/l

6.20

1414

553

Use of hypnotics and sedatives

2494

3536

4.14

307.65

6.5

4.8

377.55

356.59

umol/l

7.44

2226

3079

Other reaction to severe stress, and adjustment disorders

822

1707

4.97

307.65

6.0

5.7

363.89

375.51

umol/l

1.27

729

1519

Disorders of adult personality and behaviour

1563

1505

11.46

307.65

7.0

5.7

377.47

370.79

umol/l

0.69

1399

1322

Unspecified mental disorder

3550

1363

30.82

307.65

7.5

3.4

383.70

347.92

umol/l

13.62

3211

1163

Psychiatric diseases

2034

912

11.49

307.65

6.0

2.8

367.10

352.23

umol/l

1.98

1794

758

Alcohol use disorder, ICD-based

1487

2441

6.45

307.65

6.9

5.2

370.68

360.45

umol/l

1.51

1323

2111

Specific personality disorders

1333

1158

12.80

307.65

7.1

5.7

377.82

371.41

umol/l

0.56

1195

1010

Organic, including symptomatic, mental disorders

1335

1597

6.13

307.65

5.2

4.9

351.51

350.64

umol/l

0.06

1171

1377

Mental disorders, not otherwise specified

339

210

17.64

307.65

7.6

3.7

378.12

343.31

umol/l

2.27

314

191

Non-selective monoamine reuptake inhibitors

854

1134

7.50

307.65

5.9

4.5

360.39

360.30

umol/l

0.01

755

981

Implicit Sepsis

1641

3370

3.68

307.65

5.6

5.3

354.48

363.61

umol/l

1.49

1457

2926

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1366

1520

9.75

307.65

6.8

5.5

379.02

372.18

umol/l

0.67

1214

1343

Symptoms and signs involving cognition, perception, emotional state and behaviour

2103

3975

3.62

307.65

5.9

5.4

365.87

365.68

umol/l

0.02

1861

3488

Other antidepressants

2081

2103

5.18

307.65

5.6

4.7

357.81

362.80

umol/l

0.58

1812

1820

Other anxiety disorders

1510

2064

6.51

307.65

6.2

5.6

366.47

374.97

umol/l

1.07

1331

1838

Schizoaffective disorder

1160

287

61.32

307.65

9.0

4.9

392.45

354.12

umol/l

4.68

1068

253

General examination and investigation of persons without complaint and reported diagnosis

1441

1786

4.30

307.65

6.5

4.8

373.29

359.16

umol/l

2.33

1300

1536

Kela-code for severe mental illness

3483

1203

35.01

307.65

7.5

3.4

384.57

347.74

umol/l

13.21

3150

1026

Mixed and other personality disorders

419

378

12.42

307.65

7.2

6.2

370.32

364.33

umol/l

0.26

368

335

Use of disulfiram, acamprosate or naltrexone

499

564

10.03

307.65

8.8

6.2

380.08

370.51

umol/l

0.59

465

496

Emotionally unstable personality disorder

788

536

16.75

307.65

6.9

5.7

378.58

367.79

umol/l

0.75

699

463

Implicit Sepsis, including avohilmo

1753

3618

3.55

307.65

5.6

5.4

358.33

366.96

umol/l

1.45

1560

3149

Depression

2584

2675

6.70

307.65

6.1

4.3

369.11

359.96

umol/l

1.64

2295

2330

1825

3205

5.16

307.65

6.8

5.0

368.74

360.48

umol/l

1.26

1620

2776

Other degenerative diseases of the nervous system

619

448

10.43

307.65

4.2

6.5

335.66

373.30

umol/l

4.58

524

368

Other and unspecified mood [affective] disorders

432

179

27.38

307.65

6.9

5.7

372.04

370.39

umol/l

0.05

376

161

Personality disorders, excluding more controls

1461

305

53.14

307.65

6.9

2.8

376.17

357.36

umol/l

1.25

1304

261

Any dementia

854

1082

5.65

307.65

4.3

4.2

335.42

335.56

umol/l

0.01

720

935

Neurological diseases

1463

1737

4.31

307.65

5.3

6.8

370.18

381.72

umol/l

1.68

1319

1495

Influenza and pneumonia

2043

4303

2.99

307.65

6.3

5.2

373.12

366.64

umol/l

1.02

1831

3769

Pneumonias (Asthma/COPD co-morbidities)

2019

4379

3.07

307.65

6.4

5.2

373.86

366.54

umol/l

1.22

1812

3842

Mood disorders

3521

2768

8.53

307.65

6.5

4.3

372.64

357.54

umol/l

4.45

3145

2398

Malaise and fatigue

1317

1726

6.22

307.65

6.4

5.2

368.11

362.19

umol/l

0.59

1179

1474

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1759

3151

3.33

307.65

6.4

5.2

373.61

365.72

umol/l

1.18

1577

2760

Other symptoms and signs involving cognitive functions and awareness

1328

2054

5.98

307.65

5.4

4.9

354.88

354.09

umol/l

0.06

1158

1766

Personality disorders

1461

1413

11.41

307.65

6.9

5.7

376.17

371.96

umol/l

0.36

1304

1242

Mental retardation, wide definition

331

256

15.61

307.65

6.6

5.6

417.38

377.68

umol/l

3.20

312

234

Poisoning by drugs, medicaments and biological substances

1295

1263

11.34

307.65

7.3

5.4

380.13

368.94

umol/l

1.25

1155

1112

Focal epilepsy, mode (most common among epilepsy diagnosis)

1505

702

25.49

307.65

3.8

6.2

366.39

359.05

umol/l

0.60

1334

602

Schizophrenia, schizotypal and delusional disorders

2719

1351

23.81

307.65

7.7

4.3

384.82

354.39

umol/l

9.81

2496

1156

Convulsions, not elsewhere classified

1507

993

16.77

307.65

5.2

5.5

367.02

370.56

umol/l

0.25

1356

847

Mood [affective] disorders

3510

2774

8.50

307.65

6.5

4.3

372.81

357.51

umol/l

4.56

3135

2405

Use of biperiden

561

272

27.55

307.65

8.4

5.9

398.32

357.50

umol/l

4.64

517

240

Mental and behavioural disorders due to alcohol

1694

2779

6.10

307.65

6.8

5.0

368.91

360.78

umol/l

1.15

1503

2402

Substance use, excluding alcohol

911

1007

9.84

307.65

7.3

5.4

374.37

368.54

umol/l

0.41

811

884

Mood disorders, excluding more controls

3255

1044

19.30

307.65

6.6

2.8

371.33

348.41

umol/l

5.07

2908

872

Alcohol dependence

1027

1382

7.96

307.65

7.3

5.1

370.60

359.97

umol/l

1.12

924

1187

Schizophrenia or delusion

2715

1348

23.84

307.65

7.7

4.3

384.82

354.96

umol/l

9.45

2493

1153

Other and unspecified nonorganic psychotic disorders

1764

811

26.25

307.65

7.9

4.4

387.15

355.68

umol/l

6.80

1623

704

Hypothyroidism and >3 levothyroxin purchases

467

177

15.18

307.65

7.2

3.0

393.71

398.44

umol/l

0.14

416

148

Anxiety disorders

2354

3557

4.69

307.65

6.2

5.3

369.13

369.93

umol/l

0.08

2097

3136

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1577

2590

6.38

307.65

6.8

5.1

369.31

359.72

umol/l

1.43

1403

2236

Benzodiazepine use

3591

3047

8.35

307.65

6.3

4.5

374.54

353.57

umol/l

8.45

3185

2634

Speech and linguistic disorders, excluding more controls

247

26.12

307.65

6.0

3.2

377.63

379.72

umol/l

0.04

227

Any mental disorder

2747

1078

13.22

307.65

6.1

2.8

368.25

349.27

umol/l

3.61

2425

902

Episodal and paroxysmal disorders

2221

2689

4.29

307.65

5.0

6.4

369.08

369.03

umol/l

0.00

1968

2337

All anxiety disorders

1901

2666

5.76

307.65

6.2

5.6

367.31

374.56

umol/l

1.03

1687

2372

Persistent delusional disorders

350

291

13.34

307.65

7.3

4.5

376.66

344.90

umol/l

2.59

322

250

General symptoms and signs

1971

2665

3.78

307.65

5.8

5.5

364.32

367.63

umol/l

0.36

1754

2299

Any dementia, excluding more controls

820

517

11.33

307.65

4.4

2.9

338.90

328.13

umol/l

0.80

691

432

Alcohol use disorder, Swedish definition

1731

2987

5.51

307.65

6.8

5.0

368.95

358.67

umol/l

1.74

1541

2577

Delirium, not induced by alcohol and other psychoactive substances

457

446

10.99

307.65

5.8

4.7

352.53

345.79

umol/l

0.35

412

383

Intracranial trauma

1217

1438

5.87

307.65

5.6

6.9

363.30

385.38

umol/l

3.93

1074

1237

Anxiety (asthma-related co-morbidities)

1874

1259

11.84

307.65

6.2

3.8

366.69

363.57

umol/l

0.25

1666

1091

Status epilepticus

356

113

40.55

307.65

5.2

7.2

364.98

376.35

umol/l

0.34

329

Bipolar affective disorders

2326

526

57.78

307.65

7.2

5.0

380.32

359.22

umol/l

2.65

2074

459

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

481

422

13.21

307.65

7.7

6.3

381.43

375.45

umol/l

0.27

435

377

Suicide or other Intentional self-harm

1240

1345

10.12

307.65

6.9

5.5

382.56

369.62

umol/l

1.59

1106

1190

Any reimbursement code in KELA

1075

455

12.13

307.65

6.4

3.3

371.82

335.77

umol/l

3.29

959

358

Generalized epilepsy

449

172

34.48

307.65

5.4

6.4

399.63

371.25

umol/l

1.45

416

148

Dementia

866

1122

5.44

307.65

4.4

4.5

338.74

343.88

umol/l

0.39

736

962

Generalized epilepsy, mode (most common among epilepsy diagnosis)

308

121

33.17

307.65

5.1

6.6

391.82

360.12

umol/l

1.45

283

108

Schizophrenia or delusion, excluding more controls

2715

431

74.00

307.65

7.7

2.9

384.82

350.70

umol/l

5.05

2493

365

Dementia, including avohilmo

923

1294

5.02

307.65

4.4

4.5

340.01

343.58

umol/l

0.26

788

1117

Implicit bacterial Sepsis, including avohilmo

1032

2015

4.39

307.65

5.8

4.9

349.99

351.25

umol/l

0.09

911

1723

Poisoning by medicine

1198

1151

11.55

307.65

7.3

5.4

381.90

369.92

umol/l

1.28

1068

1009

Substance abuse

2009

3158

6.22

307.65

6.8

5.0

368.03

362.79

umol/l

0.68

1778

2745

1759

3151

3.33

307.65

6.4

5.2

373.61

365.72

umol/l

1.18

1577

2760

Traumatic subdural haemorrhage

295

204

14.08

306.20

4.9

6.6

342.23

358.13

umol/l

0.66

242

160

Injuries to the head

2017

4591

2.65

306.13

5.7

5.4

363.18

367.35

umol/l

0.53

1773

4032

Symptoms and signs involving the nervous and musculoskeletal systems

1183

3704

3.27

298.37

5.6

5.2

371.49

358.43

umol/l

2.09

1071

3203

Syncope and collapse

790

1523

4.43

292.85

4.9

5.1

350.00

357.68

umol/l

0.66

679

1286

Intracranial injury

1163

3473

3.19

277.04

5.4

5.3

360.37

364.37

umol/l

0.36

1015

3036

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

338

394

9.53

271.10

8.1

6.1

384.74

367.12

umol/l

0.89

311

352

Constipation

1596

3994

2.76

271.03

6.6

4.9

371.76

361.78

umol/l

1.72

1432

3463

Secondary parkinsonism+Parkinsonism in other disease

216

128

20.68

268.35

7.7

5.0

381.06

353.48

umol/l

1.22

206

115

Generalized anxiety disorder

425

643

6.88

267.71

5.5

6.1

362.85

374.60

umol/l

0.66

383

575

Secondary parkinsonism

215

127

20.86

267.69

7.7

4.9

381.69

353.06

umol/l

1.28

205

114

Persons encountering health services in other circumstances, wide

1922

3910

2.56

262.41

6.6

4.7

369.43

363.28

umol/l

0.91

1710

3402

Panic disorder

398

577

7.21

261.66

5.7

5.9

368.68

374.38

umol/l

0.21

346

512

Other disorders of fluid, electrolyte and acid-base balance

715

1627

4.28

261.17

6.1

4.6

365.47

350.25

umol/l

1.78

630

1380

Other mental disorders due to brain damage and dysfunction and to physical disease

344

432

8.44

257.26

6.1

4.8

353.04

347.11

umol/l

0.27

300

371

Fever of other and unknown origin

903

2216

3.59

255.85

6.0

5.4

367.03

366.32

umol/l

0.05

801

1897

Anaemias

341

196

11.40

251.56

6.9

3.5

372.81

418.98

umol/l

2.82

309

167

Problems related to lifestyle

370

521

7.57

250.94

6.5

5.2

371.27

365.24

umol/l

0.27

328

460

Hypo-osmolality and hyponatraemia

477

867

5.71

247.66

5.9

4.8

382.10

347.21

umol/l

4.76

426

729

Sequelae of cerebrovascular disease

700

1451

4.24

246.18

3.8

4.9

338.56

341.06

umol/l

0.16

613

1239

Degenerative diseases of the nervous system

688

1145

4.44

242.01

4.0

4.2

320.11

336.27

umol/l

1.78

575

972

Oedema, not elsewhere classified

564

1183

4.77

241.15

6.4

4.9

370.64

359.29

umol/l

0.82

508

994

Phobic anxiety disorders

366

545

7.01

233.99

6.3

6.2

377.47

379.96

umol/l

0.09

329

493

Headache

1008

2464

3.21

232.54

5.2

5.5

353.56

369.43

umol/l

2.42

885

2132

Mild mental retardation

206

148

17.16

231.78

6.8

5.9

410.93

376.75

umol/l

1.74

193

136

Schizotypal disorder

166

24.37

223.43

7.8

5.9

397.85

361.17

umol/l

1.57

146

Mental and behavioural disorders due to cannabinoids

229

211

12.90

220.35

7.7

5.6

380.97

367.99

umol/l

0.41

208

185

Other bacterial diseases

1608

4409

2.45

216.02

6.2

5.3

364.11

365.57

umol/l

0.14

1413

3876

Nonorganic sleeping disorders

567

1356

4.35

214.52

6.7

5.8

377.03

366.81

umol/l

0.86

509

1191

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

606

1298

4.23

212.06

6.1

6.3

372.49

386.63

umol/l

1.26

546

1159

Other bacterial diseases, including avohilmo

1697

4505

2.39

211.60

6.3

5.3

364.56

369.04

umol/l

0.55

1495

3960

Implicit viral Sepsis, including avohilmo

615

1588

3.98

207.96

5.4

4.8

355.55

356.67

umol/l

0.06

545

1348

Acute alcohol intoxication, ICD10

543

1299

4.36

205.64

6.8

5.6

365.85

363.39

umol/l

0.12

484

1147

Obsessive-compulsive disorder

244

266

9.80

204.44

6.4

6.0

381.86

387.48

umol/l

0.17

218

235

Open wound of head

1004

3320

2.90

203.19

5.8

5.4

365.46

362.46

umol/l

0.23

890

2898

Neurological diseases, wide definition

527

500

5.40

196.57

6.0

7.2

376.16

405.87

umol/l

3.26

472

432

Alcohol abuse, main dg

454

985

4.84

195.08

7.1

5.7

366.90

365.06

umol/l

0.08

409

872

Cerebrovascular diseases

1169

3042

2.71

194.18

4.2

5.5

346.57

360.72

umol/l

2.45

1017

2640

Unspecific neurodegenerative disorder

680

1255

3.79

192.69

3.7

4.2

325.83

332.06

umol/l

0.47

573

1071

Viral hepatitis, IBD co-morbidity

192

169

12.13

187.00

6.1

8.7

356.29

401.75

umol/l

2.69

168

151

Disorders of psychological development

404

758

5.22

184.12

6.1

6.0

393.97

381.31

umol/l

0.79

366

681

Fall on same level

1792

4363

2.22

181.60

5.9

5.5

365.43

370.33

umol/l

0.63

1583

3838

Bacterial pneumonia, not elsewhere classified

675

1758

3.45

179.68

6.4

4.8

372.90

354.35

umol/l

2.35

604

1501

Implicit viral Sepsis

454

1049

4.47

179.33

5.6

4.9

354.03

360.76

umol/l

0.40

406

902

Viral Sepsis

454

1051

4.47

178.88

5.6

4.9

354.03

360.71

umol/l

0.39

406

904

Medical observation and evaluation for suspected diseases and conditions

1014

1787

2.94

177.82

5.9

4.8

369.06

359.06

umol/l

1.11

879

1537

Bacterial infection, other or unspecified, including avohilmo

977

2940

2.77

176.78

6.3

4.9

356.90

355.86

umol/l

0.07

862

2545

Dizziness and giddiness

1100

3314

2.62

176.65

5.8

5.2

362.50

362.17

umol/l

0.02

972

2888

Bacterial pneumoniae

697

1883

3.32

175.02

6.4

4.8

372.32

354.78

umol/l

2.22

625

1616

Covid-19 confirmed case

713

2286

3.19

172.92

6.6

4.8

370.93

351.19

umol/l

2.85

642

1948

Non-invasive ventilation

311

435

6.28

172.25

5.5

3.6

361.87

368.45

umol/l

0.24

284

355

Other and unspecified mental retardation

147

19.29

172.18

6.4

5.3

445.93

384.90

umol/l

2.96

137

Other symptoms and signs involving the nervous and musculoskeletal systems

757

2531

3.06

171.01

5.0

5.5

368.65

361.83

umol/l

0.55

680

2201

Monoamine oxidase A inhibitors

230

292

8.18

169.84

6.1

5.3

368.18

360.45

umol/l

0.27

199

262

Bacterial infection, other or unspecified

893

2708

2.83

169.56

6.1

4.8

354.46

352.70

umol/l

0.13

782

2344

Early onset COPD, excluding more controls

401

878

4.71

169.10

6.6

5.1

359.83

363.03

umol/l

0.15

353

741

Alzheimer disease

551

1017

3.97

168.24

3.4

4.0

314.82

328.48

umol/l

1.22

455

856

Acute tubulo-interstitial nephritis

1016

3322

2.62

166.72

6.0

5.0

357.53

360.88

umol/l

0.29

900

2865

Stroke, including SAH

962

2572

2.73

163.68

4.0

5.4

345.50

353.73

umol/l

0.91

831

2226

Other symptoms and signs involving general sensations and perceptions

178

174

11.24

162.41

7.5

5.4

368.02

361.16

umol/l

0.20

159

151

Superficial injury of head

501

1338

3.85

161.98

5.9

5.3

368.91

366.07

umol/l

0.15

429

1168

Alzheimer disease, including avohilmo

588

1126

3.69

161.41

3.5

4.1

318.07

330.80

umol/l

1.17

490

956

Any death

977

2591

2.69

159.78

4.5

5.6

346.56

363.46

umol/l

2.60

857

2272

Pneumonitis due to solids and liquids

266

432

6.54

157.79

6.6

4.9

355.01

341.21

umol/l

0.71

238

381

Dissociative [conversion] disorders

152

123

13.46

156.67

6.8

5.9

376.62

382.41

umol/l

0.12

136

111

Recurrent or chronic depression

318

365

6.11

156.64

3.0

2.9

322.95

374.64

umol/l

5.00

259

304

Stroke, excluding SAH

905

2423

2.74

155.53

4.0

5.3

341.66

351.17

umol/l

1.09

783

2089

Heart failure, not strict

1123

3091

2.48

155.32

6.2

5.1

364.10

361.30

umol/l

0.26

1017

2659

Unspecified dementia

227

275

7.66

151.54

5.0

3.6

339.38

329.89

umol/l

0.35

191

225

Post-traumatic stress disorder

214

287

7.79

151.01

5.7

6.1

366.85

381.11

umol/l

0.54

192

254

Depression or dysthymia

469

582

4.44

149.71

3.3

2.7

333.51

357.50

umol/l

1.92

395

473

Other extrapyramidal and movement disorders in other diseases

483

1349

3.69

146.68

6.6

4.9

387.60

353.24

umol/l

5.32

442

1149

COPD (mode)

491

1027

3.81

146.47

6.4

4.7

351.25

349.64

umol/l

0.08

430

871

Other functional intestinal disorders

817

2780

2.72

146.13

6.6

5.0

372.84

364.77

umol/l

0.77

741

2400

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1552

3892

2.14

145.08

6.5

4.7

366.10

363.69

umol/l

0.24

1399

3390

Renal tubulo-interstitial diseases

1305

4351

2.23

145.07

6.1

5.2

357.89

364.19

umol/l

0.79

1159

3788

Mental and behavioural disorders due to use of other stimulants, including caffeine

169

183

10.54

144.28

7.4

6.1

385.28

381.09

umol/l

0.09

151

156

severe traumatic brain injury, does not include concussion

461

1267

3.75

143.45

5.0

4.9

348.35

346.37

umol/l

0.09

390

1085

Abnormal involuntary movements

329

705

4.87

143.36

7.0

5.2

376.06

356.62

umol/l

1.29

300

613

Other disorders of urethra and urinary system

1022

2920

2.47

141.65

6.2

4.9

371.24

360.06

umol/l

1.50

911

2524

Dementia in Alzheimer disease

296

460

5.52

141.50

3.2

3.5

313.03

323.56

umol/l

0.49

228

379

Examination and observation for other reasons

854

1773

2.76

138.34

5.5

4.8

358.04

359.86

umol/l

0.12

775

1527

Antihypertensive medication - note that there are other indications

970

1977

2.60

137.43

6.3

5.5

368.22

379.88

umol/l

1.35

859

1735

Other headache syndromes

543

1692

3.25

137.06

4.8

6.5

345.73

372.04

umol/l

3.81

473

1470

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

546

1697

3.26

136.95

6.5

5.7

385.51

373.47

umol/l

1.04

478

1498

Alzheimer’s disease, strict definition

421

873

3.98

134.87

3.2

4.0

307.35

325.77

umol/l

1.61

349

726

Vascular dementia

196

264

7.42

131.18

3.7

3.5

321.89

323.77

umol/l

0.05

163

221

Nontraumatic intracranial haemmorrhage

357

877

4.18

129.95

3.8

5.0

344.00

343.74

umol/l

0.01

302

755

COPD/asthma related infections

1352

3151

2.17

128.77

5.9

5.2

362.93

365.72

umol/l

0.27

1194

2760

COPD/asthma/ILD related infections

1352

3151

2.17

128.77

5.9

5.2

362.93

365.72

umol/l

0.27

1194

2760

Schizoid personality disorder

112

17.00

127.47

6.9

6.2

365.44

350.71

umol/l

0.33

102

Care involving use of rehabilitation procedures

1013

4025

2.30

126.58

5.5

370.41

364.95

umol/l

0.53

929

3502

Dementia in other diseases classified elsewhere

149

160

10.00

126.57

6.5

4.3

358.33

343.87

umol/l

0.45

125

141

Other CVD (FINNGEN)

268

374

5.68

126.07

5.8

5.2

361.48

360.63

umol/l

0.03

229

309

Pain, not elsewhere classified

409

1132

3.68

125.39

5.2

5.3

353.01

368.43

umol/l

1.01

366

967

Erysipelas, including avohilmo

1089

3632

2.25

124.78

6.2

5.2

358.51

363.27

umol/l

0.44

954

3177

Cerebrovascular diseases (FINNGEN)

559

1265

3.16

122.10

4.8

6.1

358.39

385.58

umol/l

3.78

506

1103

Erysipelas

854

3056

2.45

121.99

6.2

5.0

360.64

355.76

umol/l

0.38

747

2644

Mental and behavioural disorders due to opioids

173

236

8.07

121.80

5.9

6.3

356.26

379.93

umol/l

0.71

146

204

Codes for special purposes

867

3648

2.39

121.46

6.3

5.2

368.75

358.40

umol/l

1.26

776

3160

Provisional assignment of new diseases of uncertain etiology

866

3643

2.40

121.41

6.3

5.2

368.70

358.41

umol/l

1.25

775

3156

STROKE

854

2328

2.51

121.23

4.6

5.7

363.21

370.56

umol/l

0.70

758

2038

Symptoms and signs concerning food and fluid intake

206

338

6.29

119.84

5.8

5.0

379.17

355.08

umol/l

1.21

180

283

Symptoms and signs involving emotional state

138

145

10.52

119.77

7.5

6.0

370.31

371.83

umol/l

0.03

125

132

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

486

668

3.70

119.41

6.3

5.7

368.15

372.98

umol/l

0.25

437

583

Intentional self-harm by sharp object

137

144

10.72

119.30

6.9

6.4

374.33

367.74

umol/l

0.16

122

131

Hypothyroidism, strict autoimmune

1088

3242

2.23

118.61

6.8

5.0

378.07

359.55

umol/l

3.66

972

2828

Alzheimer’s disease (Late onset)

371

790

3.95

118.54

3.1

3.7

303.19

320.62

umol/l

1.36

305

651

Focal brain injury

139

150

9.65

116.91

5.2

6.8

357.63

372.36

umol/l

0.37

119

125

Bacterial pneumonia (organism specified)

713

2528

2.60

116.68

6.4

4.9

371.32

350.78

umol/l

3.13

639

2164

Hypothyroidism, strict autoimmune, 3 medication purchases required

1174

3734

2.14

116.09

6.6

4.9

376.74

358.03

umol/l

4.00

1049

3236

Other and unspecified myopathies

243

486

5.27

115.35

5.9

5.1

347.48

343.55

umol/l

0.15

214

433

Explicit Sepsis, including avohilmo

651

2222

2.70

115.15

5.8

5.0

361.11

355.67

umol/l

0.36

559

1907

Unspecified fall

834

3511

2.37

113.88

5.2

5.3

356.92

361.92

umol/l

0.44

718

3065

Intracerebral haemorrhage

250

516

5.01

113.67

3.7

4.7

336.08

332.23

umol/l

0.14

213

449

Persons encountering health services for specific procedures and health care

1562

4830

1.93

113.36

5.6

5.5

368.94

367.09

umol/l

0.17

1395

4222

Hypothyreosis and Thyroxine purchase for inclusion criteria

1270

4086

2.06

113.29

6.8

4.9

378.48

357.44

umol/l

5.27

1131

3540

Endocrine, nutritional and metabolic diseases

1125

2590

2.22

112.87

6.4

4.9

368.86

371.00

umol/l

0.17

1009

2254

Explicit Sepsis

635

2185

2.69

111.72

5.9

5.0

360.69

355.37

umol/l

0.34

543

1873

Falls/tendency to fall

1455

3689

1.99

111.60

5.7

5.5

363.82

371.03

umol/l

0.98

1283

3239

Exposure to unspecified factor

1490

5328

1.92

110.61

5.3

5.5

355.63

368.79

umol/l

2.52

1294

4695

Hypothyroidism, other/unspecified

1228

3957

2.06

110.30

6.8

5.0

378.52

357.06

umol/l

5.36

1092

3432

Somnolence, stupor and coma

143

175

8.76

109.71

8.2

5.5

388.07

358.97

umol/l

1.23

134

152

Parasetamol

1005

2234

2.30

109.69

5.7

5.5

357.93

376.85

umol/l

3.43

894

1955

Dental caries

425

1232

3.32

109.38

6.7

4.8

377.71

358.81

umol/l

1.81

380

1070

Other neurotic disorders

143

177

8.63

108.62

7.6

5.1

392.99

353.90

umol/l

1.93

133

154

Memory loss

188

313

6.27

108.41

4.0

4.9

320.86

345.67

umol/l

1.27

164

270

Hypothyroidism, drug reimbursement

149

105

10.07

107.98

7.0

2.8

386.23

394.03

umol/l

0.15

132

Ischaemic Stroke, excluding all haemorrhages

774

2352

2.46

107.92

4.0

5.2

338.33

348.61

umol/l

1.13

670

2021

Hypotension

330

880

3.86

107.40

5.3

4.2

353.86

337.25

umol/l

1.16

280

748

All kidney diseases

1386

4821

1.95

106.42

6.0

5.4

358.79

367.88

umol/l

1.44

1235

4221

Alcohol withdrawal state with delirium

210

399

5.61

106.00

6.8

5.8

360.11

356.70

umol/l

0.12

183

360

Migraine

604

1742

2.73

105.98

4.6

6.7

347.26

377.41

umol/l

4.98

527

1521

Behavioural syndromes associated with physiological disturbances and physical factors

1368

4809

1.95

105.15

6.0

5.4

366.36

367.41

umol/l

0.09

1216

4228

All influenza

433

1393

3.17

104.79

6.6

5.1

374.11

360.87

umol/l

1.01

384

1202

Paranoid personality disorder

15.76

103.25

6.8

6.2

387.84

358.08

umol/l

0.77

Lung diseases due to external agents

294

745

4.08

103.05

6.5

4.8

352.42

343.65

umol/l

0.44

264

641

Caries of dentine

383

1113

3.39

102.31

6.8

4.7

378.29

358.07

umol/l

1.84

342

959

Other septicaemia, including avohilmo

584

2087

2.67

102.04

6.0

4.6

360.66

348.84

umol/l

0.96

501

1780

Other problems related to primary support group, including family circumstances

281

673

4.23

101.84

6.6

6.0

391.43

385.60

umol/l

0.24

246

603

Early onset COPD

401

1257

3.28

101.76

6.6

5.0

359.83

355.89

umol/l

0.20

353

1078

Bronchitis

1516

4913

1.87

100.69

6.0

5.2

367.32

363.26

umol/l

0.47

1332

4303

Assault

344

993

3.60

100.05

7.0

6.1

377.01

374.32

umol/l

0.10

301

888

Undefined dementia

230

445

4.91

99.90

5.0

3.6

339.66

316.10

umol/l

1.44

194

368

Migraine without aura

299

783

3.89

99.52

4.3

6.7

342.50

385.69

umol/l

4.76

262

686

Dissocial personality disorder

101

13.19

99.21

9.5

5.9

407.40

362.85

umol/l

1.01

Other CVD

352

1035

3.49

98.88

5.2

4.4

351.52

339.65

umol/l

0.74

298

876

Other septicaemia

567

2043

2.66

98.48

6.0

4.6

359.99

347.70

umol/l

0.99

484

1745

Septicaemia

617

2245

2.54

97.26

5.9

4.6

361.69

348.94

umol/l

1.12

527

1920

Use of other anti-dementia drugs

409

1035

3.24

97.22

3.2

3.8

304.64

324.60

umol/l

1.95

333

864

Use of memantine

409

1035

3.24

97.22

3.2

3.8

304.64

324.60

umol/l

1.95

333

864

Emotional disorders and disorders of social functioning with onset specific to childhood

167

271

6.40

96.41

6.5

5.9

374.18

409.19

umol/l

1.95

152

243

Circumscribed brain atrophy

12.91

96.27

6.3

5.4

325.26

359.79

umol/l

1.08

Infections, IBD-co-morbidities

217

285

5.45

96.04

6.2

7.5

352.46

395.40

umol/l

3.38

199

250

Use of anticholinesterases

481

1284

2.94

95.92

3.3

4.0

317.84

328.42

umol/l

0.81

398

1080

N06DA Anticholinesterases

481

1284

2.94

95.92

3.3

4.0

317.84

328.42

umol/l

0.81

398

1080

Metabolic disorders

1313

4150

1.92

94.27

6.2

5.4

365.68

366.70

umol/l

0.09

1174

3639

252

615

4.21

92.78

6.3

5.1

366.08

367.83

umol/l

0.06

229

530

Diseases of the myoneural junction and muscle

268

687

4.05

92.66

5.9

5.1

347.68

351.44

umol/l

0.15

236

606

Other chronic obstructive pulmonary disease, including avohilmo

746

2697

2.30

92.52

6.2

4.7

351.86

349.04

umol/l

0.21

655

2316

Psychotic depression

15.40

92.38

3.7

3.9

328.23

349.00

umol/l

0.36

Cystitis

1068

3132

2.05

92.21

6.0

5.0

366.79

360.53

umol/l

0.68

939

2718

Chronic apical periodontitis

1518

4711

1.82

92.06

6.4

5.1

365.86

363.45

umol/l

0.25

1354

4094

Social phobias

186

361

5.33

90.90

6.2

368.39

386.08

umol/l

0.73

166

320

Other neurological diseases

964

3660

2.07

90.31

4.7

5.3

360.53

355.85

umol/l

0.44

847

3162

Bleeding

1135

4111

1.96

89.57

4.9

5.6

351.59

363.89

umol/l

1.98

994

3598

Speech disturbances, not elsewhere classified

213

474

4.69

88.87

4.5

5.3

360.07

348.19

umol/l

0.52

185

417

Conduct disorder

114

140

9.13

88.08

8.8

6.3

397.32

378.40

umol/l

0.59

109

132

Disturbance of activity and attention

297

823

3.63

87.77

4.6

6.5

362.04

390.32

umol/l

1.86

265

731

Other diseases of urinary system

1271

3788

1.90

87.74

5.7

5.2

367.46

361.88

umol/l

0.64

1106

3305

Volume depletion

206

450

4.74

87.71

6.7

4.6

354.79

337.56

umol/l

0.77

178

383

Intestinal infectious diseases

1326

5426

1.83

87.12

5.7

5.4

364.21

366.00

umol/l

0.17

1176

4753

Symptoms and signs involving the urinary system

1047

4031

1.98

86.87

6.1

5.2

357.97

361.01

umol/l

0.28

913

3516

Asthma, unspecified (mode)

688

2140

2.35

86.81

5.6

5.3

351.07

369.07

umol/l

2.46

618

1866

Asthma, unspecified (mode), excluding more controls

674

2060

2.37

86.61

5.6

5.4

352.25

370.09

umol/l

2.39

607

1796

Personality and behavioural disorders due to brain disease, damage and dysfunction

14.77

86.11

4.9

6.0

350.06

361.04

umol/l

0.18

Nausea and vomiting

446

1587

2.79

85.62

5.7

5.0

368.51

362.42

umol/l

0.38

394

1378

Continuous positive airway pressure

208

370

4.76

85.05

6.8

3.7

352.40

371.50

umol/l

0.84

182

301

Eating disorder

195

419

4.82

84.51

6.4

5.9

377.81

373.65

umol/l

0.11

163

366

Type 2 diabetes, wide definition

1063

3428

1.98

84.37

6.2

5.2

354.43

362.76

umol/l

1.09

957

2967

Disorders of the thyroid gland

1230

4300

1.87

83.95

6.6

5.0

379.03

356.61

umol/l

6.02

1085

3731

Diarrhoea and gastroenteritis of presumed infectious origin

1023

4741

1.95

83.51

5.8

5.4

363.30

365.79

umol/l

0.21

904

4144

Sleep disorders

1249

4687

1.85

83.50

5.9

5.5

366.62

367.82

umol/l

0.10

1108

4116

Other chronic obstructive pulmonary disease

609

2104

2.41

83.22

6.2

4.7

348.17

348.16

umol/l

0.00

534

1788

Asthma, excluding more controls

916

2245

2.11

82.74

5.3

5.4

352.60

372.05

umol/l

3.31

815

1965

Speech and linguistic disorders

256

657

3.91

82.59

5.9

6.0

381.09

393.71

umol/l

0.61

236

601

Hyperkinetic disorders

322

978

3.31

82.32

4.8

6.5

362.23

388.00

umol/l

1.80

288

873

Other acute lower respiratory infections

813

3742

2.10

82.27

6.1

5.3

370.08

362.13

umol/l

0.89

741

3241

COPD

627

2191

2.36

81.94

6.2

4.7

348.98

348.64

umol/l

0.02

552

1864

Behavioural disorders

114

153

8.36

81.84

8.9

6.2

396.68

374.93

umol/l

0.73

109

143

Asthma

935

2334

2.08

81.65

5.3

5.4

351.77

371.20

umol/l

3.39

831

2042

Chronic viral hepatitis

178

370

5.14

81.31

6.1

7.2

354.41

379.72

umol/l

1.30

157

328

External causes of morbidity and mortality

761

1697

2.27

80.81

5.8

5.0

361.38

372.75

umol/l

1.19

671

1479

Type 2 diabetes, strict (exclude DM1)

1272

4051

1.84

80.77

6.5

5.3

368.17

365.40

umol/l

0.28

1145

3518

Type 2 diabetes, definitions combined

1266

4040

1.84

79.88

6.5

5.3

368.32

365.62

umol/l

0.27

1139

3509

COPD, hospital admissions 3, with asthma pneumonia sepsis

414

1272

2.84

79.82

6.6

4.2

351.04

335.50

umol/l

1.39

367

1066

Type 2 diabetes, definitions combined, including avohilmo

1270

4033

1.84

79.65

6.5

5.2

367.80

365.18

umol/l

0.26

1138

3508

Traumatic subarachnoid haemorrhage

12.11

79.61

5.1

6.5

343.50

361.58

umol/l

0.34

Other external causes of accidental injury

973

2415

2.04

79.31

5.6

5.3

357.20

373.79

umol/l

2.74

853

2117

Other pulmonary diagnosis

957

2361

2.05

79.29

5.6

5.4

360.20

371.02

umol/l

1.38

849

2067

Infections of the skin and subcutaneous tissue

890

4441

2.00

79.28

6.1

5.5

364.17

369.50

umol/l

0.48

791

3905

Type 2 diabetes

1314

4236

1.81

78.84

6.5

5.3

365.45

365.08

umol/l

0.03

1183

3685

Persons encountering health services for examination and investigation

782

1788

2.21

78.56

5.8

4.8

367.19

358.89

umol/l

0.76

692

1538

Asthma-related pneumonia

554

2337

2.40

78.50

5.4

5.1

354.28

357.37

umol/l

0.19

494

2003

Asthma, hospital admissions 3, pneumonia

554

2339

2.40

78.34

5.4

5.1

354.28

357.34

umol/l

0.19

494

2005

Asthma-related pneumonia or sepsis

554

2339

2.40

78.34

5.4

5.1

354.28

357.34

umol/l

0.19

494

2005

COPD, early/later onset

611

2238

2.32

77.86

6.2

4.6

348.58

343.50

umol/l

0.37

536

1905

Other viral hepatitis

191

439

4.60

76.98

6.1

7.0

357.68

375.77

umol/l

0.85

167

390

COPD, hospital admission 2, with asthma infections

469

1576

2.61

76.71

6.6

4.4

353.63

339.81

umol/l

1.26

414

1332

Other (not insulin) diabetes medications

1292

4246

1.80

76.41

6.4

5.3

364.51

364.57

umol/l

0.01

1157

3693

Cutaneous abscess, furuncle and carbuncle

445

1727

2.63

76.27

6.2

5.6

362.33

367.83

umol/l

0.29

395

1514

Other eating disorders

134

227

6.19

76.09

6.8

6.2

362.64

373.63

umol/l

0.32

111

200

Eating disorders

216

545

4.09

76.07

6.4

5.8

374.75

373.27

umol/l

0.04

181

474

COPD related to multimorbidity

535

1890

2.43

75.33

6.1

4.4

342.61

339.55

umol/l

0.19

465

1604

Acute bronchitis

612

2694

2.26

75.32

6.1

5.2

367.06

358.24

umol/l

0.82

551

2322

Accidents

959

2415

2.01

75.21

5.7

5.3

360.19

373.79

umol/l

1.96

841

2117

Biguanides

1255

4236

1.80

75.10

6.2

5.3

363.19

364.00

umol/l

0.07

1118

3682

Injuries to the abdomen, lower back, lumbar spine and pelvis

607

2684

2.26

74.88

6.1

5.2

353.63

360.44

umol/l

0.54

537

2319

Dependent personality disorder

11.49

74.83

6.6

364.12

368.99

umol/l

0.08

Other viral hepatitis, including avohilmo

196

470

4.40

74.74

6.1

7.0

367.94

375.44

umol/l

0.20

172

420

Transport accidents

606

2233

2.28

74.38

5.4

5.3

352.58

373.79

umol/l

2.86

528

1959

Other sleep disorders

180

403

4.58

74.18

6.6

6.4

376.87

371.17

umol/l

0.18

164

342

Excluding asthma or asthma-COPD overlap

939

2361

2.01

73.99

5.4

361.03

371.02

umol/l

1.19

834

2067

Emotional disorders starting during childhood or adolescence

151

291

5.44

73.95

6.2

5.6

375.20

398.88

umol/l

1.06

138

259

Dental pulpitis, including avohilmo

1261

4567

1.78

73.66

6.6

5.5

365.07

372.44

umol/l

1.00

1140

4018

Toxic effects of substances chiefly nonmedicinal as to source

251

726

3.58

72.86

6.0

5.8

390.36

363.10

umol/l

1.43

210

648

1429

4197

1.74

72.62

5.8

5.2

360.31

364.57

umol/l

0.49

1258

3668

COPD, hospital admissions

593

2225

2.28

72.14

6.2

4.6

348.02

343.73

umol/l

0.30

520

1895

Certain infectious and parasitic diseases

1203

3324

1.83

71.81

5.8

5.3

364.61

368.16

umol/l

0.34

1060

2904

Persons encountering health services for specific procedures, not carried out

197

487

4.20

71.71

6.9

5.8

367.05

367.13

umol/l

0.00

170

421

Diffuse brain injury

102

9.16

71.70

4.8

7.2

337.22

368.78

umol/l

0.85

Alzheimer’s disease (Atypical or mixed)

177

396

4.53

71.57

3.2

3.4

312.56

320.04

umol/l

0.28

144

317

ILD differential diagnosis

930

2363

1.99

71.24

5.5

5.4

361.96

371.40

umol/l

1.08

826

2067

COPD differential diagnosis

929

2364

1.99

70.88

5.5

5.4

361.76

371.48

umol/l

1.13

825

2068

Migraine with aura

295

957

3.13

70.35

4.0

6.6

337.16

382.55

umol/l

5.52

258

830

Other nutritional deficiencies

914

4433

1.90

70.09

6.6

5.4

358.30

370.84

umol/l

1.82

812

3896

Parkinson's disease, including avohilmo

258

779

3.40

69.76

6.8

4.2

373.07

340.79

umol/l

2.96

237

665

Hydrocephalus

162

354

4.76

69.19

4.9

5.2

375.92

347.01

umol/l

1.45

146

311

Other special examinations and investigations of persons without complaint or reported diagnosis

746

1788

2.13

68.76

5.2

4.8

359.28

358.89

umol/l

0.02

646

1538

Diseases of pulp and periapical tissues, including avohilmo

1280

3783

1.76

68.61

6.0

4.9

359.73

364.70

umol/l

0.56

1129

3281

Viral hepatitis

195

502

4.07

67.49

6.1

6.7

357.64

373.48

umol/l

0.74

171

450

Habit and impulse disorders

9.88

67.47

7.1

6.3

395.80

376.79

umol/l

0.44

Asthma (mode)

882

2363

1.98

67.39

5.3

5.4

350.21

371.40

umol/l

3.77

781

2067

Visual disturbances and blindness

706

3511

2.03

66.62

4.9

5.3

360.42

360.19

umol/l

0.01

623

3053

Diabetes mellitus

1334

4539

1.71

66.01

6.4

5.3

364.98

367.67

umol/l

0.27

1200

3955

Diabetes, varying definitions

1329

4538

1.71

65.93

6.4

5.3

365.69

367.64

umol/l

0.19

1197

3955

Vascular dementia (undefined)

9.52

65.80

3.8

2.8

307.39

301.51

umol/l

0.11

Parkinson's disease

245

745

3.37

65.53

6.8

4.2

375.32

340.98

umol/l

3.12

224

637

Abnormalities of gait and mobility

211

583

3.73

65.51

5.7

4.9

386.05

346.14

umol/l

3.30

193

508

Insomnia

1186

4769

1.74

65.43

5.8

5.6

364.92

368.71

umol/l

0.37

1053

4190

Injuries to the thorax

657

3209

2.07

65.27

5.9

5.3

353.11

357.88

umol/l

0.36

580

2778

Viral hepatitis, including avohilmo

200

538

3.89

65.02

6.1

6.8

367.66

372.51

umol/l

0.13

176

481

Pain in limb

1154

4192

1.76

64.96

5.6

356.64

370.16

umol/l

2.13

1006

3707

Obesity

851

4274

1.89

64.75

6.7

5.5

356.98

370.94

umol/l

2.04

760

3752

Obesity and other hyperalimentation

853

4288

1.89

64.41

6.7

5.5

356.89

371.00

umol/l

2.08

762

3765

Injury, poisoning and certain other consequences of external causes

595

1322

2.28

63.92

5.7

5.0

362.71

375.14

umol/l

1.15

532

1150

Diabetes medication

1346

4688

1.69

63.91

6.3

5.3

363.01

366.82

umol/l

0.43

1204

4089

Supplementary factors related to causes of morbidity and mortality classified elsewhere

486

2142

2.31

63.00

5.8

5.5

375.62

362.13

umol/l

0.91

416

1866

Acute upper respiratory infections of multiple and unspecified sites

1030

4230

1.79

62.83

6.3

5.4

368.36

368.52

umol/l

0.01

905

3704

12.19

62.37

7.0

5.9

393.90

355.47

umol/l

0.96

Cerebral palsy and other paralytic syndromes

222

659

3.47

61.89

5.7

395.79

362.12

umol/l

2.44

206

579

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

180

464

4.01

61.88

6.6

5.5

384.71

364.13

umol/l

0.96

161

403

Poisoning by medicine, drug-induced

10.86

61.86

7.9

6.9

398.73

366.67

umol/l

0.90

Intentional self-harm by unspecified means

10.72

61.72

6.8

6.7

387.89

386.88

umol/l

0.02

Injuries to the hip and thigh

649

2870

2.05

61.64

4.7

5.1

340.51

353.08

umol/l

1.42

560

2474

Factors influencing health status and contact with health services

368

658

2.84

61.10

6.5

4.3

371.79

348.66

umol/l

2.14

329

563

Use of donepezil

285

935

2.96

60.96

3.3

3.8

310.04

323.60

umol/l

0.82

232

779

Mixed specific developmental disorders

132

7.39

60.69

6.4

5.8

435.03

411.08

umol/l

0.63

124

Previous suicide attempt

12.51

60.39

7.7

6.4

384.00

375.08

umol/l

0.14

Low back pain

1069

4144

1.76

60.06

5.5

5.6

355.63

368.79

umol/l

2.10

926

3640

Fracture of skull and facial bones

335

1274

2.68

59.93

6.1

5.7

368.03

364.85

umol/l

0.14

294

1122

Other soft tissue disorders, not elsewhere classified

1279

4353

1.68

59.71

5.7

5.6

356.03

370.62

umol/l

2.60

1111

3851

Periapical abscess

667

3388

1.99

59.65

6.8

5.7

378.06

367.85

umol/l

1.07

591

2982

Invasive ventilation

164

409

4.18

59.20

7.4

5.3

374.36

353.93

umol/l

0.63

142

363

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1300

5065

1.66

58.71

5.6

5.4

364.62

366.58

umol/l

0.17

1142

4443

Injuries to the ankle and foot

992

4855

1.76

58.70

5.7

367.72

372.75

umol/l

0.48

879

4291

Toxic effect of other and unspecified substances

10.82

58.69

5.6

6.4

369.81

365.94

umol/l

0.06

Agoraphobia

128

7.25

58.09

5.7

6.3

387.72

387.82

umol/l

0.00

115

119

232

5.28

57.79

6.8

4.3

381.87

346.99

umol/l

1.63

103

205

Fracture of rib(s), sternum and thoracic spine

441

1939

2.31

57.53

5.7

5.1

347.36

352.43

umol/l

0.30

385

1671

Visual disturbances

638

3234

2.00

57.35

4.8

5.3

354.47

361.84

umol/l

0.58

561

2813

Other and unspecified drugs and medicaments

172

455

3.91

57.10

6.8

5.7

386.74

362.96

umol/l

1.15

153

398

Asthma-related infections

812

4342

1.84

57.00

5.4

354.50

367.08

umol/l

1.70

718

3783

Asthma, hospital admission 2, infections

812

4342

1.84

57.00

5.4

354.50

367.08

umol/l

1.70

718

3783

Asthma (only as main-diagnosis)

795

2334

1.92

56.88

5.2

5.4

349.60

371.20

umol/l

3.61

700

2042

Unknown and unspecified causes of morbidity

121

244

5.11

56.74

7.1

5.6

382.12

361.46

umol/l

0.78

112

209

Pain in throat and chest

1093

3780

1.72

56.20

5.8

5.6

365.90

370.49

umol/l

0.45

972

3311

Alzheimer’s disease (Early onset)

103

182

5.89

56.04

3.5

4.9

323.32

342.49

umol/l

0.55

156

Personal history of risk-factors, not elsewhere classified

9.87

56.01

8.0

6.0

387.00

373.85

umol/l

0.23

Abnormalities of breathing

1138

3844

1.71

55.85

5.8

5.6

367.39

371.34

umol/l

0.37

1013

3372

Missing teeth due to accident, extraction or parodontitis

775

3750

1.86

55.80

6.2

5.1

359.47

358.60

umol/l

0.06

676

3262

Intestinal infectious diseases, including avohilmo, including avohilmo

1438

5017

1.61

55.77

5.6

5.4

360.70

366.56

umol/l

0.78

1269

4401

Urinary track infection

625

1504

2.10

55.45

6.1

5.1

373.01

377.55

umol/l

0.29

547

1318

Asthma (only as main-diagnosis), excluding more controls

774

2245

1.92

55.42

5.3

5.4

351.75

372.05

umol/l

3.16

681

1965

Specific development disorders of scholastic skills

127

267

4.91

55.38

5.3

6.0

371.79

377.05

umol/l

0.12

119

249

Mixed disorders of conduct and emotions

156

6.52

55.11

7.0

5.7

386.64

379.92

umol/l

0.15

141

Assault by bodily force

188

546

3.57

54.47

6.5

6.6

365.99

378.13

umol/l

0.51

166

485

Mental and behavioural disorders due to tobacco

168

453

3.83

54.25

6.9

5.8

361.84

365.16

umol/l

0.10

151

404

Somatoform disorder

218

694

3.20

54.03

4.7

5.3

351.99

367.10

umol/l

0.64

194

616

Fracture of lower leg, including ankle

743

3961

1.86

53.99

5.8

5.6

366.91

368.50

umol/l

0.10

658

3475

Poisoning by narcotics and psychodysleptics [hallucinogens]

8.80

53.85

6.2

6.3

388.45

366.28

umol/l

0.42

Diagnoses used for exclusion with ILD

365

1523

2.44

53.75

6.1

5.1

351.47

355.45

umol/l

0.20

329

1312

Retention of urine

453

1649

2.25

53.47

5.7

4.5

353.40

343.70

umol/l

0.72

391

1424

Specific development disorders of speech and language

152

371

4.12

53.25

6.4

5.9

393.38

386.56

umol/l

0.21

141

348

Implicit fungal Sepsis, including avohilmo

131

298

4.54

53.21

5.2

5.1

341.72

356.39

umol/l

0.48

114

266

Maltreatment syndromes

144

354

4.27

53.19

6.0

6.4

370.52

381.32

umol/l

0.30

129

314

Viral pneumonia

207

648

3.27

52.88

7.7

5.3

391.99

359.55

umol/l

2.39

181

560

Caries of dentine, including avohilmo

879

2484

1.82

52.61

5.9

4.5

357.31

359.29

umol/l

0.14

778

2119

Hypokalaemia

190

567

3.43

52.44

5.3

5.0

332.21

355.82

umol/l

1.37

165

489

Periodontitis

1241

4901

1.63

51.88

6.3

5.3

374.12

360.10

umol/l

2.83

1101

4300

Chronic periodontitis, including avohilmo

1238

4896

1.62

51.72

6.3

5.3

374.61

359.99

umol/l

3.04

1098

4295

Other and unspecified effects of external causes

411

1837

2.27

51.64

6.1

5.8

361.50

370.59

umol/l

0.57

358

1617

Dental caries, including avohilmo

810

2251

1.86

51.40

5.7

4.5

358.14

355.07

umol/l

0.22

714

1914

Fracture of lumbar spine and pelvis

319

1276

2.54

51.20

5.6

4.7

339.89

346.58

umol/l

0.36

275

1090

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1172

4252

1.65

50.89

6.0

5.3

354.93

367.34

umol/l

2.22

1048

3714

Fracture of femur

358

1358

2.41

50.57

4.5

4.6

339.91

340.25

umol/l

0.01

305

1149

Hypertension, essential

966

3173

1.73

50.23

5.8

5.9

355.33

374.54

umol/l

3.68

865

2774

Wide developmental disorders

115

248

4.90

50.06

6.3

5.8

393.91

382.77

umol/l

0.31

229

Hyperosmolality and hypernatraemia

10.64

50.03

9.1

4.9

379.17

353.90

umol/l

0.46

Malignant neoplasm of brain, including Hilmo

127

298

4.47

49.88

3.4

5.8

355.88

360.99

umol/l

0.14

119

265

Other diseases of intestines

1334

4700

1.59

49.85

6.0

5.4

363.43

370.25

umol/l

0.87

1187

4106

Sleep disorders (combined)

1304

4272

1.60

49.71

5.6

5.3

359.90

364.56

umol/l

0.51

1135

3754

Vascular dementia (subcortical)

8.21

49.70

3.6

3.4

310.32

321.92

umol/l

0.25

Disorders of thyroid, IBD co-morbidities

172

317

3.76

49.09

5.4

7.2

372.50

399.61

umol/l

1.40

142

274

Other and unspecified injuries of head

141

362

4.02

48.81

5.5

354.04

360.50

umol/l

0.19

126

320

Mycoses, including avohilmo

1161

5521

1.61

48.60

6.4

5.3

367.00

364.73

umol/l

0.20

1021

4851

Hypertensive diseases (excluding secondary)

683

2110

1.90

48.03

6.4

6.1

361.00

383.47

umol/l

3.56

617

1876

Sequelae of injuries of head

133

333

4.18

47.95

3.8

6.4

347.22

364.71

umol/l

0.59

111

304

Dysphagia

340

1449

2.38

47.77

5.2

4.9

355.97

355.22

umol/l

0.03

292

1247

Malignant neoplasm of brain

104

216

5.11

47.65

3.2

5.9

356.05

363.45

umol/l

0.19

193

Obesity, other/unspecified

449

2159

2.11

46.87

6.7

5.6

351.78

371.44

umol/l

1.95

404

1894

Type of accident

421

1977

2.16

46.83

5.5

5.4

372.94

361.88

umol/l

0.61

359

1721

Polyuria

309

1275

2.46

46.74

5.8

4.7

347.81

348.20

umol/l

0.02

258

1100

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1192

5072

1.59

46.70

5.7

5.4

361.49

365.88

umol/l

0.45

1046

4455

Normal-pressure hydrocephalus

104

219

4.97

46.67

5.0

4.0

380.42

336.56

umol/l

2.04

193

Lower back pain or/and sciatica

1314

5260

1.56

46.50

5.4

5.5

353.64

365.83

umol/l

2.21

1150

4606

Special screening examination for infectious and parasitic diseases

310

908

2.52

46.10

7.1

5.5

370.53

371.39

umol/l

0.03

270

793

Diseases of pulp and periapical tissues and dental caries

712

1972

1.87

45.99

5.8

4.6

355.79

355.84

umol/l

0.00

632

1680

Smoking dependency

168

507

3.42

45.82

6.9

6.0

361.84

362.48

umol/l

0.02

151

457

Cardiovascular diseases

810

2430

1.78

45.70

6.0

370.67

387.34

umol/l

2.03

727

2147

Transient ischemic attack

556

2287

1.95

45.47

4.4

5.1

352.67

349.25

umol/l

0.22

485

1963

608

3263

1.87

44.98

5.5

5.6

358.31

371.50

umol/l

1.45

536

2865

Use of rivastigmine

210

727

2.93

44.82

3.1

3.8

322.41

326.14

umol/l

0.14

177

597

Cardiovascular diseases (excluding rheumatic etc)

829

2737

1.75

44.38

6.2

6.0

368.96

386.22

umol/l

2.34

735

2423

Chronic lower respiratory diseases

1470

5135

1.52

43.99

5.8

5.4

357.93

370.19

umol/l

2.47

1307

4500

Necrosis of pulp, including avohilmo

762

4388

1.73

43.73

6.5

5.7

366.62

371.56

umol/l

0.42

685

3870

Anankastic personality disorder

166

5.47

43.70

5.0

6.3

362.06

372.47

umol/l

0.23

145

Aplastic and other anaemias

543

2609

1.92

43.43

5.3

4.6

348.58

346.85

umol/l

0.09

471

2234

Codeine

1135

3861

1.60

43.10

5.2

5.8

349.49

376.58

umol/l

7.68

995

3389

Obesity due to excess calories

600

3279

1.85

43.07

6.6

5.5

353.73

372.50

umol/l

2.42

534

2891

Amenorrhoea

123

314

4.03

42.92

6.1

5.9

371.59

378.91

umol/l

0.20

107

271

Other and unspecified anaemias

504

2440

1.96

42.74

5.4

4.5

348.92

344.84

umol/l

0.24

436

2080

Acute upper respiratory infections

1233

4781

1.55

42.51

5.9

5.2

358.02

363.97

umol/l

0.74

1090

4177

Abnormalities of heart beat

452

2186

2.03

42.46

5.3

357.83

359.65

umol/l

0.09

397

1884

Problems related to social environment

139

5.91

42.28

6.0

5.6

397.98

357.33

umol/l

1.74

124

Other anaemias

506

2458

1.95

42.10

5.4

4.5

349.54

345.02

umol/l

0.28

438

2096

Cerebral cysts

120

308

4.04

41.73

5.2

6.2

378.72

373.21

umol/l

0.16

105

276

Vocal cord dysfunction

114

239

4.24

41.70

5.6

3.7

343.89

365.46

umol/l

0.65

200

Fracture of shoulder and upper arm

478

2454

1.97

41.46

5.4

358.05

363.62

umol/l

0.35

429

2140

Aneurysms, operations, SAH

205

735

2.84

41.29

4.1

5.5

355.52

353.17

umol/l

0.07

174

642

Diabetes, insulin treatment (Kela reimbursement)

1214

4690

1.55

41.23

6.0

5.4

354.16

367.90

umol/l

2.73

1083

4104

Autism

157

5.53

41.20

6.9

6.4

400.94

366.19

umol/l

1.15

146

Follow-up examination after treatment for conditions other than malignant neoplasms

445

1446

2.07

41.04

6.1

4.9

359.34

357.68

umol/l

0.08

397

1237

Symptoms and signs involving the circulatory and respiratory systems

1198

3863

1.56

40.75

5.8

5.6

367.32

371.68

umol/l

0.46

1064

3388

Malignant neoplasm of eye, brain and central nervous system

109

267

4.27

40.54

3.2

5.8

350.77

358.67

umol/l

0.21

101

241

Event of undetermined intent

144

431

3.46

39.96

5.4

6.2

363.94

372.23

umol/l

0.17

126

386

Dipeptidyl peptidase 4 (DPP-4) inhibitors

629

2768

1.80

39.67

5.9

4.8

343.79

354.40

umol/l

1.11

559

2370

Hypertension

948

3296

1.63

39.65

5.9

5.8

357.05

375.29

umol/l

3.32

853

2888

Hypertensive diseases

948

3298

1.63

39.58

5.9

5.8

357.05

375.30

umol/l

3.33

853

2890

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

139

409

3.51

39.53

3.4

5.6

348.58

358.01

umol/l

0.32

130

362

Irregular menses

528

2108

1.90

39.26

6.3

5.6

375.04

381.30

umol/l

0.44

461

1873

Symptoms and signs involving the digestive system and abdomen

1206

3931

1.55

39.17

5.7

5.5

364.22

367.74

umol/l

0.34

1060

3445

Dental operations

658

1879

1.81

39.12

5.6

4.5

351.83

351.69

umol/l

0.01

574

1610

Certain infectious and parasitic diseases, including avohilmo

795

2340

1.71

38.76

5.6

5.2

362.86

369.27

umol/l

0.59

707

2043

Tramadol

944

3538

1.61

38.30

4.7

5.9

337.55

374.18

umol/l

11.85

808

3111

Acute renal failure

297

1317

2.29

38.23

5.8

4.6

333.13

348.13

umol/l

1.04

267

1124

Exclusions for E4_PCOS_CONSORTIUM

841

3195

1.65

37.84

6.1

5.6

368.30

373.19

umol/l

0.37

731

2836

COPD, hospital admissions 1, only main diagnosis

394

1665

2.06

37.76

5.8

4.5

346.29

338.64

umol/l

0.50

347

1408

Open wound of forearm

176

613

2.95

37.65

6.1

5.6

359.51

365.45

umol/l

0.21

154

543

Chronic periodontitis, complicated

668

3819

1.72

37.47

6.6

5.3

370.62

361.51

umol/l

0.97

593

3334

Symptoms and signs involving speech and voice

401

2019

2.01

37.04

4.5

5.2

349.14

361.50

umol/l

0.92

345

1740

Fracture of foot, except ankle

342

1627

2.13

36.93

6.0

5.8

368.05

368.30

umol/l

0.01

311

1428

Heart failure and antihypertensive medication

293

819

2.35

36.65

5.6

5.3

357.01

363.42

umol/l

0.32

270

699

Diseases of oral cavity, salivary glands and jaws

604

1723

1.82

36.31

5.7

4.4

352.94

350.92

umol/l

0.12

531

1472

Obesity related asthma

436

2277

1.94

36.22

5.9

5.7

352.96

368.64

umol/l

1.56

388

2002

Neuromuscular dysfunction of bladder

139

432

3.30

36.15

4.6

5.1

354.17

350.41

umol/l

0.10

116

376

Diseases of the respiratory system

670

1923

1.76

35.76

5.2

5.4

359.28

371.81

umol/l

1.35

593

1686

Migraine without aura and triptan purchases

241

1012

2.42

35.25

4.0

6.4

338.47

382.03

umol/l

4.20

210

887

Superficial injury of hip and thigh

209

821

2.59

35.24

4.5

5.1

329.78

353.16

umol/l

1.52

185

718

Injuries to the elbow and forearm

875

4759

1.59

35.22

5.3

5.6

358.98

370.14

umol/l

1.28

751

4211

Other/unspecified dorsalgia

475

2546

1.86

34.92

5.1

5.6

349.21

366.32

umol/l

1.84

414

2233

Injuries to the knee and lower leg

1397

5210

1.46

34.77

5.5

358.60

367.34

umol/l

1.35

1229

4571

Disorders of speech understanding and production

105

274

3.92

34.70

6.2

5.7

371.77

386.33

umol/l

0.46

257

Dorsalgia

1214

4317

1.50

34.61

5.1

5.6

351.29

370.29

umol/l

4.34

1054

3799

Opioids

1148

3932

1.52

34.42

5.2

5.8

348.78

376.55

umol/l

8.30

1004

3453

Gingivitis and periodontal diseases

1106

3760

1.53

34.33

6.1

5.1

370.27

357.19

umol/l

2.10

978

3259

Progressive vascular leukoencephalopathy

122

5.60

34.29

4.1

3.6

309.49

339.89

umol/l

0.86

107

Leisure time condition

259

1138

2.31

34.18

5.9

5.4

374.94

359.99

umol/l

0.87

216

1000

Strabismus

345

1691

2.06

34.16

5.4

5.6

387.12

369.02

umol/l

1.18

309

1487

Subarachnoid haemorrhage

139

447

3.17

34.14

3.9

5.6

364.09

345.74

umol/l

0.70

116

399

Pervasive developmental disorders excl. Autism + Asperger

7.10

34.04

6.4

6.3

405.27

410.91

umol/l

0.08

Paralytic ileus and intestinal obstruction

317

1510

2.12

34.03

6.2

4.7

352.61

355.83

umol/l

0.14

284

1281

Statin medication

831

2904

1.62

33.94

6.4

5.8

369.44

372.98

umol/l

0.28

752

2541

Complications of medical and surgical care

839

4797

1.58

33.64

5.6

5.3

349.61

363.03

umol/l

1.87

735

4197

Cluster headache, wide

139

5.21

33.61

3.1

7.1

316.56

384.10

umol/l

2.56

119

Candidiasis, including avohilmo

371

1883

1.99

33.56

6.2

5.5

357.94

363.74

umol/l

0.32

327

1642

Injuries to the wrist and hand

1197

5394

1.48

33.50

5.7

5.5

363.03

367.27

umol/l

0.44

1042

4762

All influenza (not pneumonia)

203

808

2.55

33.36

6.5

5.7

367.34

366.26

umol/l

0.03

172

703

Cellulitis

301

1420

2.15

33.31

5.7

5.5

363.11

364.84

umol/l

0.06

262

1239

Superficial injury of lower leg

340

1679

2.05

33.25

5.5

5.7

357.17

369.55

umol/l

0.86

296

1458

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

7.46

33.23

5.2

6.7

387.18

369.10

umol/l

0.26

Codeine or tramadol medication

1313

4909

1.46

33.15

5.2

5.6

346.31

369.41

umol/l

6.64

1149

4305

Disorders of other endocrine glands

530

2973

1.77

33.10

6.7

5.4

366.25

366.00

umol/l

0.01

464

2602

Other strabismus

292

1361

2.17

32.97

5.5

5.6

396.26

367.80

umol/l

2.03

265

1198

Heart failure,strict

535

2099

1.79

32.90

5.0

4.8

346.75

347.11

umol/l

0.02

474

1780

Acute alcohol intoxication ICD-9

131

5.33

32.81

6.9

4.8

358.09

347.92

umol/l

0.18

118

Other and unspecified degenerative diseases of nervous system

6.21

32.74

5.8

4.7

332.21

343.06

umol/l

0.18

Polycystic ovarian syndrome, consortium definition

714

2484

1.66

32.08

5.8

5.4

367.18

373.34

umol/l

0.48

610

2194

Anorexia (incl.atypical)

263

3.82

31.95

6.5

5.8

365.05

368.21

umol/l

0.07

228

Diplopia

183

709

2.63

31.88

5.4

367.37

357.83

umol/l

0.34

159

626

Visual field defects

133

435

3.14

31.86

4.2

5.5

352.45

352.09

umol/l

0.01

122

388

Abdominal and pelvic pain

1159

3929

1.49

31.78

5.7

5.5

365.59

367.74

umol/l

0.18

1018

3443

Intermittent heterotropia

116

350

3.42

31.72

5.9

5.6

408.12

376.78

umol/l

1.00

106

317

Later onset COPD, excluding more controls

195

577

2.61

31.64

5.5

3.9

330.25

332.59

umol/l

0.08

169

471

Autism spe

180

4.57

31.53

6.5

6.2

403.39

368.43

umol/l

1.16

164

Disorders of ocular muscles, binocular movement, accommodation and refraction

588

3478

1.69

31.16

5.8

5.7

391.45

369.03

umol/l

2.82

523

3072

Dermatophytosis, including avohilmo

794

4992

1.57

31.16

6.7

5.4

370.10

365.81

umol/l

0.36

706

4386

Cluster headache, strict

137

5.06

31.14

3.2

7.2

315.02

384.10

umol/l

2.54

119

Exclusions for E4_PCOS_BROAD

248

1113

2.26

31.11

7.1

5.5

371.12

371.18

umol/l

0.00

225

992

Sleep apnoea

1096

4678

1.49

31.06

5.8

5.5

362.31

365.82

umol/l

0.33

964

4129

Assault by blunt object

6.37

30.47

8.1

7.2

414.74

368.98

umol/l

0.57

Exposure to other specified factors

961

5539

1.50

29.94

5.5

5.6

353.24

370.76

umol/l

2.77

842

4885

Used for control exclusion in common control thyroid runs

1218

4253

1.45

29.43

6.0

5.2

366.42

365.22

umol/l

0.10

1059

3743

Disorders of lipoprotein metabolism and other lipidaemias

880

3497

1.54

29.34

5.7

5.3

356.34

364.24

umol/l

0.90

783

3046

Fall involving bed

145

4.81

29.19

5.5

4.4

384.81

344.17

umol/l

1.42

132

Cramp and spasm

267

3.69

29.16

6.6

6.0

373.55

357.69

umol/l

0.46

238

Inflammatory diseases of the central nervous system

137

480

2.93

29.11

5.1

5.9

350.67

362.65

umol/l

0.46

117

431

Other respiratory disorders and diseases

249

1154

2.19

28.90

6.6

4.6

358.00

345.69

umol/l

0.74

220

988

Other diseases of the respiratory system

249

1154

2.19

28.90

6.6

4.6

358.00

345.69

umol/l

0.74

220

988

Agranulocytosis

158

600

2.69

28.75

6.8

5.5

387.54

361.91

umol/l

1.20

143

537

Pure hypercholesterolaemia

788

3230

1.56

28.05

5.7

5.2

351.84

362.68

umol/l

1.31

703

2803

Unspecified acute lower respiratory infection

219

977

2.28

28.00

6.7

5.7

383.30

362.69

umol/l

1.54

205

853

Complications of surgical and medical care, not elsewhere classified

1116

5179

1.44

27.85

5.2

5.5

344.88

366.42

umol/l

4.87

972

4542

Other bacterial intestinal infections

228

1036

2.23

27.83

6.1

5.0

348.76

350.96

umol/l

0.08

205

891

Migraine with aura and triptan purchases

215

954

2.29

27.81

4.0

6.2

332.52

380.87

umol/l

4.75

184

830

Renal failure

520

2622

1.70

27.79

5.8

4.7

331.02

345.68

umol/l

1.52

460

2242

Bulimia nervosa (incl. atypical)

135

4.82

27.74

6.7

6.6

371.02

363.52

umol/l

0.09

118

Sleep disorders, other/unspecified

196

4.08

27.25

6.3

6.8

360.92

370.99

umol/l

0.21

177

Weight loss

147

554

2.71

27.19

5.2

363.25

353.89

umol/l

0.32

125

489

Other diseases of hard tissues of teeth

556

1702

1.70

27.00

5.8

4.4

358.75

351.63

umol/l

0.52

487

1459

Other general symptoms and signs

173

4.22

26.95

6.8

5.4

366.26

368.74

umol/l

0.04

153

Decubitus ulcer and pressure area

102

316

3.31

26.84

5.9

4.6

337.51

347.49

umol/l

0.27

279

Asthma (diagnoses ohter than nonallergic)

999

5573

1.46

26.76

5.3

5.5

350.82

367.84

umol/l

3.33

889

4874

Unspecified urinary incontinence

124

432

2.93

26.62

7.1

5.1

367.75

360.88

umol/l

0.20

104

382

Enterocolitis due to Clostridium difficile

144

547

2.68

26.20

5.5

5.0

345.97

344.72

umol/l

0.03

125

479

Fall on and from stairs and steps

316

1658

1.93

26.10

5.6

5.3

362.56

361.71

umol/l

0.04

274

1445

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

271

3.46

26.08

4.0

5.2

343.18

341.55

umol/l

0.04

243

Benign neoplasm of meninges

138

515

2.73

26.03

3.9

5.5

350.70

354.82

umol/l

0.15

131

456

Other or unspecified ileus, impaction or obstruction

226

1054

2.17

25.85

6.4

4.8

350.89

356.89

umol/l

0.24

206

895

Tubulo-interstitial nephritis, not specified as acute or chronic

100

313

3.27

25.84

5.4

4.4

354.40

348.73

umol/l

0.15

269

Superficial injury of abdomen, lower back and pelvis

212

965

2.23

25.84

6.4

5.3

362.93

363.33

umol/l

0.01

193

857

Other complications of surgical and medical care, not elsewhere classified

139

523

2.71

25.80

6.0

5.6

391.12

365.98

umol/l

0.87

122

459

Dyspnoea

988

4936

1.45

25.72

5.6

5.4

359.51

363.48

umol/l

0.37

871

4304

Encephalitis

161

4.35

25.70

5.5

6.0

339.39

366.86

umol/l

0.84

143

Sequelae of injuries, of poisoning and of other consequences of external causes

301

1569

1.94

25.40

4.9

5.9

343.92

366.86

umol/l

1.98

249

1380

Extreme obesity with alveolar hypoventilation

211

3.83

25.37

6.8

5.4

370.62

359.74

umol/l

0.27

190

Other encephalitis

150

4.47

25.37

5.5

6.3

331.14

371.65

umol/l

1.61

134

Benign neoplasm: Cerebral meninges

127

461

2.81

25.29

3.8

5.5

352.15

355.34

umol/l

0.10

122

410

Sleep apnoea, including avohilmo

1137

4871

1.42

25.28

5.9

5.5

363.42

365.99

umol/l

0.23

1008

4285

Bacterial intestinal infections, IBD co-morbidities

225

1058

2.16

25.26

6.0

5.1

345.29

352.94

umol/l

0.35

201

917

Non-ischemic cardiomyopathy

344

1470

1.87

25.13

5.3

4.7

355.00

344.20

umol/l

0.71

300

1246

Other bacterial intestinal infections, including avohilmo

274

1396

1.98

24.71

5.8

5.0

352.08

355.39

umol/l

0.14

244

1191

Genitourinary diseases

713

2300

1.56

24.68

5.8

5.7

366.19

376.77

umol/l

1.07

640

2027

Autoimmune diseases

1244

4550

1.39

24.23

5.9

5.3

364.32

365.70

umol/l

0.12

1084

4001

Undetermined asthma, excluding more controls

145

574

2.56

24.17

5.2

5.4

327.51

367.00

umol/l

3.04

126

482

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

109

367

2.99

24.00

6.1

394.93

409.17

umol/l

0.48

332

Injuries to the shoulder and upper arm

981

5314

1.43

23.96

5.2

5.5

359.07

364.19

umol/l

0.51

871

4658

Superficial injury of wrist and hand

272

1398

1.97

23.96

6.1

5.8

365.34

372.83

umol/l

0.35

238

1233

Undetermined asthma

145

579

2.53

23.74

5.2

5.4

327.51

366.99

umol/l

3.05

126

487

Venous thromboembolism

560

3416

1.59

23.38

5.8

5.0

347.90

354.37

umol/l

0.44

485

2945

Tobacco use

318

3.14

23.34

6.8

6.3

354.93

360.15

umol/l

0.12

283

Superficial injury of forearm

151

624

2.46

23.14

6.0

5.8

356.55

368.77

umol/l

0.44

127

557

Unspecified event, undetermined intent

157

4.21

23.10

5.4

6.5

356.07

378.98

umol/l

0.28

144

Asthma, including avohilmo

1329

5401

1.36

22.76

5.4

5.5

356.61

368.50

umol/l

2.11

1179

4728

Toxic effect of ethanol

252

3.41

22.74

5.7

6.3

391.63

367.03

umol/l

0.68

224

Pain (limb, back, neck, head abdominally)

805

2723

1.49

22.32

5.5

353.48

372.74

umol/l

3.13

710

2390

Special screening examination for other diseases and disorders

129

505

2.58

22.05

5.3

4.9

364.04

355.91

umol/l

0.24

114

430

5.42

21.96

7.4

5.7

418.72

386.86

umol/l

0.75

Subjective visual disturbances

281

1504

1.89

21.93

4.2

5.6

344.74

361.73

umol/l

1.12

246

1311

Glucagon-like peptide-1 (GLP-1) analogues

341

1937

1.78

21.90

6.4

5.5

357.27

372.11

umol/l

1.25

310

1687

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

341

1937

1.78

21.90

6.4

5.5

357.27

372.11

umol/l

1.25

310

1687

Intestinal stricture

332

1873

1.79

21.81

6.1

4.8

353.27

356.01

umol/l

0.13

298

1605

Hyperkinetic disorders (excl. ADHD)

144

4.27

21.80

5.9

6.8

378.96

413.31

umol/l

0.94

138

Other disorders starting during childhood or adolescence

106

376

2.87

21.75

6.2

5.5

396.00

398.90

umol/l

0.07

338

Visual impairment including blindness (binocular or monocular)

100

348

2.94

21.62

6.0

5.2

409.77

359.09

umol/l

2.28

308

COPD-related respiratory insufficiency

139

575

2.46

21.26

7.4

4.3

346.30

339.55

umol/l

0.21

122

485

Other symptoms and signs involving the urinary system

138

573

2.45

20.97

7.9

5.2

369.14

351.34

umol/l

0.86

130

497

Diseases of the digestive system

483

3019

1.60

20.86

5.2

5.1

353.77

352.24

umol/l

0.08

421

2601

Gastrointestinal diseases

665

2194

1.53

20.84

6.1

5.4

359.28

379.48

umol/l

2.83

591

1929

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

459

2824

1.62

20.72

5.6

6.0

369.77

375.76

umol/l

0.35

405

2491

Osteoporosis

260

1267

1.90

20.58

4.6

4.8

335.81

349.68

umol/l

0.83

221

1102

Open wound of lower leg

186

883

2.13

20.50

6.0

5.5

358.87

365.00

umol/l

0.22

159

775

Diseases of the skin and subcutaneous tissue

1093

3981

1.38

20.47

5.6

5.5

352.90

368.70

umol/l

2.99

964

3491

GASTRO-related operations

905

3190

1.43

20.45

5.4

5.7

355.97

380.14

umol/l

5.15

799

2832

Any gastric operation

905

3190

1.43

20.45

5.4

5.7

355.97

380.14

umol/l

5.15

799

2832

Viral and other specified intestinal infections

281

1503

1.84

20.32

5.5

5.9

371.93

371.42

umol/l

0.02

257

1337

Other and unspecified intracranial injuries

159

3.91

20.18

6.5

5.8

370.31

360.70

umol/l

0.16

143

Degeneration of the brain due to alcohol

100

4.81

20.07

5.5

5.8

334.50

356.16

umol/l

0.35

Blood alcohol or alcohol intoxication level

138

4.16

20.00

7.9

6.3

390.94

373.43

umol/l

0.35

124

Fungal Sepsis

183

3.65

19.96

5.5

4.8

341.02

351.76

umol/l

0.19

164

Fall on same level involving ice and snow

638

4312

1.49

19.91

5.7

5.5

361.93

364.03

umol/l

0.14

562

3772

Viral and other specified intestinal infections, including avohilmo

351

1989

1.71

19.75

5.7

5.8

372.63

372.33

umol/l

0.01

319

1764

Open wound of abdomen, lower back and pelvis

192

3.57

19.39

6.5

6.0

345.88

378.54

umol/l

1.02

173

Abnormal weight loss

124

509

2.48

19.38

4.8

5.2

353.75

351.86

umol/l

0.05

105

450

All-cause Heart Failure

563

2566

1.53

19.32

4.8

344.89

346.14

umol/l

0.07

496

2198

Other diseases of blood and blood-forming organs, wide

246

1320

1.88

19.16

6.7

5.3

382.71

359.20

umol/l

1.61

217

1145

Unspecified privation

147

654

2.29

19.14

6.0

5.7

345.35

360.58

umol/l

0.62

134

578

Diseases of salivary glands

351

2091

1.69

19.06

5.9

5.5

360.31

367.45

umol/l

0.35

305

1819

Mycoses

309

1778

1.75

19.06

5.5

5.3

347.25

360.98

umol/l

0.83

276

1539

Other heart diseases

521

2185

1.56

18.95

5.8

6.2

373.16

387.56

umol/l

1.43

464

1942

Hypoglycaemia, other or unspecified

109

427

2.61

18.86

5.5

5.6

351.79

365.13

umol/l

0.44

386

Respiratory insufficiency

280

3.00

18.84

6.1

4.7

348.85

340.42

umol/l

0.21

225

Oxycodone

413

2185

1.63

18.83

4.3

5.4

321.35

364.42

umol/l

7.71

354

1882

Osteopathies and chondropathies

590

3623

1.50

18.79

4.9

5.5

347.56

363.57

umol/l

1.89

513

3165

Other disorders of glucose regulation and pancreatic internal secretion

125

523

2.44

18.77

5.6

5.5

348.44

362.85

umol/l

0.53

110

471

Chromosomal abnormalities, not elsewhere classified

141

4.01

18.59

4.3

6.6

416.81

399.41

umol/l

0.33

131

Injuries to the neck

277

1557

1.80

18.56

4.8

5.8

349.95

364.50

umol/l

0.81

233

1362

Other diseases of lip and oral mucosa

446

2841

1.58

18.48

5.8

5.5

359.67

367.33

umol/l

0.47

393

2500

All chronic kidney diseases

536

2813

1.53

18.45

6.3

5.0

345.24

357.31

umol/l

1.15

468

2428

GI-bleeding

334

1981

1.70

18.43

4.9

4.8

345.81

343.72

umol/l

0.09

292

1692

Sequelae of external causes of morbidity and mortality

281

1591

1.78

18.37

5.6

5.1

352.43

358.04

umol/l

0.26

240

1373

Diseases of oesophagus, stomach and duodenum

1143

5046

1.34

18.35

5.3

5.6

350.84

368.01

umol/l

3.58

1011

4425

Congenital malformations of the nervous system

139

3.98

18.18

6.9

6.8

452.60

388.32

umol/l

1.72

128

Heart failure, strict

565

2610

1.51

18.18

4.9

344.97

346.33

umol/l

0.08

499

2240

Parkinson's disease, strict definition

151

694

2.20

18.14

6.2

4.2

369.96

341.47

umol/l

1.70

141

593

Irritable bowel syndrome

294

1693

1.75

18.10

5.2

5.4

338.79

369.45

umol/l

3.19

256

1477

Complications of procedures, not elsewhere classified

850

4938

1.39

18.09

5.1

5.5

339.53

365.81

umol/l

5.79

743

4327

Open wound of wrist and hand

524

3354

1.52

18.07

6.2

5.7

366.25

368.40

umol/l

0.11

446

2959

Abnormal findings on diagnostic imaging of central nervous system

280

2.97

17.85

4.0

6.2

366.44

366.69

umol/l

0.01

251

Implicit fungal Sepsis

169

3.58

17.70

5.6

4.8

350.33

348.84

umol/l

0.02

151

Divergent concomitant strabismus

107

429

2.54

17.65

5.8

6.0

384.88

366.30

umol/l

0.54

384

Degeneration of nervous system due to alcohol

111

4.33

17.65

5.5

334.50

356.75

umol/l

0.36

Hemiplegia

266

3.00

17.60

5.3

6.1

364.57

357.74

umol/l

0.13

238

Diseases of external ear

380

2361

1.62

17.54

5.6

5.3

364.29

362.81

umol/l

0.07

326

2051

Optic atrophy

4.60

17.30

4.7

6.1

431.20

365.84

umol/l

1.35

Other diseases of the digestive system

330

1986

1.67

17.29

5.0

4.7

343.87

344.64

umol/l

0.03

287

1698

Fracture at wrist and hand level

412

2611

1.59

17.27

5.7

5.8

360.64

370.73

umol/l

0.66

357

2303

Injuries involving multiple body regions

217

3.23

17.25

6.6

6.3

344.81

356.33

umol/l

0.27

198

Foreign body in alimentary tract

330

2.77

17.24

6.9

5.7

371.32

357.85

umol/l

0.37

299

Other maltreatment syndromes

223

3.21

17.21

6.9

6.5

378.64

374.03

umol/l

0.09

194

Other dorsopathies, not elsewhere classified

1111

4326

1.34

17.17

5.1

5.6

354.30

370.37

umol/l

3.18

960

3807

Viral encephalitis, not elsewhere classified/unspecified

106

4.34

16.93

4.8

6.0

367.50

370.73

umol/l

0.05

Other fall from one level to another

270

1549

1.76

16.89

5.7

5.5

365.63

366.21

umol/l

0.02

238

1346

Hard cardiovascular diseases

856

3666

1.39

16.85

5.0

5.9

359.77

370.88

umol/l

1.41

764

3249

Diseases of arteries, arterioles and capillaries (FINNGEN)

243

919

1.84

16.55

5.1

6.0

338.53

378.79

umol/l

2.73

215

792

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

661

4045

1.43

16.52

5.6

5.1

359.56

357.08

umol/l

0.17

578

3518

Paralytic ileus

192

3.32

16.51

6.5

5.0

371.62

357.85

umol/l

0.32

174

Pilonidal cyst

128

574

2.27

16.45

6.5

377.07

374.84

umol/l

0.06

115

516

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

109

4.21

16.33

4.8

6.1

367.50

371.49

umol/l

0.06

Optic atrophy, wide definition

101

4.36

16.23

4.7

6.2

431.20

367.98

umol/l

1.30

Use of levodopa decarboxylase inhibitor

146

693

2.13

16.22

5.3

4.2

372.23

339.86

umol/l

1.79

132

591

Cardiac arrhythmias

581

2544

1.47

16.15

5.2

5.8

365.57

379.28

umol/l

1.29

519

2238

DVT of lower extremities and pulmonary embolism

406

2601

1.56

16.15

5.8

4.9

345.36

352.05

umol/l

0.42

349

2234

Other viral diseases, not elsewhere classified

224

1230

1.84

16.13

5.6

5.7

383.48

374.08

umol/l

0.49

205

1088

Single delivery by forceps and vacuum extractor

829

0.28

16.02

4.0

6.4

345.06

387.37

umol/l

1.00

736

Injuries to unspecified part of trunk, limb or body region

133

613

2.20

15.97

6.4

5.6

363.69

364.36

umol/l

0.01

113

546

Superficial injury of thorax

180

929

1.96

15.89

5.8

5.3

363.19

362.98

umol/l

0.01

162

810

Other condition

180

932

1.96

15.76

5.3

5.6

377.29

364.44

umol/l

0.34

157

823

Myalgia

260

1508

1.74

15.70

6.3

5.9

354.59

374.24

umol/l

1.35

229

1324

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

437

1788

1.55

15.49

6.3

6.1

355.74

383.40

umol/l

2.90

390

1574

Hypothermia

4.31

15.29

6.5

6.0

352.63

362.81

umol/l

0.16

Stomatitis and related lesions

225

1263

1.80

15.26

6.5

5.5

356.82

364.58

umol/l

0.34

201

1103

Explicit bacterial Sepsis, including avohilmo

117

521

2.27

15.26

5.0

5.2

366.99

358.00

umol/l

0.28

106

450

Hyperfunction of pituitary gland

266

2.85

15.24

7.8

6.3

396.77

372.54

umol/l

0.79

235

Endovascular or surgical operations to intracerebral aneurysms

267

2.82

15.10

3.6

6.3

352.52

367.68

umol/l

0.33

241

Burns and corrosions

179

940

1.93

15.07

6.2

5.8

367.84

364.15

umol/l

0.13

171

842

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

148

3.15

15.00

5.2

7.1

334.50

394.31

umol/l

2.22

124

Open wound of ankle and foot

137

657

2.12

14.90

5.8

5.7

346.79

360.41

umol/l

0.56

119

581

Personal history of certain other diseases

4.20

14.86

8.0

5.7

352.49

356.16

umol/l

0.06

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

601

4169

1.42

14.85

5.3

5.2

336.83

361.73

umol/l

4.12

524

3637

Other diseases of pleura

435

2511

1.51

14.70

5.9

4.7

347.85

345.45

umol/l

0.13

386

2142

Elevated blood glucose level

113

505

2.28

14.69

5.6

5.7

371.88

356.25

umol/l

0.52

102

449

Restless leg syndrome

157

795

2.00

14.69

6.6

5.6

380.26

360.22

umol/l

1.10

145

705

Open wound of hip and thigh

193

3.15

14.42

5.3

6.5

346.86

376.09

umol/l

0.84

173

Suppurative and necrotic conditions of lower respiratory tract

309

2.65

14.36

7.8

5.4

388.58

353.43

umol/l

1.28

279

Nutritional anaemias

471

3054

1.48

14.35

5.0

4.8

347.14

352.53

umol/l

0.34

401

2624

Scabies, including avohilmo

186

1005

1.87

14.34

6.0

5.9

371.37

371.31

umol/l

0.00

161

886

Injury of other and unspecified intrathoracic organs

382

2.46

14.19

6.8

5.7

357.11

356.96

umol/l

0.00

341

Disorders of tooth development and eruption

163

680

1.97

14.15

6.9

4.9

378.62

368.91

umol/l

0.37

144

594

Cerebral aneurysm, nonruptured

389

2.43

14.07

4.0

5.9

358.20

363.24

umol/l

0.11

347

Attention to artificial openings

191

3.11

13.99

4.8

4.7

337.50

341.62

umol/l

0.07

167

Explicit bacterial Sepsis

112

509

2.23

13.95

5.0

5.2

367.78

357.22

umol/l

0.33

102

440

Iron deficiency anaemia

407

2655

1.51

13.95

5.1

4.9

348.89

354.63

umol/l

0.33

345

2274

Other and unspecified iron deficiency

329

2087

1.58

13.91

5.2

4.9

348.65

354.57

umol/l

0.31

283

1786

Fitting and adjustment of other devices

332

1858

1.58

13.78

5.2

4.6

363.20

345.64

umol/l

1.27

284

1566

Acute sinusitis

538

3452

1.42

13.41

5.9

5.6

359.66

372.40

umol/l

1.17

475

3041

Other and unspecified injuries of lower leg

423

2.33

13.39

6.4

5.8

349.57

377.22

umol/l

1.18

369

Disorders of refraction and accommodation

300

1878

1.60

13.35

6.1

5.8

407.18

371.45

umol/l

3.27

267

1662

Inflammatory disease of uterus

135

671

2.03

13.34

5.8

5.7

390.26

372.14

umol/l

0.61

112

579

Atrial fibrillation and flutter

301

1201

1.63

13.29

5.5

6.1

357.78

385.93

umol/l

3.07

273

1049

Benign neoplasm: Brain, supratentorial

4.47

13.28

5.1

5.5

374.71

380.48

umol/l

0.07

Hyperparathyroidism

171

912

1.87

13.25

6.8

4.7

363.62

345.77

umol/l

0.91

147

793

ILD medications: immunosuppressive drugs

361

4899

0.66

13.21

4.8

5.8

346.62

371.84

umol/l

3.06

311

4368

Asthma, hospital admissions , main diagnosis only

856

5663

1.32

13.18

5.2

5.5

349.34

369.60

umol/l

3.89

754

4965

Acute pharyngitis

187

1029

1.82

13.18

6.2

5.8

366.96

377.49

umol/l

0.49

170

916

Pulmonary heart disease

280

1737

1.62

13.15

5.9

4.9

350.57

350.22

umol/l

0.01

247

1485

Other degenerative diseases of the basal ganglia

4.31

13.10

5.2

5.0

374.66

357.05

umol/l

0.33

Superficial injury of shoulder and upper arm

144

739

1.97

13.04

5.5

5.7

378.76

364.91

umol/l

0.54

130

648

Pain associated with micturition

130

644

2.04

13.00

5.7

5.3

343.06

362.59

umol/l

0.74

113

568

Dermatitis and eczema

1186

5540

1.27

12.98

5.3

5.5

362.06

366.29

umol/l

0.44

1040

4869

Erosion of teeth , including avohilmo

297

1880

1.59

12.87

7.0

5.8

360.47

370.23

umol/l

0.54

268

1654

Pulmonary embolism

280

1747

1.61

12.86

5.9

4.8

350.57

349.89

umol/l

0.03

247

1493

Disorders of parathyroid gland

188

1044

1.79

12.76

7.0

4.8

360.54

346.58

umol/l

0.65

160

906

Drug-induced neutropenia

395

2.35

12.75

6.7

5.7

386.44

356.40

umol/l

1.08

347

Other disorders of eye and adnexa

157

836

1.90

12.73

6.2

5.5

379.31

368.37

umol/l

0.40

137

742

Candidiasis

150

787

1.93

12.72

6.3

5.5

344.55

360.84

umol/l

0.65

134

700

Fibromyalgia

102

465

2.22

12.67

5.0

6.1

358.76

380.45

umol/l

0.81

414

Insulin medication

594

3567

1.39

12.65

5.5

5.2

335.82

362.67

umol/l

4.70

526

3096

Other acute viral hepatitis

4.43

12.64

5.7

7.5

331.38

373.54

umol/l

0.73

Postpartum haemorrhage

1435

0.43

12.61

5.5

6.1

366.48

384.78

umol/l

0.55

1260

Inflammatory diseases of female pelvic organs

546

2655

1.41

12.57

5.5

374.00

371.56

umol/l

0.14

478

2335

Superficial injury of ankle and foot

149

784

1.92

12.55

5.6

5.9

367.61

373.00

umol/l

0.17

132

694

Single spontaneous delivery

175

1635

0.56

12.52

5.1

5.7

352.31

375.83

umol/l

1.43

149

1441

Assault by unspecified means

147

3.32

12.49

7.3

6.9

360.57

369.37

umol/l

0.17

136

Caries of enamel

1016

5183

1.29

12.47

6.5

5.5

375.27

367.70

umol/l

0.97

916

4567

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

551

3957

1.40

12.45

5.3

337.33

361.50

umol/l

3.62

480

3445

Single delivery by caesarean section

952

0.42

12.40

5.7

6.4

354.82

390.88

umol/l

1.49

848

Unspecified haematuria

392

2153

1.49

12.28

4.7

4.9

324.29

351.13

umol/l

3.22

333

1863

Burns and corrosions of external body surface, specified by site

142

742

1.94

12.25

5.9

366.97

365.38

umol/l

0.04

136

662

Premature rupture of membranes

1064

0.39

12.25

4.4

6.0

317.71

381.94

umol/l

2.92

935

Insulin, intermediate and long-acting

560

3922

1.38

12.01

5.5

5.3

336.53

360.51

umol/l

3.80

497

3398

Noninfectious colitis NAS

154

832

1.87

11.98

5.3

5.6

370.48

367.80

umol/l

0.08

139

733

Cluster headache, wide,, including avohilmo

326

2.44

11.95

3.6

6.4

329.04

369.69

umol/l

1.47

289

Dermatitis

626

4529

1.36

11.92

5.4

5.5

357.21

364.02

umol/l

0.53

549

3976

Atrial fibrillation and flutter with reimbursement

232

870

1.69

11.88

5.3

5.7

351.69

379.44

umol/l

2.22

209

745

Ulcer of lower limb, not elsewhere classified

152

820

1.87

11.87

5.5

5.0

330.97

352.22

umol/l

1.14

132

703

Streptococcal septicaemia, including avohilmo

439

2.21

11.87

5.0

4.6

362.50

348.71

umol/l

0.43

382

Disease of hard tissues of teeth, NOS

454

1636

1.46

11.84

5.7

4.5

363.14

353.15

umol/l

0.74

397

1402

Superficial injury of neck

107

3.67

11.84

6.2

7.0

334.52

379.59

umol/l

1.05

Reimbursement for rheumatic diseases

270

4163

0.64

11.83

4.1

5.5

353.66

364.90

umol/l

0.73

235

3657

Pediculosis, acariasis and other infestations, including avohilmo

200

1172

1.72

11.81

5.8

375.57

369.75

umol/l

0.18

175

1032

Cardiac arrest

258

2.50

11.80

4.2

5.1

345.81

356.95

umol/l

0.26

212

Toxic effect of alcohol

117

3.54

11.79

5.2

6.0

420.64

351.17

umol/l

1.57

106

Diaphragmatic hernia

332

2198

1.52

11.79

5.2

5.1

331.55

361.20

umol/l

3.57

296

1901

Other and unspecified injuries of wrist and hand

240

2.69

11.72

5.8

6.4

369.11

373.92

umol/l

0.10

216

Cluster headache, strict, including avohilmo

311

2.46

11.70

3.7

6.6

328.24

372.29

umol/l

1.58

275

Asthma/COPD (KELA code 203)

979

5123

1.28

11.69

5.2

5.4

357.18

369.84

umol/l

2.01

864

4488

Delivery

181

1640

0.58

11.68

5.1

5.7

356.11

375.68

umol/l

1.08

154

1445

Other and unspecified local infections of skin and subcutaneous tissue

114

563

2.05

11.57

6.6

6.0

372.19

363.88

umol/l

0.26

103

506

Chronic ulcer of skin, not elsewhere classified

369

2.31

11.48

5.1

5.2

363.01

352.86

umol/l

0.25

324

Second line medication for Crohn's disease

302

4541

0.66

11.46

4.8

5.7

349.92

369.55

umol/l

1.76

258

4011

Ill-defined and unknown causes of mortality

106

513

2.09

11.37

4.2

4.7

317.56

337.45

umol/l

0.79

452

Pain in joint

580

2597

1.38

11.34

5.1

5.6

351.20

373.19

umol/l

3.02

504

2286

Enlarged lymph nodes

115

574

2.02

11.28

6.2

5.0

355.79

367.54

umol/l

0.33

105

480

Congenital malformations, deformations and chromosomal abnormalities

619

4371

1.35

11.26

5.4

5.8

373.37

371.84

umol/l

0.10

555

3855

Other symptoms and signs involving the circulatory and respiratory systems

360

2.31

11.22

5.7

5.5

339.45

362.82

umol/l

0.78

312

Sciatica+with lumbago

527

3387

1.38

11.22

5.2

5.7

340.48

368.95

umol/l

4.77

467

2986

Malignant neoplasm of digestive organs

158

2109

0.57

11.15

4.0

5.0

325.70

349.67

umol/l

1.28

135

1819

Delivery, wide proxy

153

1435

0.56

11.01

5.1

5.7

352.26

373.86

umol/l

1.10

127

1264

Other disorders of optic [2nd] nerve and visual pathways

351

2.32

11.00

5.2

5.9

409.26

365.17

umol/l

1.64

313

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

674

4648

1.33

10.93

5.4

5.8

372.18

371.47

umol/l

0.04

599

4104

L04AX Other immunosuppressants

291

4358

0.66

10.83

4.9

5.7

350.92

369.03

umol/l

1.50

248

3840

Other local infections of skin and subcutaneous tissue

117

598

1.98

10.82

6.5

6.0

373.32

364.81

umol/l

0.27

106

532

Streptococcal septicaemia

425

2.17

10.72

5.0

4.6

363.26

347.32

umol/l

0.50

370

Pulmonary heart disease, diseases of pulmonary circulation

290

1907

1.53

10.68

5.9

4.8

350.80

349.71

umol/l

0.05

255

1627

Non-allergic asthma (mode)

154

856

1.79

10.59

4.3

5.2

363.53

366.19

umol/l

0.08

132

725

Other noninfective gastroenteritis and colitis

250

1596

1.58

10.51

5.5

5.3

364.48

367.41

umol/l

0.12

220

1389

Scabies

296

2.41

10.51

6.1

6.5

368.98

371.41

umol/l

0.04

268

Other heart diseases, wide

958

4583

1.27

10.50

5.3

5.9

363.52

373.13

umol/l

1.19

851

4035

Soft tissue disorders

1081

4424

1.25

10.49

5.4

5.6

353.10

371.50

umol/l

3.40

936

3917

Familial hypercholesterolemia

133

717

1.87

10.46

4.9

4.5

351.62

344.17

umol/l

0.25

112

603

Otitis externa

234

1476

1.60

10.41

5.7

5.5

361.40

365.27

umol/l

0.16

207

1287

Other medical care

433

2582

1.41

10.41

4.7

5.0

342.24

353.23

umol/l

0.80

377

2209

Unspecified kidney failure

106

531

2.02

10.38

6.5

4.3

352.59

340.92

umol/l

0.38

453

Car occupant injured in other and unspecified transport accidents

202

1231

1.65

10.36

5.3

5.9

339.91

366.24

umol/l

1.68

171

1087

Adverse effects, not elsewhere classified

197

1193

1.66

10.34

5.9

5.7

362.54

369.94

umol/l

0.31

168

1044

Supervision of normal pregnancy

885

0.45

10.32

5.3

6.5

357.65

388.49

umol/l

1.01

782

Other diseases of anus and rectum

282

1852

1.53

10.28

5.4

4.9

345.04

357.81

umol/l

0.76

243

1580

Non-allergic asthma (mode), excluding more controls

154

864

1.78

10.28

4.3

5.1

363.53

364.80

umol/l

0.04

132

729

Other viral diseases

314

2112

1.49

10.23

5.4

5.9

374.16

373.44

umol/l

0.03

284

1869

Other and unspecified injuries of ankle and foot

246

2.53

10.15

8.0

6.3

389.23

375.90

umol/l

0.26

222

Peripheral artery disease

378

2078

1.44

10.14

4.7

4.6

331.07

339.71

umol/l

0.45

325

1771

Other gastritis (incl. Duodenitis)

209

1292

1.63

10.12

4.9

5.0

321.94

358.36

umol/l

3.37

191

1115

Pyothorax

241

2.54

10.08

7.5

5.3

377.90

352.67

umol/l

0.65

222

Senile cataract

561

2525

1.36

10.01

5.5

5.2

356.23

360.49

umol/l

0.28

491

2191

Abnormal results of function studies

106

539

1.99

10.00

6.7

5.7

399.51

365.15

umol/l

1.51

476

Otalgia

471

2.06

9.99

5.6

5.8

366.98

371.21

umol/l

0.10

415

Antenatal screening

902

0.47

9.93

4.4

6.5

329.88

388.59

umol/l

3.13

795

Vitamin deficiency

261

2.46

9.90

7.2

5.5

355.00

359.84

umol/l

0.09

232

Vitamin deficiency, wide

261

2.46

9.90

7.2

5.5

355.00

359.84

umol/l

0.09

232

Perineal laceration during delivery

935

0.39

9.86

5.2

6.1

336.43

376.77

umol/l

1.13

810

Maternal care for known or suspected malpresentation of fetus

950

0.42

9.84

4.6

6.3

349.61

384.53

umol/l

1.06

831

Disorders of lens

622

2913

1.33

9.76

5.5

5.4

360.08

363.84

umol/l

0.25

542

2537

Disturbances of skin sensation

271

1794

1.52

9.74

5.0

5.8

360.84

369.32

umol/l

0.39

241

1573

Phlebitis and thrombophlebitis (not including DVT)

217

1370

1.60

9.66

6.5

5.4

355.49

364.39

umol/l

0.29

186

1184

Cholecystitis

134

744

1.82

9.63

5.5

4.8

342.26

348.94

umol/l

0.21

123

643

Viral infections of the central nervous system

439

2.08

9.56

4.5

5.9

344.55

369.89

umol/l

0.92

390

Corns and callosities

360

2.20

9.55

7.3

5.8

365.94

363.67

umol/l

0.05

317

Myopia

144

821

1.77

9.49

6.8

5.8

403.39

366.89

umol/l

2.30

129

721

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

320

2203

1.46

9.48

6.3

5.6

369.66

368.05

umol/l

0.07

281

1937

Viral infections of the central nervous system, including avohilmo

481

2.02

9.48

4.5

5.7

349.55

369.67

umol/l

0.70

422

Other viral diseases, not elsewhere classified, including avohilmo

286

1914

1.49

9.47

5.7

5.9

375.99

373.59

umol/l

0.11

263

1692

Gastric ulcer

162

955

1.71

9.46

4.5

4.8

352.68

349.49

umol/l

0.10

132

811

Toxic effect of carbon monoxide

3.60

9.44

5.2

6.1

374.65

352.79

umol/l

0.35

Malignant neoplasm of digestive organs, including Hilmo

193

2258

0.62

9.43

4.2

5.0

333.45

352.35

umol/l

1.03

167

1947

Haemorrhage from respiratory passages

315

1910

1.47

9.39

4.9

5.0

348.43

355.92

umol/l

0.42

275

1641

Mouth breathing

392

2803

1.40

9.34

5.6

368.42

369.68

umol/l

0.06

353

2464

Pedestrian injured in transport accident

430

2.08

9.31

6.8

6.0

369.05

364.38

umol/l

0.11

382

Hypertensive Heart Disease

202

949

1.62

9.31

4.1

4.7

325.91

347.23

umol/l

1.17

178

784

Use of galantamine

344

2.21

9.31

3.0

3.7

312.94

325.36

umol/l

0.32

291

Other disorders of skin and subcutaneous tissue, not elsewhere classified

140

797

1.77

9.28

5.4

5.3

348.55

358.22

umol/l

0.32

118

702

Fracture of forearm

530

3574

1.34

9.20

5.0

5.5

357.72

368.77

umol/l

0.98

448

3158

Faecal incontinence

425

2.07

9.18

5.3

4.9

331.05

362.06

umol/l

1.21

375

Other and unspecified dermatitis

500

3732

1.35

9.17

5.5

353.34

365.59

umol/l

1.03

436

3276

Heart failure and bmi 25plus

344

1593

1.45

9.17

5.3

5.6

345.54

353.11

umol/l

0.47

302

1373

Other ill-defined and unspecified causes of mortality

467

2.01

9.12

4.2

4.7

310.02

341.82

umol/l

1.50

416

Exposure to smoke, fire and flames

154

2.87

9.11

5.9

6.7

390.45

357.62

umol/l

0.73

138

Sequelae with surgical and medical care as external cause

194

1212

1.61

9.07

6.2

5.2

350.37

356.24

umol/l

0.23

167

1047

Other shoulder lesions

106

559

1.92

9.02

4.8

5.7

337.18

374.30

umol/l

1.65

489

Allergic asthma (mode), excluding more controls

200

1229

1.60

8.97

5.1

5.6

342.78

375.81

umol/l

2.34

172

1077

Postpartum hemorraghe, all women as controls

1484

0.49

8.96

5.5

5.9

366.48

379.79

umol/l

0.36

1296

Hypertensive heart and/or renal disease

219

1019

1.58

8.94

4.4

4.8

326.22

349.88

umol/l

1.48

195

847

Symptoms and signs involving the skin and subcutaneous tissue

699

5169

1.28

8.93

5.2

5.4

353.39

364.39

umol/l

1.20

619

4522

Allergic asthma (mode)

200

1232

1.59

8.89

5.1

5.7

342.78

376.68

umol/l

2.44

172

1079

Abscess of lung

3.89

8.87

9.7

5.3

414.33

344.75

umol/l

1.44

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

155

920

1.70

8.85

6.7

5.7

382.98

370.96

umol/l

0.46

136

800

Conjunctivitis (acute, non atopic)

286

1947

1.47

8.82

5.7

380.59

373.70

umol/l

0.38

250

1719

Hyperlipidaemia, other/unspecified

322

2022

1.44

8.71

4.7

4.8

347.05

348.60

umol/l

0.07

276

1720

Fracture of neck

342

2.17

8.66

3.7

5.5

356.03

352.47

umol/l

0.07

308

Dermatophytosis

143

838

1.72

8.61

4.8

5.4

348.68

356.27

umol/l

0.23

129

734

Astigmatism

369

2.11

8.58

6.3

5.5

412.66

369.88

umol/l

1.05

328

Car occupant injured in noncollision transport accident

231

2.43

8.47

5.2

6.5

361.76

366.37

umol/l

0.08

208

Complications of labour and delivery

295

2354

0.69

8.47

4.8

5.8

365.71

378.96

umol/l

0.91

255

2078

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

495

1.94

8.42

6.7

5.6

357.25

355.77

umol/l

0.04

438

Abnormal findings on examination of blood, without diagnosis

435

2913

1.36

8.39

5.1

348.59

352.72

umol/l

0.25

390

2505

Maternal care related to the fetus and amniotic cavity and possible delivery problems

196

1779

0.64

8.35

5.2

6.1

359.09

387.96

umol/l

2.02

172

1578

Pediculosis, acariasis and other infestations

381

2.08

8.32

5.9

6.1

382.24

367.78

umol/l

0.24

341

Labour and delivery complicated by fetal stress [distress]

1114

0.53

8.23

4.6

6.2

357.30

383.09

umol/l

0.91

972

Other disorders of skin and subcutaneous tissue

681

4528

1.27

8.22

5.5

5.2

346.78

360.33

umol/l

1.62

593

3955

Disorders of skin appendages

494

3724

1.32

8.22

5.7

362.30

370.66

umol/l

0.59

433

3291

Other and unspecified tonsillitis

359

2145

1.40

8.21

5.7

6.0

371.37

378.23

umol/l

0.37

325

1899

Other and unspecified visual disturbances

104

564

1.86

8.16

4.9

5.6

329.58

361.52

umol/l

1.57

499

Speech therapy

232

1549

1.51

8.11

5.7

5.2

354.85

359.31

umol/l

0.19

207

1341

Dorsopathies

1049

4361

1.22

8.05

5.2

5.6

358.33

371.22

umol/l

2.06

905

3842

Insulin, combination of fast acting with intermediate-acting or long-acting

594

4190

1.29

8.05

5.5

5.3

335.82

360.18

umol/l

4.05

526

3638

Obstructed labour due to malposition and malpresentation of fetus

1414

0.52

7.97

4.4

6.3

346.07

385.73

umol/l

1.86

1246

Hypothyroidism due to medicaments and other exogenous substances

4.08

7.97

6.5

5.1

370.00

360.02

umol/l

0.08

Heartburn

110

612

1.81

7.95

6.8

5.6

377.49

363.43

umol/l

0.50

101

543

Pedal cyclist injured in transport accident

227

1516

1.51

7.94

5.1

5.7

358.46

366.82

umol/l

0.39

201

1329

Presence of other devices

211

1364

1.53

7.94

4.7

4.4

360.67

336.41

umol/l

1.61

188

1156

Fentanyl

525

1.88

7.94

4.0

4.8

330.58

351.71

umol/l

0.70

437

Diseases of the eye and adnexa

842

3396

1.25

7.81

5.9

5.8

370.19

371.54

umol/l

0.09

734

3009

Persons encountering health services in circumstances related to reproduction

400

3602

0.74

7.80

5.2

6.2

374.71

382.38

umol/l

0.50

357

3222

Rheumatoid arthritis

135

1963

0.61

7.76

3.7

5.3

332.89

366.59

umol/l

2.03

109

1701

Other infectious diseases, including avohilmo

503

1.89

7.72

5.9

5.2

350.87

356.08

umol/l

0.13

444

Recurrent aphthous stomatitis , including avohilmo

141

849

1.67

7.72

5.9

5.5

355.30

364.17

umol/l

0.30

125

754

Ocular pain

491

1.89

7.63

5.7

5.8

347.33

365.98

umol/l

0.58

433

Dermatitis due to substances taken internally

300

2.16

7.63

5.8

5.6

368.74

365.52

umol/l

0.06

268

Acute suppurative otitis media

297

1959

1.42

7.62

6.3

6.1

385.62

375.71

umol/l

0.47

271

1753

Acute laryngitis and tracheitis

143

854

1.66

7.60

6.9

5.9

379.72

377.75

umol/l

0.05

129

762

Diseases of the ear and mastoid process

1171

4899

1.20

7.57

5.7

5.5

369.89

364.69

umol/l

0.54

1023

4321

Use of pramipexole

188

1220

1.55

7.55

5.8

5.1

342.63

354.63

umol/l

0.64

166

1053

Viral pneumonia (unknown virus, not influenza)

410

1.98

7.50

6.8

5.9

381.33

370.81

umol/l

0.26

362

Other disorders of penis

123

722

1.72

7.42

6.5

5.7

351.18

361.66

umol/l

0.31

104

635

Otitis externa, unspecified

120

700

1.73

7.42

6.6

5.8

359.20

364.07

umol/l

0.15

109

621

Contusion of other and unspecified parts of foot

317

2.11

7.40

5.5

6.1

379.16

370.10

umol/l

0.19

286

Cough

369

2538

1.36

7.40

5.0

5.4

354.12

368.68

umol/l

1.18

320

2214

Polyneuropathies and other disorders of the peripheral nervous system

196

1290

1.53

7.39

5.1

4.9

345.73

349.00

umol/l

0.12

172

1110

Triptan medication for migraine, min. 3 purchases

529

3055

1.30

7.39

4.6

6.1

343.94

380.44

umol/l

6.71

453

2721

Medical treatment for female infertility

1225

0.49

7.38

4.8

6.1

353.20

377.91

umol/l

0.51

1072

Amputation

518

1.85

7.36

4.5

4.6

323.57

336.81

umol/l

0.38

444

DVT of lower extremities

170

1086

1.58

7.33

5.6

5.1

337.85

357.04

umol/l

0.87

142

938

Benign neoplasm: Colon

471

3381

1.31

7.33

5.3

5.0

350.40

353.92

umol/l

0.22

411

2912

Oligomenorrhoea

161

2.59

7.30

6.2

5.8

364.23

382.23

umol/l

0.35

138

Childhood asthma (age<16)

137

643

1.68

7.28

5.0

6.3

357.28

381.62

umol/l

1.11

119

577

D07AA Corticosteroids, weak (group I)

161

1016

1.59

7.28

5.7

5.8

350.07

374.06

umol/l

1.35

142

901

Injury of intra-abdominal organs

150

2.66

7.27

8.0

6.4

349.03

369.40

umol/l

0.39

139

Other follicular disorders

457

1.90

7.26

5.7

6.2

343.49

371.87

umol/l

1.15

410

Other and unspecified polyneuropathies, also in other diseases

172

1105

1.57

7.25

4.9

344.12

346.40

umol/l

0.08

151

950

Pregnancy, childbirth and the puerperium

147

1224

0.62

7.18

5.0

5.6

346.42

370.88

umol/l

1.33

121

1078

Flat foot [pes planus] (acquired)

552

1.81

7.17

6.5

5.9

386.67

379.97

umol/l

0.18

487

Erythema intertrigo

134

2.75

7.15

5.0

5.3

362.23

361.62

umol/l

0.01

121

Heterophoria

446

1.90

7.11

5.5

5.7

387.23

367.70

umol/l

0.56

399

Complications of internal orthopaedic prosthetic devices, implants and grafts

184

1208

1.53

7.03

4.2

4.8

339.00

352.21

umol/l

0.63

155

1024

Mental and behavioural disorders due to cocaine

19.37

7.00

4.0

4.8

410.40

280.67

umol/l

—

Suppurative and unspecified otitis media

380

2513

1.34

6.99

5.9

388.28

371.68

umol/l

1.21

340

2224

Biological medication for rheuma

1252

0.51

6.99

4.1

5.9

353.33

372.52

umol/l

0.63

1105

Melanocytic naevi

129

2082

0.62

6.99

5.1

5.6

370.37

364.47

umol/l

0.18

114

1816

malignant neoplasm of male genital organs, including Hilmo

141

1350

0.62

6.98

3.4

5.1

324.37

346.12

umol/l

1.11

110

1162

Carpal tunnel syndrome

339

3955

0.74

6.92

4.2

5.6

346.12

365.25

umol/l

1.26

296

3459

Post-traumatic wound infection, not elsewhere classified

154

2.59

6.91

3.9

6.4

340.39

369.28

umol/l

0.44

141

Childhood asthma (age<16), excluding more controls

137

653

1.65

6.89

5.0

6.2

357.28

381.18

umol/l

1.08

119

585

Infections with a predominantly sexual mode of transmission, including avohilmo

400

2762

1.33

6.87

6.1

6.0

354.04

375.44

umol/l

2.08

348

2447

Nonalcoholic fatty liver disease

111

650

1.73

6.82

6.7

6.1

353.48

371.03

umol/l

0.60

579

Other disorders of bladder

100

568

1.77

6.81

5.2

4.7

344.77

350.19

umol/l

0.14

489

Primary hyperparathyroidism

561

1.78

6.81

7.7

5.4

382.74

354.67

umol/l

1.30

499

Chronic gastritis

221

1517

1.46

6.80

4.1

4.8

329.41

353.38

umol/l

1.74

184

1290

Maternal care for other known or suspected fetal problems

1062

0.58

6.79

4.0

6.2

336.95

384.97

umol/l

2.88

933

Other symptoms and signs involving the digestive system and abdomen

142

889

1.61

6.71

5.8

5.3

364.12

366.01

umol/l

0.05

115

795

Diseases of arteries, arterioles and capillaries

573

3323

1.27

6.69

4.7

5.0

337.87

352.49

umol/l

1.38

496

2863

Combinations of oral blood glucose lowering drugs

240

1680

1.44

6.67

6.0

4.9

352.26

356.15

umol/l

0.17

213

1438

Pruritus

101

580

1.76

6.64

4.7

5.2

345.89

361.13

umol/l

0.46

513

Tumor necrosis factor alpha inhibitors

1109

0.49

6.62

4.3

5.9

358.46

369.28

umol/l

0.27

986

Benign neoplasm of colon, rectum, anus and anal canal

552

3690

1.27

6.59

5.2

5.1

349.80

355.72

umol/l

0.46

478

3195

Prolonged pregnancy

901

0.48

6.58

5.4

6.1

385.79

382.55

umol/l

0.05

787

Trochanteric bursitis

126

771

1.65

6.55

5.1

5.7

348.48

372.30

umol/l

1.06

115

678

Anogenital herpesviral [herpes simplex] infection, including avohilmo

115

688

1.69

6.53

6.3

6.1

360.10

372.91

umol/l

0.40

103

597

Malnutrition

101

2.94

6.52

5.5

4.9

391.34

379.16

umol/l

0.14

Need for other prophylactic measures

389

1.93

6.52

7.8

5.9

354.97

360.51

umol/l

0.13

355

malignant neoplasm of male genital organs

139

1316

0.63

6.51

3.4

5.1

322.82

345.50

umol/l

1.21

108

1134

Infections with a predominantly sexual mode of transmission

293

2129

1.38

6.48

6.0

5.9

350.08

374.90

umol/l

2.03

257

1877

Malignant neoplasm of prostate, including Hilmo

130

1223

0.62

6.47

3.5

5.0

325.76

343.54

umol/l

0.78

103

1050

Acute posthaemorrhagic anaemia

159

2.49

6.47

4.5

4.4

339.87

350.44

umol/l

0.15

141

Other disturbances of cerebral status of newborn

15.67

6.45

6.1

4.3

450.00

475.50

umol/l

—

Artificial opening status

294

2.07

6.44

6.5

5.0

347.57

346.49

umol/l

0.02

265

Generalized skin eruption due to drugs and medicaments

203

2.30

6.41

4.9

5.8

380.27

367.63

umol/l

0.22

181

Gastro-oesophageal reflux disease

643

4380

1.24

6.39

4.9

5.5

347.79

365.44

umol/l

2.49

570

3843

Sulfasalazine

123

1962

0.62

6.38

3.7

5.8

336.51

367.38

umol/l

1.85

108

1726

Excessive, frequent and irregular menstruation

324

1264

1.37

6.35

5.4

365.49

377.84

umol/l

0.74

266

1100

Long labour

1377

0.59

6.32

4.8

6.1

356.31

384.62

umol/l

1.02

1204

Vitamin D deficiency

103

2.89

6.32

8.6

5.6

372.13

371.91

umol/l

0.00

Injury of eye and orbit

130

810

1.62

6.30

5.8

5.9

369.04

370.97

umol/l

0.04

108

717

Gastroduodenal ulcer

215

1491

1.44

6.21

4.7

4.6

348.85

345.08

umol/l

0.14

178

1253

Other viral diseases, including avohilmo

385

2912

1.31

6.20

5.5

5.9

368.42

375.22

umol/l

0.46

349

2584

Other spirochaetal diseases, including avohilmo

151

2288

0.66

6.19

4.6

5.5

365.71

364.75

umol/l

0.03

119

2009

Malignant neoplasm of prostate

128

1198

0.63

6.17

3.4

5.0

326.23

343.15

umol/l

0.73

101

1025

Coagulation defects, purpura and other haemorrhagic conditions

176

1180

1.50

6.16

5.8

5.2

387.65

359.06

umol/l

1.79

157

1027

Later onset COPD

211

1170

1.45

6.15

5.4

3.6

327.46

324.79

umol/l

0.11

184

972

Other blood glucose lowering drugs, excl. Insulins

127

792

1.61

6.15

5.6

4.5

342.27

346.81

umol/l

0.15

118

669

Disorders of mineral metabolism

404

1.87

6.12

6.1

5.3

341.49

354.20

umol/l

0.31

352

Seropositive rheumatoid arthritis

1497

0.58

6.10

3.3

5.2

330.61

363.77

umol/l

1.74

1306

Personal history of other diseases and conditions

106

631

1.68

6.05

4.5

5.5

358.43

383.99

umol/l

0.92

555

Other spirochaetal diseases

149

2249

0.66

6.01

4.7

5.5

365.73

364.52

umol/l

0.03

117

1974

Disorders of calcium metabolism

295

2.02

6.00

6.2

5.5

350.42

356.77

umol/l

0.12

259

Chondrocostal junction syndrome [Tietze]

203

2.25

5.99

7.3

5.9

366.74

364.84

umol/l

0.03

181

Osteoporosis with pathological fracture (FG)

344

1.94

5.97

4.5

4.6

334.63

356.74

umol/l

0.65

298

Spirochaetal infections, other/unspecified, including avohilmo

149

2245

0.66

5.96

4.7

5.5

364.85

364.79

umol/l

0.00

117

1970

Disorders of optic nerve and visual pathways

532

1.75

5.96

5.2

5.8

407.52

368.18

umol/l

1.56

471

Redundant prepuce, phimosis and paraphimosis

250

1774

1.40

5.94

6.1

6.0

359.19

367.15

umol/l

0.42

231

1579

Diseases of the musculoskeletal system and connective tissue

594

2385

1.25

5.93

5.8

5.9

359.20

382.51

umol/l

3.46

527

2129

Lyme disease

148

2230

0.66

5.93

4.6

5.5

364.58

364.54

umol/l

0.00

116

1956

Lyme disease, including avohilmo

148

2230

0.66

5.93

4.6

5.5

364.58

364.54

umol/l

0.00

116

1956

Colorectal adenocarcinoma

1232

0.55

5.90

4.5

4.6

345.75

344.01

umol/l

0.04

1041

Female infertility, cervical, vaginal, other or unspecified origin

1017

0.59

5.89

4.5

5.8

355.27

386.25

umol/l

1.15

892

Contusion of ankle

251

2.10

5.85

6.0

6.2

383.18

370.05

umol/l

0.25

225

Other coagulation defects

404

1.85

5.83

5.2

5.8

372.91

362.59

umol/l

0.24

356

Diseases of male genital organs

575

2318

1.25

5.78

5.5

5.8

361.99

367.23

umol/l

0.37

509

2051

Disorders of gallbladder, biliary tract and pancreas

911

4767

1.19

5.78

5.4

353.45

362.61

umol/l

1.14

809

4156

Acute generalized exanthematous pustulosis

239

2.12

5.77

4.7

6.0

371.45

368.30

umol/l

0.05

215

Acne, including avohilmo

226

1296

1.42

5.77

5.9

375.00

377.33

umol/l

0.09

185

1155

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

288

2135

1.36

5.76

5.3

5.8

353.51

364.90

umol/l

0.72

256

1877

Other/unspecified seropositive rheumatoid arthritis

1456

0.59

5.76

3.3

5.3

331.81

358.48

umol/l

1.21

1260

Seropositive rheumatoid arthritis, wide

1481

0.59

5.76

3.3

5.3

330.61

358.99

umol/l

1.37

1283

Ulcer of oesophagus

335

1.93

5.74

5.3

4.9

356.63

341.92

umol/l

0.35

287

Hirsutism in women

2.89

5.72

6.3

7.1

431.24

391.18

umol/l

0.25

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

554

1.71

5.71

5.7

5.5

320.15

355.39

umol/l

1.51

493

Maternal care for known or suspected abnormality of pelvic organs

110

1188

0.62

5.70

4.3

6.1

333.74

384.06

umol/l

2.93

1044

Effects of foreign body entering through natural orifice

244

1767

1.39

5.68

6.2

5.8

363.33

365.72

umol/l

0.10

213

1569

Urticaria and erythema

326

2468

1.33

5.65

5.1

5.7

339.17

372.80

umol/l

3.61

286

2166

Striking against or struck by other objects

351

2682

1.31

5.64

5.6

5.8

359.20

371.03

umol/l

0.75

299

2378

Pacemaker

284

1958

1.35

5.60

3.4

4.5

326.13

336.31

umol/l

0.58

242

1644

Pain in thoracic spine

139

908

1.54

5.55

4.3

6.0

332.42

374.14

umol/l

2.98

124

803

Pain and other conditions associated with female genital organs and menstrual cycle

178

1018

1.47

5.53

5.4

5.7

357.75

387.99

umol/l

1.84

157

891

Abnormal findings on diagnostic imaging of lung

402

2973

1.28

5.50

5.6

4.9

350.49

351.44

umol/l

0.05

348

2559

Seborrhoeic dermatitis

583

1.68

5.50

6.3

5.6

372.71

360.38

umol/l

0.35

514

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1436

0.60

5.48

3.3

5.3

331.81

358.28

umol/l

1.19

1243

Rheumatoid arthritis, including avohilmo

162

2357

0.68

5.45

3.9

5.3

333.63

361.74

umol/l

1.79

131

2047

Early complications of trauma

279

2.00

5.44

4.3

6.2

351.86

368.35

umol/l

0.30

254

!Aliquae complicationes praecoces traumatis

279

2.00

5.44

4.3

6.2

351.86

368.35

umol/l

0.30

254

Other infective otitis externa

342

1.89

5.42

5.9

6.1

347.63

362.74

umol/l

0.41

308

Oesophagitis

286

1.98

5.42

4.7

5.5

357.17

353.97

umol/l

0.05

253

Sulfonylureas

253

1469

1.37

5.39

4.6

4.0

331.55

334.67

umol/l

0.13

225

1216

Infective dermatitis

102

626

1.64

5.34

5.5

387.08

358.74

umol/l

1.31

548

Other congenital malformations

527

1.70

5.33

5.0

6.0

400.25

381.01

umol/l

0.58

476

Conduction disorders

250

1464

1.37

5.33

4.4

4.9

339.67

348.90

umol/l

0.46

209

1233

Pustular psoriasis

247

2.05

5.32

6.6

6.2

390.90

363.21

umol/l

0.63

227

Cervicalgia

181

1260

1.44

5.30

5.2

5.7

341.06

370.40

umol/l

1.89

158

1093

Artificial joint operation, meniscal resection

606

4711

0.82

5.28

4.6

5.5

340.91

362.47

umol/l

3.60

503

4141

Leiomyoma of uterus

316

2325

0.76

5.26

5.6

365.23

373.82

umol/l

0.50

276

2059

Misadventures to patients during surgical and medical care

119

761

1.57

5.25

5.2

345.92

364.55

umol/l

0.76

104

658

Coxarthrosis, primary, with hip surgery

218

2774

0.73

5.21

3.9

4.8

321.98

349.65

umol/l

2.44

188

2387

Soft tissue disorders related to use, overuse and pressure

242

1778

1.37

5.18

5.2

5.6

355.58

368.29

umol/l

0.71

210

1562

Persons with potential health hazards related to communicable diseases

367

2838

1.29

5.12

6.8

5.9

373.18

376.26

umol/l

0.16

327

2510

Hypertrichosis

110

2.59

5.08

6.3

7.0

429.83

385.06

umol/l

0.32

L04AA Selective immunosuppressants

1443

0.61

5.07

4.2

5.7

322.98

366.78

umol/l

2.52

1273

Diseases of liver

307

2345

1.31

5.06

5.2

5.5

349.68

362.63

umol/l

0.82

264

2052

Pedal cyclist injured in other and unspecified transport accidents

117

753

1.57

5.06

5.3

5.8

368.85

365.92

umol/l

0.08

102

668

Solid cancers

580

4134

0.82

5.04

4.9

5.7

356.67

367.16

umol/l

1.05

508

3644

Malignant neoplasm

600

4258

0.82

5.03

4.9

5.8

357.00

368.16

umol/l

1.16

524

3758

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

212

2.11

5.03

4.5

6.6

356.83

368.22

umol/l

0.20

192

Other infectious diseases

417

1.77

5.01

6.1

5.3

350.12

349.68

umol/l

0.01

370

Oral leukoplakia, including avohilmo

154

2.32

5.00

5.7

6.1

378.45

365.02

umol/l

0.25

137

Pustulosis palmaris et plantaris

226

2.06

4.99

6.5

6.3

389.83

368.63

umol/l

0.41

207

Other embolism and thrombosis

107

677

1.59

4.97

5.8

5.3

337.57

361.79

umol/l

1.06

599

Lifestyle-related condition

3.21

4.97

5.2

6.3

443.26

345.55

umol/l

0.50

AV-block

148

854

1.49

4.97

4.0

4.5

324.93

332.58

umol/l

0.29

121

710

Female infertility

112

1037

0.64

4.95

4.6

5.7

356.79

386.34

umol/l

1.25

103

909

Other and unspecified injuries of shoulder and upper arm

187

2.17

4.94

6.2

6.3

368.89

367.81

umol/l

0.01

170

Cholelithiasis, broad definition with cholecystitis

765

4285

1.19

4.94

5.2

5.3

349.98

360.71

umol/l

1.28

676

3723

Conjunctivitis (acute, non atopic), including avohilmo

1000

5190

1.17

4.92

5.5

362.62

367.43

umol/l

0.50

882

4568

Other menopausal disorders

111

957

0.64

4.91

5.1

5.8

367.02

384.23

umol/l

0.64

104

841

Malignant neoplasm of breast

197

1760

0.72

4.88

5.3

5.7

373.32

375.58

umol/l

0.08

170

1557

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1139

0.58

4.85

4.7

4.9

336.45

349.62

umol/l

0.34

970

Malignant neoplasm of breast, HER2-negative

197

1758

0.72

4.84

5.3

5.7

373.32

375.46

umol/l

0.07

170

1555

Idiopathic gout

505

1.68

4.81

6.1

4.9

338.92

342.67

umol/l

0.09

439

Neuralgia and neuritis, unspecified

285

1.92

4.80

5.4

6.1

329.00

364.31

umol/l

1.07

252

Excessive earwax

575

4302

1.21

4.79

5.3

371.44

359.00

umol/l

1.27

511

3738

Injury of unspecified body region

438

1.73

4.78

5.8

5.5

364.20

362.10

umol/l

0.02

391

Other and unspecified psoriasis

394

1.77

4.77

5.4

6.0

347.62

359.87

umol/l

0.28

358

Alcohol-induced chronic pancreatitis

402

1.76

4.75

6.2

5.8

358.62

360.03

umol/l

0.03

363

Malignant neoplasm

605

4264

0.83

4.75

4.9

5.8

357.20

368.34

umol/l

1.16

529

3765

Colorectal cancer

1443

0.64

4.73

4.1

4.7

335.04

345.46

umol/l

0.32

1218

Examination and encounter for administrative purposes

336

1.83

4.73

5.4

4.3

329.84

336.04

umol/l

0.13

289

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

588

0.42

4.72

4.3

4.8

344.07

346.17

umol/l

0.02

504

Inflammatory disorders of breast

301

1.88

4.70

6.3

6.1

374.89

370.71

umol/l

0.07

263

Lesion of ulnar nerve

129

863

1.50

4.69

5.2

5.7

368.15

362.79

umol/l

0.17

116

741

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

932

5059

1.17

4.68

5.5

5.6

363.13

367.45

umol/l

0.39

812

4456

Chronic kidney disease

259

1880

1.33

4.67

5.5

4.3

317.45

339.56

umol/l

1.76

224

1591

Acute pancreatitis

171

1209

1.42

4.66

5.6

5.2

352.69

356.33

umol/l

0.11

152

1048

Acne vulgaris

555

1.63

4.65

5.2

6.2

376.59

378.15

umol/l

0.04

495

Colorectal cancer, including Hilmo

115

1608

0.66

4.61

3.9

4.7

336.00

344.22

umol/l

0.27

1364

Contact with sharp object, undetermined intent

147

2.29

4.61

6.2

6.6

332.89

374.33

umol/l

0.82

129

Thyrotoxicosis, other and/or unspecified

148

1021

1.46

4.61

5.6

5.1

373.40

360.57

umol/l

0.56

123

900

Fissure and fistula of anal and rectal regions

207

1515

1.37

4.60

4.6

5.4

359.78

367.92

umol/l

0.40

179

1315

Supervision of high-risk pregnancy

875

0.63

4.59

5.2

6.5

358.17

388.97

umol/l

1.12

775

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

115

751

1.53

4.57

5.8

5.9

380.08

382.16

umol/l

0.05

104

672

Paracetamol or NSAID medication

178

629

1.43

4.56

5.8

6.2

366.92

397.41

umol/l

2.02

160

573

Postmenopausal osteoporosis with pathological fracture

269

1.91

4.55

4.7

4.6

344.83

351.57

umol/l

0.14

234

Atherosclerosis, excluding cerebral and coronary sclerosis

310

1884

1.30

4.54

4.7

4.4

322.54

336.13

umol/l

0.93

265

1591

Orchitis and epididymitis

101

647

1.57

4.51

5.9

5.4

372.77

355.43

umol/l

0.62

563

Retinal breaks without detachment

937

0.55

4.50

4.8

5.5

369.95

356.68

umol/l

0.34

817

Hypopituitarism

546

1.63

4.50

6.0

6.1

378.31

379.83

umol/l

0.03

494

Burn and corrosion of hip and lower limb, except ankle and foot

136

2.32

4.49

5.7

6.2

346.84

377.57

umol/l

0.47

119

Malignant neoplasm of breast, including Hilmo

205

1782

0.73

4.48

5.3

5.7

373.58

375.58

umol/l

0.07

177

1576

Malignant neoplasm of breast, HER2-negative, including Hilmo

205

1782

0.73

4.48

5.3

5.7

373.58

375.58

umol/l

0.07

177

1576

Contact with sharp glass

271

1.91

4.48

5.6

6.5

335.49

378.59

umol/l

1.27

239

Other disorders of the musculoskeletal system and connective tissue

122

816

1.50

4.46

5.4

5.5

345.08

358.31

umol/l

0.45

107

720

Other disorders of kidney and ureter

109

712

1.54

4.46

5.9

5.1

356.28

350.97

umol/l

0.14

624

Other disorders of lacrimal gland

306

2381

1.29

4.45

5.0

5.5

358.56

367.38

umol/l

0.39

269

2072

Disorder of lipoprotein metabolism, unspecified

100

641

1.57

4.44

5.4

4.7

343.98

345.90

umol/l

0.05

545

Postpartum care and examination

646

0.57

4.42

4.3

6.6

381.38

386.96

umol/l

0.10

569

Amputation of thigh

118

2.40

4.41

5.2

4.4

317.95

342.99

umol/l

0.36

105

Adenocarcinoma and papilloma adenocarcinoma of rectum

571

0.43

4.41

4.3

4.7

344.07

346.17

umol/l

0.02

493

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

256

0.27

4.29

8.0

6.5

382.29

359.05

umol/l

—

235

Excessive attrition of teeth

569

4705

1.20

4.29

6.4

5.6

368.42

369.78

umol/l

0.08

507

4146

Acute gastritis

393

1.72

4.25

4.7

5.4

342.85

354.61

umol/l

0.32

345

Other congenital malformations of ear

2.81

4.23

3.7

5.2

330.90

391.62

umol/l

1.11

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

193

1420

1.37

4.20

6.5

6.1

354.98

374.85

umol/l

1.03

170

1254

Other factor of the environment

2.87

4.16

5.2

5.8

443.26

357.30

umol/l

0.42

Other diseases of liver

160

1144

1.41

4.15

6.0

5.5

354.93

366.10

umol/l

0.44

136

1006

Rheumatism, unspecified

105

692

1.53

4.15

5.0

5.8

340.81

375.17

umol/l

1.55

611

Psoriasis

245

1871

1.31

4.14

5.1

5.7

341.66

366.17

umol/l

1.83

204

1639

Disorders of lacrimal system

367

2897

1.25

4.14

5.1

5.4

363.01

367.28

umol/l

0.18

322

2537

Other cataract

363

2154

1.26

4.13

5.5

5.1

356.11

358.58

umol/l

0.11

322

1855

Meningitis

280

1.84

4.07

4.7

6.1

363.28

368.09

umol/l

0.09

249

Dialysis, with operation codes

115

777

1.49

4.05

6.7

5.3

344.83

358.05

umol/l

0.43

106

674

Malignant neoplasm of rectum, including Hilmo

699

0.51

4.04

3.8

4.7

308.28

345.43

umol/l

0.87

599

Paralytic strabismus

369

1.72

4.04

4.8

5.5

348.42

346.59

umol/l

0.03

327

Routine general health check-up of defined subpopulation

2.79

4.03

7.7

374.58

375.46

umol/l

0.01

Bronchitis, not specified as acute or chronic

453

1.65

4.02

7.0

5.7

339.76

366.08

umol/l

0.91

398

Hypogonadotropic hypogonadism

246

1.90

4.02

7.2

6.6

352.38

371.79

umol/l

0.42

217

Disorders of eyelid, lacrimal system and orbit

784

4946

1.16

3.99

5.0

5.4

355.74

362.56

umol/l

0.59

684

4335

Meniscus derangement

370

3037

0.81

3.98

4.4

5.8

342.95

368.18

umol/l

2.98

311

2668

Impacted cerumen

619

1.54

3.97

5.0

5.1

376.76

347.77

umol/l

1.02

545

Lung cancer and mesothelioma

108

610

1.51

3.97

4.9

4.5

384.75

343.80

umol/l

1.87

503

Diseases of middle ear and mastoid

551

3771

1.20

3.96

5.9

5.6

380.74

368.15

umol/l

1.09

483

3325

Acute pancreatitis (for exclusion)

171

1249

1.38

3.92

5.6

5.2

352.69

356.65

umol/l

0.12

152

1083

Other female pelvic inflammatory diseases

111

753

1.48

3.84

4.6

5.7

367.61

373.90

umol/l

0.16

658

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

105

1490

0.68

3.81

3.6

4.9

337.83

350.68

umol/l

0.47

1270

Deforming dorsopathies

231

1772

1.31

3.80

5.0

5.7

356.32

371.34

umol/l

0.78

205

1556

Hernia of abdominal wall, postoperative

159

1146

1.38

3.79

4.7

5.5

317.45

372.93

umol/l

5.48

137

1015

Other predominantly sexually transmitted diseases, not elsewhere classified

151

1089

1.39

3.76

6.3

6.1

354.99

371.64

umol/l

0.67

131

955

Other otitis externa (chronic)

370

1.69

3.74

4.7

6.0

363.07

362.44

umol/l

0.01

335

Prominent ears

3.08

3.72

3.9

5.8

323.67

390.46

umol/l

0.88

Insulin, fast-acting

322

2583

1.25

3.70

5.5

341.55

366.23

umol/l

2.41

285

2247

Cholelithiasis

715

4198

1.16

3.68

5.2

5.3

349.88

360.74

umol/l

1.23

625

3648

Cervicocranial syndrome

591

1.53

3.67

5.2

5.9

340.40

367.48

umol/l

1.23

525

Other congenital malformations, including avohilmo

116

802

1.45

3.66

5.0

5.8

390.38

376.96

umol/l

0.43

100

715

Nonspecific lymphadenitis

320

1.73

3.65

5.2

6.3

345.09

368.08

umol/l

0.53

289

Malignant neoplasm of rectum

582

0.49

3.65

3.8

4.8

312.33

345.43

umol/l

0.56

499

Pedal cyclist injured in noncollision transport accidents

113

779

1.46

3.64

4.8

5.9

328.37

366.12

umol/l

1.97

103

695

Gout, idiopatic and unspecified

201

1524

1.32

3.64

5.6

4.5

342.60

342.44

umol/l

0.01

171

1301

Disorders of continuity of bone

593

1.53

3.62

6.2

5.7

343.93

370.16

umol/l

1.00

523

Lesion of lateral popliteal nerve

284

1.78

3.61

6.2

6.0

336.38

363.58

umol/l

0.68

251

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.40

3.61

6.4

5.5

424.32

381.81

umol/l

0.83

Otitis media, unspecified

110

695

1.47

3.59

5.8

5.6

425.50

374.29

umol/l

2.29

100

618

Diabetic maculopathy

941

0.62

3.56

5.1

6.2

302.80

355.46

umol/l

2.34

841

Certain conditions originating in the perinatal period

534

1.52

3.55

5.7

393.87

388.81

umol/l

0.11

491

Benign neoplasm: Rectum, anus and anal canal

155

1135

1.37

3.54

4.2

5.1

343.05

350.60

umol/l

0.27

125

980

Malignant neoplasm of skin

296

2502

0.80

3.54

4.7

5.3

332.18

358.39

umol/l

2.45

254

2174

Benign neoplasm of brain and other parts of central nervous system

361

1.68

3.54

5.6

372.16

359.51

umol/l

0.30

319

Localized swelling, mass and lump of skin and subcutaneous tissue

266

2101

1.27

3.53

5.4

349.70

365.22

umol/l

1.10

229

1831

Malignant neoplasm, wide definition

646

4376

0.86

3.53

4.9

5.8

359.96

368.46

umol/l

0.80

563

3862

Postpartum hemorraghe, parous women as controls

967

0.65

3.51

5.5

5.4

366.48

370.64

umol/l

0.09

829

Asthma and allergy

645

1.49

3.50

5.1

5.8

317.14

377.33

umol/l

3.90

571

Collagenous colitis

510

1.56

3.50

5.6

5.5

343.36

364.77

umol/l

0.63

450

Malignant neoplasm of breast, ER-positive, including Hilmo

151

1526

0.73

3.49

5.5

5.6

360.74

374.59

umol/l

0.56

128

1352

Medicines for HER+ breast cancer

157

1968

0.74

3.47

5.5

5.4

360.51

371.20

umol/l

0.42

134

1742

Malignant neoplasm of breast, HER-positive

151

1524

0.74

3.44

5.5

5.6

360.74

374.55

umol/l

0.56

128

1350

Crushed, pushed or stepped on by crowd or human stampede

545

1.54

3.42

6.7

6.1

342.44

376.76

umol/l

1.51

483

Malignant neoplasm, including Hilmo

647

4373

0.86

3.42

4.9

5.8

359.64

368.55

umol/l

0.85

564

3860

Nonsuppurative otitis media

220

1475

1.30

3.42

5.9

5.8

377.67

373.70

umol/l

0.15

197

1309

Disorders of muscles

601

1.51

3.42

5.7

5.5

354.59

369.53

umol/l

0.49

527

Procreative management

243

2538

0.79

3.42

5.2

6.3

371.34

381.73

umol/l

0.48

221

2280

Asthma and allergy, excluding more controls

658

1.48

3.39

5.1

5.9

317.70

376.01

umol/l

3.77

585

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

133

958

1.39

3.37

5.1

5.6

345.42

365.47

umol/l

0.91

118

846

Solid cancers, including Hilmo

630

4263

0.86

3.37

4.9

5.8

358.87

368.01

umol/l

0.88

550

3764

Chronic laryngitis and laryngotracheitis

116

817

1.43

3.36

4.7

5.3

334.52

361.58

umol/l

1.17

722

Colitis, primary sclerosing

0.00

3.34

0.0

7.1

—

394.35

—

Neurofibromatosis, type 2

9.24

3.33

4.0

3.7

387.33

294.29

umol/l

—

Benign neoplasm: Colon, unspecified

190

1451

1.31

3.31

4.9

4.8

343.31

352.43

umol/l

0.41

169

1239

Iron deficiency anaemia secondary to blood loss (chronic)

120

853

1.41

3.30

5.1

4.9

349.07

350.34

umol/l

0.03

100

737

Sensorineural hearing loss

637

3657

1.16

3.28

4.8

5.2

361.81

359.00

umol/l

0.18

547

3192

Pleural effusion

116

821

1.42

3.28

5.1

4.4

336.23

342.61

umol/l

0.21

105

700

Other disorders of bone

166

1246

1.34

3.27

5.5

5.7

370.87

369.92

umol/l

0.03

144

1090

Complications of other internal prosthetic devices, implants and grafts

205

1.87

3.27

5.1

378.12

356.55

umol/l

0.35

180

Other and unspecified disorders of vitreous body

211

2641

0.78

3.26

4.3

5.3

347.37

363.10

umol/l

0.96

187

2309

Recurrent dislocation of patella

301

1.71

3.26

5.1

6.4

369.82

382.33

umol/l

0.27

264

Emergency coronary revascularization (for ACS)

588

4129

0.86

3.25

4.5

5.6

349.06

365.08

umol/l

1.94

502

3628

Post-traumatic hydrocephalus, unspecified

6.75

3.24

4.1

4.0

347.14

324.64

umol/l

—

Other diseases of oesophagus

504

1.54

3.23

3.5

5.2

341.13

351.66

umol/l

0.26

435

Intestinal adhesions without obstruction

449

1.57

3.22

7.1

4.9

342.48

356.48

umol/l

0.35

397

Osteonecrosis

341

1.66

3.19

5.0

5.6

352.44

357.91

umol/l

0.10

306

Dislocation, sprain and strain of joints and ligaments of thorax

207

1.86

3.19

3.3

6.3

331.78

368.65

umol/l

0.77

185

Viral infections characterized by skin and mucous membrane lesions

365

3021

1.21

3.16

5.2

5.5

374.90

364.60

umol/l

0.73

329

2630

Atopic dermatitis, strict definition with reimbursement

272

2099

1.25

3.15

5.2

6.0

366.02

380.79

umol/l

0.97

245

1869

Menorrhagia

260

1148

1.27

3.15

5.7

5.6

358.79

376.00

umol/l

1.11

217

1005

False labour

160

1318

0.75

3.15

4.8

6.2

382.59

386.68

umol/l

0.14

144

1164

Diabetic retinopathy

221

1744

0.78

3.14

5.2

6.0

341.20

356.53

umol/l

0.86

187

1564

Other inflammation of eyelid

115

820

1.41

3.14

4.8

5.8

370.44

363.25

umol/l

0.19

730

Carrier of infectious disease

138

2.06

3.13

7.5

6.0

404.74

360.14

umol/l

0.93

123

Benign neoplasm: Rectum

137

1006

1.37

3.13

4.2

5.1

348.71

349.38

umol/l

0.02

108

881

Embedded teeth, including avohilmo

589

1.49

3.13

5.4

6.0

413.73

372.58

umol/l

1.98

515

Insulin, fast-acting or short human

325

2664

1.22

3.12

5.4

5.5

340.57

364.34

umol/l

2.29

287

2321

Paroxysmal tachycardia

166

1039

1.33

3.11

5.3

5.9

377.67

380.44

umol/l

0.08

151

902

Female genital prolapse

130

989

0.73

3.10

5.1

5.6

351.37

377.55

umol/l

1.46

121

867

Non-small cell lung cancer, including Hilmo

824

0.62

3.10

5.1

4.4

404.46

340.95

umol/l

2.34

698

Gout, unspecified

163

1231

1.33

3.10

5.4

4.5

340.72

342.37

umol/l

0.05

136

1055

Trigger finger

853

0.62

3.10

4.1

5.8

339.70

372.37

umol/l

1.06

745

Acne

103

719

1.43

3.07

5.2

6.0

377.48

374.79

umol/l

0.07

638

Convulsions of newborn

8.52

3.07

7.8

4.9

535.50

486.00

umol/l

—

Nail disorders

527

1.51

3.06

5.5

5.9

361.64

370.08

umol/l

0.21

466

Other superficial mycoses, including avohilmo

103

724

1.43

3.06

7.0

5.8

376.44

368.50

umol/l

0.22

645

Salpingitis and oophoritis

120

866

1.39

3.06

5.0

6.0

349.36

379.98

umol/l

1.68

107

767

Noninfective enteritis and colitis

414

3477

1.19

3.06

5.6

360.26

367.28

umol/l

0.46

367

3066

L02BG Aromatase inhibitors

121

1632

0.73

3.02

5.9

5.3

371.18

369.83

umol/l

0.03

102

1444

Coxarthrosis, primary

336

3367

0.83

3.01

4.1

5.0

320.59

353.60

umol/l

4.48

289

2902

Basal cell carcinoma, including Hilmo

269

2251

0.81

2.99

4.5

5.1

335.48

355.79

umol/l

1.47

229

1949

Malignant neoplasm of skin, including Hilmo

324

2632

0.82

2.99

4.6

5.3

338.72

359.76

umol/l

1.91

276

2286

Peripheral arterial reconstruction

117

845

1.39

2.97

3.9

4.1

316.47

334.60

umol/l

0.69

718

Scoliosis

458

1.54

2.97

5.3

5.4

376.12

379.51

umol/l

0.06

404

Osteomyelitis

348

1.62

2.97

4.1

5.3

350.33

350.34

umol/l

0.00

311

Hyperplasia of prostate

302

1381

1.23

2.96

4.9

5.1

351.93

348.83

umol/l

0.14

266

1180

Functional dyspepsia

210

1652

1.28

2.96

5.9

5.6

357.91

368.67

umol/l

0.50

186

1431

Other disorders of white blood cells

295

1.68

2.94

6.2

5.7

391.50

352.84

umol/l

1.02

259

Other and unspecified disorders of white blood cells

213

1.80

2.93

6.2

5.5

397.75

352.30

umol/l

1.10

191

Amputation of toe

365

1.60

2.93

4.3

4.8

325.12

338.43

umol/l

0.31

325

Urticaria

248

1992

1.25

2.92

4.8

5.9

337.16

374.09

umol/l

3.34

217

1753

Other demyelinating diseases of the central nervous system

206

1.82

2.92

3.8

7.1

353.82

368.36

umol/l

0.20

185

Impingement syndrome of shoulder

111

1527

0.72

2.92

3.6

5.7

356.71

371.65

umol/l

0.49

1343

Inflammatory bowel disease, strict (require KELA)

124

1673

0.74

2.88

4.7

5.9

339.24

368.40

umol/l

1.37

107

1474

Conductive and sensorineural hearing loss

672

3899

1.15

2.88

4.8

5.3

363.81

360.53

umol/l

0.22

582

3409

Contact with other sharp object(s)

479

1.52

2.86

4.3

6.2

355.64

373.61

umol/l

0.41

426

Covid-19 suspected case

176

1361

1.30

2.85

5.8

5.6

356.19

368.08

umol/l

0.54

154

1186

Intracranial nontraumatic haemorrhage of fetus and newborn

6.62

2.78

6.7

3.6

471.67

391.90

umol/l

—

Trigeminal neuralgia

308

1.64

2.77

3.6

5.6

353.05

358.20

umol/l

0.09

267

Pregnancy examination and test

703

0.68

2.75

4.8

6.5

357.43

386.20

umol/l

1.14

619

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

253

2053

1.24

2.75

4.9

5.9

359.40

371.21

umol/l

0.59

213

1812

Sexual assault by bodily force

6.32

2.74

11.3

6.2

428.17

406.30

umol/l

—

Follicular cysts of skin and subcutaneous tissue

153

1169

1.31

2.73

6.7

5.6

359.24

366.54

umol/l

0.28

136

1022

Benign neoplasm: Sigmoid colon

141

1065

1.33

2.73

5.7

5.1

353.03

350.17

umol/l

0.08

117

924

Atopic dermatitis

555

3836

1.15

2.72

5.3

5.9

361.76

377.26

umol/l

1.79

493

3409

Cachexia

6.13

2.71

6.3

4.1

350.50

290.90

umol/l

—

Hernia

864

5122

1.12

2.69

5.1

5.6

344.73

368.44

umol/l

5.41

757

4514

Lichen planus, including avohilmo

1109

0.69

2.69

3.6

5.4

352.73

361.18

umol/l

0.19

972

Inflammatory diseases of prostate (prostatitis)

114

839

1.37

2.64

4.7

5.2

345.76

353.48

umol/l

0.20

723

Lichen ruber planus, wide definition including periferal and oral lichen planus

100

1373

0.73

2.64

3.5

5.6

353.17

364.65

umol/l

0.32

1202

Other maternal disorders predominantly related to pregnancy

307

2310

0.83

2.62

5.1

5.9

359.32

382.74

umol/l

2.06

275

2042

Colitis, primary sclerosing, strict definition

0.00

2.62

0.0

7.3

—

378.61

—

Primary open-angle glaucoma, strict

177

1383

1.28

2.62

5.0

4.4

338.25

337.41

umol/l

0.03

149

1172

Exposure to other and unspecified inanimate mechanical forces

530

1.46

2.62

4.8

6.2

345.78

376.80

umol/l

1.09

477

Simple and mucopurulent chronic bronchitis

184

1.81

2.61

4.7

4.9

374.00

355.49

umol/l

0.32

167

Melanocytic naevi of trunk

729

0.63

2.59

4.2

5.8

357.89

363.57

umol/l

0.08

643

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

144

1102

1.31

2.56

5.1

5.4

344.07

365.43

umol/l

1.04

126

967

Other abnormal products of conception

157

1324

0.78

2.52

5.5

6.2

367.45

386.61

umol/l

0.81

135

1167

Other orthopaedic follow-up care

285

1.63

2.52

4.4

5.8

368.39

352.58

umol/l

0.28

247

Fenamates

145

753

1.32

2.51

5.3

6.4

348.30

376.72

umol/l

1.41

116

679

IBD patients in KELA-register

124

1634

0.76

2.50

4.7

5.8

339.24

370.04

umol/l

1.48

107

1440

Voice disturbances

194

1548

1.26

2.49

4.4

5.4

337.55

365.37

umol/l

1.88

165

1344

Convergent concomitant strabismus

341

1.57

2.49

5.4

6.1

410.06

372.96

umol/l

0.83

304

Basal cell carcinoma

260

2150

0.82

2.48

4.4

5.0

335.90

353.96

umol/l

1.19

220

1853

Diabetes mellitus in pregnancy

167

1351

0.78

2.48

4.3

6.1

345.48

383.34

umol/l

2.49

147

1182

146

1049

1.30

2.47

4.0

3.8

324.27

328.72

umol/l

0.14

119

873

Rotator cuff syndrome

401

3222

0.85

2.46

3.9

5.5

347.04

366.25

umol/l

1.87

350

2837

Other disorders of veins

323

2674

1.19

2.45

6.3

5.4

366.33

367.62

umol/l

0.06

277

2344

Appendectomy

575

4809

1.14

2.45

6.3

5.7

366.50

370.10

umol/l

0.25

507

4245

Purpura and other haemorrhagic conditions

107

790

1.36

2.45

6.2

5.4

397.98

360.38

umol/l

1.89

698

Other malignant neoplasms of skin (=non-melanoma skin cancer)

271

2218

0.83

2.44

4.6

5.1

335.78

355.09

umol/l

1.38

232

1916

Unspecified misadventure during surgical and medical care

319

1.58

2.44

4.8

5.7

353.38

353.97

umol/l

0.01

285

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

232

2457

0.82

2.44

4.8

5.8

348.58

380.31

umol/l

2.91

206

2168

Postmenopausal atrophic vaginitis

124

894

0.75

2.44

4.8

5.7

386.68

379.60

umol/l

0.22

118

786

Unspecified maternal hypertension

0.00

2.44

0.0

7.5

—

365.52

—

Colonic or urogenital fistula

213

1724

1.24

2.42

4.6

5.5

360.07

361.31

umol/l

0.05

185

1504

Disorders of porphyrin and bilirubin metabolism

0.00

2.42

0.0

5.8

—

361.22

—

Other disorders of ear

820

4746

1.12

2.42

4.9

5.5

359.63

364.41

umol/l

0.41

717

4169

Pleural plaque without asbestos

160

0.31

2.42

3.4

4.1

409.00

331.94

umol/l

—

143

Pregnancy hypertension

205

2263

0.81

2.42

4.6

5.9

347.76

380.72

umol/l

2.73

181

1998

IBD (strict) with PSC

0.00

2.41

0.0

6.5

—

389.47

—

Atopic dermatitis, strict definition

260

2101

1.21

2.41

5.2

5.8

368.09

380.61

umol/l

0.74

236

1859

Postprocedural musculoskeletal disorders, not elsewhere classified

360

1.54

2.40

4.3

5.3

330.57

354.55

umol/l

0.59

319

Sequelae of injuries of lower limb

590

1.42

2.40

6.6

6.1

326.53

366.03

umol/l

2.31

522

Sequelae of injuries of neck and trunk

175

1.79

2.39

3.9

6.4

330.88

355.77

umol/l

0.31

161

Peripheral artery operations in Hilmo

666

1.39

2.38

4.5

323.09

341.70

umol/l

0.61

564

Psoriasis vulgaris

156

1221

1.28

2.38

5.3

5.6

337.24

364.17

umol/l

1.53

132

1062

Chondropathies

126

959

1.32

2.37

6.0

5.7

384.59

367.04

umol/l

0.64

110

848

Other diseases of intestine

119

899

1.33

2.35

5.5

5.1

357.85

363.63

umol/l

0.19

107

762

Other/unspecified disorders of vestibular function

206

1.71

2.35

4.9

5.5

368.59

357.98

umol/l

0.16

183

ILD medications: azathioprine

1008

0.70

2.34

5.1

6.0

314.86

369.43

umol/l

2.64

897

Tooth eruption problems

132

978

1.31

2.33

5.8

5.9

415.00

376.49

umol/l

2.40

121

869

Other bursopathies

101

746

1.36

2.33

5.4

5.6

350.72

363.99

umol/l

0.42

647

Other specified/unspecified hearing loss

477

1.45

2.33

5.1

5.2

354.07

349.70

umol/l

0.08

420

Coronary artery bypass grafting

124

1200

0.76

2.31

3.2

4.5

327.41

332.27

umol/l

0.13

1006

Other disorders of amniotic fluid and membranes

879

0.69

2.30

5.5

6.2

368.39

381.58

umol/l

0.30

767

Any event in cancer register

698

4565

0.89

2.30

4.8

5.8

361.41

367.35

umol/l

0.53

612

4015

Liquid cancers, including Hilmo

206

2227

0.81

2.29

4.5

5.0

339.49

353.94

umol/l

0.73

179

1927

Acute appendicitis, with complications

156

1228

1.27

2.28

6.7

5.4

361.98

362.55

umol/l

0.02

136

1067

Abrasion of teeth

284

2382

1.20

2.28

6.2

5.6

364.81

369.65

umol/l

0.22

246

2090

Raynaud syndrome

496

0.58

2.27

4.3

5.8

352.05

365.27

umol/l

0.19

433

Ulcerative colitis (strict) with PSC

0.00

2.27

0.0

6.5

—

385.87

—

Other pleural conditions

522

1.42

2.25

6.3

4.5

358.18

337.86

umol/l

0.72

447

Dislocation, sprain and strain of joints and ligaments at neck level

131

1012

1.30

2.23

4.7

6.0

358.95

368.12

umol/l

0.29

110

893

Azathioprine

998

0.71

2.23

5.1

5.9

314.86

370.04

umol/l

2.68

885

Contact with machinery

749

0.66

2.22

5.2

5.7

320.51

358.33

umol/l

1.35

657

Other disorders of nervous system

335

1.53

2.22

4.3

5.9

341.14

358.77

umol/l

0.31

298

Zoster [herpes zoster]

134

1039

1.29

2.22

4.6

5.2

355.04

353.26

umol/l

0.05

116

901

Colon adenocarcinoma

689

0.65

2.21

4.6

4.5

346.53

344.31

umol/l

0.04

588

Primary open-angle glaucoma

216

1702

1.22

2.21

4.8

4.3

336.66

337.47

umol/l

0.03

181

1443

Congenital deformities of hip

100

2.02

2.21

7.3

6.2

450.15

400.76

umol/l

0.79

Thrombocytopenia, unspecified

392

1.49

2.21

6.5

5.4

405.46

353.99

umol/l

1.67

353

Type 1 diabetes

210

1715

1.23

2.20

5.2

5.6

335.63

373.23

umol/l

3.16

184

1501

Other specified disorders of external ear

195

1.71

2.20

6.1

5.7

352.12

354.20

umol/l

0.03

177

Type 1 diabetes, strict definition

576

0.62

2.20

3.7

6.4

367.23

387.49

umol/l

0.36

524

Abscess of anal and rectal regions

567

1.40

2.19

4.9

5.8

353.13

366.99

umol/l

0.36

502

Pyoderma

2.09

2.18

4.6

5.7

368.44

364.38

umol/l

0.04

Seronegative rheumatoid arthritis

626

0.64

2.18

4.8

5.5

356.56

363.10

umol/l

0.09

555

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

292

2332

0.84

2.18

4.6

5.1

334.03

355.78

umol/l

1.77

248

2020

418

1.47

2.17

5.6

6.3

345.73

373.05

umol/l

0.63

367

Hypermetropia

402

1.47

2.16

6.3

5.4

430.81

369.67

umol/l

1.99

360

Other specific joint derangements/joint disorders

720

4021

1.12

2.15

5.1

5.8

354.14

374.19

umol/l

3.21

634

3548

Ptosis of eyelid

586

1.39

2.15

4.6

5.5

334.84

352.13

umol/l

0.55

516

Chronic pancreatitis

102

766

1.34

2.14

5.9

5.4

357.74

353.10

umol/l

0.11

667

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

387

1.48

2.13

3.7

5.0

340.92

345.96

umol/l

0.12

338

Glaucoma

426

3148

1.15

2.13

5.1

4.9

352.19

350.00

umol/l

0.11

367

2715

Synovial cyst of popliteal space [Baker]

371

1.49

2.13

5.1

5.5

380.57

365.94

umol/l

0.29

328

Ventral hernia

180

1455

1.24

2.12

4.8

5.1

329.97

360.59

umol/l

2.41

155

1254

Additional codes for the location of defect, injury or illness

323

1.53

2.12

5.2

5.9

347.84

359.33

umol/l

0.22

285

Coronary revascularization (ANGIO or CABG)

550

3771

0.88

2.11

4.5

5.7

348.16

367.69

umol/l

2.53

478

3312

Abnormal findings on diagnostic imaging of other body structures

104

785

1.33

2.11

5.7

5.1

351.22

357.82

umol/l

0.16

690

Spontaneous abortion

237

1906

0.83

2.10

5.3

5.9

369.27

380.04

umol/l

0.60

212

1684

Benign neoplasm of other and unspecified endocrine glands

743

1.34

2.09

5.7

5.4

351.41

356.93

umol/l

0.15

656

Cardiodefibrillation

175

2150

0.81

2.09

4.1

4.8

337.32

342.52

umol/l

0.21

152

1835

Other and unspecified urticaria

151

1201

1.26

2.06

5.2

5.9

342.84

371.46

umol/l

1.40

125

1056

Thiazolidinediones

557

1.39

2.06

5.1

4.4

332.06

348.80

umol/l

0.49

470

Percutaneous Coronary Intervention

550

3768

0.89

2.06

4.5

5.7

347.66

367.56

umol/l

2.65

477

3309

Medical abortion

464

2196

1.15

2.05

5.1

5.5

365.25

372.14

umol/l

0.46

399

1928

Bacterial, viral and other infectious agents

575

1.38

2.04

7.5

6.1

372.51

365.48

umol/l

0.17

513

Alcoholic liver disease

609

1.37

2.04

4.7

5.6

355.15

352.61

umol/l

0.05

534

Cholecystectomy

565

4266

1.13

2.04

5.3

347.45

360.97

umol/l

1.50

510

3704

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1230

0.75

2.00

4.3

5.9

333.00

367.58

umol/l

1.40

1087

Demyelinating diseases of the central nervous system

493

1.41

1.99

4.2

6.3

368.12

369.93

umol/l

0.03

438

Benign neoplasm: Transverse colon

569

1.38

1.99

5.0

5.1

365.77

347.23

umol/l

0.57

497

Appendicitis, broad definition

655

5281

1.11

1.98

6.0

5.6

366.11

367.28

umol/l

0.07

581

4642

Secondary uncertain malignant neoplasm

812

0.70

1.97

5.9

4.8

333.30

349.45

umol/l

0.40

695

Gestational [pregnancy-induced] hypertension

115

1472

0.78

1.97

4.6

5.9

338.84

379.43

umol/l

2.54

103

1288

Herpesviral [herpes simplex] infections

674

1.34

1.95

4.7

5.7

343.39

366.29

umol/l

0.80

595

malignant neoplasm of female genital organs, including Hilmo

905

0.72

1.95

5.8

5.0

363.42

362.31

umol/l

0.02

782

Congenital malformations and deformations of the musculoskeletal system

620

1.35

1.94

6.1

5.8

388.16

384.25

umol/l

0.08

556

Bacterial, viral and other infectious agents, including avohilmo

624

1.35

1.93

7.6

6.1

391.36

367.28

umol/l

0.42

561

Nasal polyp

1268

0.76

1.93

4.4

5.4

350.65

360.93

umol/l

0.32

1105

Ingrowing nail

347

1.48

1.93

5.0

6.2

357.48

374.31

umol/l

0.36

311

Disorders of vitreous body

290

3219

0.85

1.93

4.5

5.3

342.62

362.57

umol/l

1.67

255

2811

Lichen planus

690

0.68

1.92

3.7

5.5

364.44

358.35

umol/l

0.09

614

Chalazion

702

1.33

1.92

5.2

6.0

367.13

368.01

umol/l

0.02

624

Graves disease, strict definition

545

0.64

1.91

6.3

6.0

368.67

371.31

umol/l

0.04

475

Nonsuppurative otitis media, including avohilmo

275

2022

1.18

1.90

5.6

5.7

378.41

371.28

umol/l

0.35

246

1785

Mixed conductive and sensorineural hearing loss

634

1.35

1.90

4.2

5.2

377.68

351.94

umol/l

0.83

551

Malignant neoplasm of colon

899

0.72

1.90

4.3

4.5

346.50

343.48

umol/l

0.06

760

Diseases of appendix

658

5302

1.11

1.90

6.0

5.6

366.05

367.24

umol/l

0.07

584

4658

Benign neoplasm: Caecum

549

1.37

1.89

4.6

5.0

342.40

346.91

umol/l

0.11

478

Primary coxarthrosis, bilateral

135

1689

0.80

1.89

4.1

4.6

320.12

346.12

umol/l

1.41

114

1446

Antepartum haemorrhage, not elsewhere classified

543

0.64

1.88

5.6

6.4

368.10

380.17

umol/l

0.23

472

Type 1 diabetes, strict definition, subgroup 1

541

0.64

1.88

3.8

6.3

369.86

385.97

umol/l

0.26

493

Other noninflammatory disorders of vulva and perineum

499

1.39

1.88

5.3

6.0

382.36

384.28

umol/l

0.04

435

Nephropathy related operations

101

775

1.31

1.87

6.6

5.5

333.75

356.90

umol/l

0.84

681

Gonarthrosis

586

2959

1.12

1.87

5.0

5.7

338.90

367.89

umol/l

5.51

507

2591

Postprocedural disorders of nervous system

374

1.45

1.87

4.9

6.4

341.31

379.88

umol/l

1.11

339

Malignant melanoma, including Hilmo

1044

0.74

1.85

4.1

4.8

333.60

348.78

umol/l

0.45

891

Intestinal malabsorption

269

1.54

1.85

5.8

5.9

374.76

357.15

umol/l

0.26

235

Gestational diabetes (for exclusion)

191

1586

0.83

1.84

5.0

6.0

357.55

380.91

umol/l

1.41

168

1390

Blepharochalasis

134

1671

0.80

1.83

4.2

5.1

325.54

359.44

umol/l

2.15

114

1451

Nummular dermatitis

468

1.40

1.83

5.9

5.3

387.04

357.16

umol/l

1.00

415

Arthropathic psoriasis

705

0.69

1.82

4.4

5.8

354.77

369.36

umol/l

0.28

620

Viral infections of central nervous system, not elsewhere classified/unspecified

2.30

1.82

3.3

6.4

333.18

370.58

umol/l

0.28

Injury of muscle and tendon at shoulder and upper arm level

203

2426

0.83

1.81

3.9

5.5

333.91

360.82

umol/l

1.89

180

2101

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.02

1.81

2.8

5.4

306.55

344.81

umol/l

0.42

Coxarthrosis

343

2542

0.87

1.79

4.4

5.4

324.94

364.50

umol/l

5.63

296

2216

Abnormal blood-pressure reading, without diagnosis

239

1.56

1.79

6.7

5.9

405.75

374.54

umol/l

0.57

204

Ulcerative colitis (strict definition, all Crohn cases excluded)

979

0.74

1.77

4.5

6.0

345.51

363.78

umol/l

0.47

871

Colon adenocarcinoma, helper endpoint

654

0.69

1.77

4.6

4.7

346.53

339.44

umol/l

0.14

570

Temporomandibular joint disorders, including avohilmo

361

3058

1.14

1.77

5.7

5.8

372.28

373.98

umol/l

0.07

314

2706

Melanocytic naevi of other and unspecified parts of face

337

0.56

1.77

7.9

6.0

370.26

363.97

umol/l

0.09

298

Malignant neoplasm of colon, including Hilmo

1099

0.76

1.77

4.0

4.6

350.56

344.26

umol/l

0.17

931

Maternal care for known or suspected fetal abnormality and damage

907

0.75

1.76

6.1

6.2

324.19

381.95

umol/l

3.15

793

Melanocytic naevi of scalp and neck

135

0.37

1.76

3.4

6.0

288.00

366.57

umol/l

—

123

Lichen simplex chronicus

185

1.64

1.76

5.5

5.8

336.20

358.93

umol/l

0.30

164

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

136

0.36

1.76

12.8

4.6

378.20

368.23

umol/l

—

117

Other disorders of cornea

583

1.34

1.75

5.6

5.9

340.69

358.59

umol/l

0.60

511

Psoriatic arthropathies, ICD10

652

0.69

1.75

4.5

5.9

353.37

368.74

umol/l

0.29

575

Presence of cardiac and vascular implants and grafts

333

2128

1.15

1.74

3.3

4.9

335.32

342.56

umol/l

0.42

276

1834

Diseases of peritoneum

541

1.36

1.73

5.3

5.5

334.57

351.52

umol/l

0.49

480

Sequelae of other and unspecified infectious and parasitic diseases

339

1.46

1.73

5.6

6.6

356.21

369.60

umol/l

0.31

296

Conjunctivitis

688

5031

1.10

1.72

5.5

5.7

366.72

372.11

umol/l

0.43

593

4466

Use of dimethyl fumarate

0.00

1.72

0.0

6.6

—

369.12

—

Other diseases of peritoneum

226

1.56

1.71

4.3

5.8

356.15

355.46

umol/l

0.01

201

Other arthrosis

382

2906

0.88

1.71

4.3

5.7

351.18

368.97

umol/l

1.69

333

2557

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

840

4862

1.09

1.70

5.7

5.4

354.69

362.67

umol/l

0.79

739

4256

Coxarthrosis [arthrosis of hip](FG)

366

2866

0.88

1.70

4.5

5.3

323.77

363.78

umol/l

6.22

317

2504

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1118

0.77

1.69

4.0

5.9

331.55

365.70

umol/l

1.37

990

Other obstetric conditions, not elsewhere classified

228

1215

1.19

1.68

5.2

5.9

356.81

380.43

umol/l

1.49

192

1066

Contraceptive management

315

2528

0.87

1.68

5.4

6.5

386.96

383.14

umol/l

0.19

278

2269

Glomerular diseases

138

1118

1.24

1.67

5.4

320.46

358.76

umol/l

2.73

123

972

Hernia of abdominal wall

361

3176

1.14

1.66

4.9

5.4

334.56

360.66

umol/l

3.07

316

2754

Malignant neoplasm of breast, HER-negative

1082

0.77

1.66

4.1

5.2

376.35

366.29

umol/l

0.29

938

malignant neoplasm of female genital organs

801

0.73

1.66

5.7

4.9

356.00

361.28

umol/l

0.11

686

ILD, hospital admission 2, with pulmonary infections

384

1.41

1.65

4.8

315.70

351.65

umol/l

0.93

321

Benign neoplasm: Pancreas

148

0.40

1.64

4.5

5.4

279.50

356.53

umol/l

—

136

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

343

1.44

1.64

5.6

6.5

356.21

369.67

umol/l

0.32

300

Liquid cancers

164

1870

0.83

1.64

4.6

4.9

335.16

352.80

umol/l

0.88

140

1604

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

221

1176

1.19

1.63

5.2

5.9

356.85

379.70

umol/l

1.36

186

1030

Gout, FINNGEN

220

1858

1.18

1.62

5.4

4.7

335.54

340.26

umol/l

0.21

188

1590

Thyrotoxicosis

173

1441

1.20

1.61

5.4

5.5

371.76

362.45

umol/l

0.43

142

1265

Psoriatic arthropathies

651

0.70

1.60

4.4

5.9

353.37

379.56

umol/l

0.58

560

Gout, strict definition

132

1072

1.24

1.58

5.5

4.5

340.20

340.04

umol/l

0.00

109

914

Malignant melanoma

926

0.75

1.58

4.3

4.8

326.08

349.85

umol/l

0.74

794

Syphilis, including avohilmo

152

1.66

1.57

4.5

6.0

304.05

368.44

umol/l

1.03

135

Syphilis

152

1.66

1.57

4.5

6.0

304.05

368.44

umol/l

1.03

135

All dysplastic lesions of the cervix uteri, vagina or vulva

200

1649

1.19

1.57

5.0

5.8

369.72

378.06

umol/l

0.35

177

1446

Entropion and trichiasis of eyelid

414

1.38

1.56

4.3

4.6

340.40

342.76

umol/l

0.04

355

Muscle wasting and atrophy, not elsewhere classified

2.47

1.55

4.1

5.6

369.88

363.56

umol/l

—

Acute appendicitis

608

5132

1.10

1.54

6.0

5.6

364.13

367.76

umol/l

0.25

538

4516

Ulcerative colitis (strict definition, require KELA)

1147

0.78

1.54

4.2

5.9

329.08

365.97

umol/l

1.52

1013

Sequelae of other external causes

331

1.43

1.54

4.0

5.8

348.22

363.63

umol/l

0.28

295

Chronic respiratory disease originating in the perinatal period

3.46

1.54

3.2

4.7

349.40

409.20

umol/l

—

Gilbert syndrome

0.00

1.54

0.0

5.5

—

349.08

—

Other joint disorders

864

4152

1.09

1.52

4.9

5.8

353.96

373.91

umol/l

3.63

758

3657

Hypermobility syndrome

266

1.47

1.51

5.2

6.5

337.03

374.65

umol/l

1.08

241

Spondylopathies (FG)

884

0.76

1.50

5.1

5.7

343.95

372.28

umol/l

1.09

786

Olecranon bursitis

375

1.39

1.50

5.9

5.5

346.09

356.38

umol/l

0.22

322

Polyp of the female genital tract

156

1064

0.83

1.50

5.2

5.6

347.39

377.26

umol/l

1.74

138

934

Seborrhoeic keratosis

119

1463

0.81

1.49

4.7

5.2

348.19

358.40

umol/l

0.30

107

1259

L02BA Anti-estrogens

837

0.75

1.49

4.0

5.7

343.16

372.67

umol/l

0.94

732

Pneumonia due to other infectious organisms, not elsewhere classified

147

1.64

1.48

4.3

5.4

334.32

352.55

umol/l

0.23

126

Disorders of globe

124

1.71

1.48

5.5

4.8

345.81

359.79

umol/l

0.16

111

Artificial joint re-operation

351

1.40

1.47

4.2

4.9

369.61

353.50

umol/l

0.33

310

Varicose veins

365

3101

0.89

1.47

4.9

5.1

354.82

359.65

umol/l

0.26

317

2696

Disorders of eyelid in diseases classified elsewhere

179

1.58

1.46

4.3

6.2

346.23

361.54

umol/l

0.24

159

Panniculitis affecting regions of neck and back

187

1.56

1.46

2.6

6.1

361.91

372.84

umol/l

0.17

165

189

1375

1.18

1.46

4.0

3.9

323.47

328.23

umol/l

0.18

154

1163

Periodontal disease, other/unspecified

117

1.72

1.45

7.7

5.2

327.55

361.05

umol/l

0.40

103

ILD, hospital admissions 3, with pneumonia sepsis

335

1.41

1.45

5.1

4.3

310.08

338.37

umol/l

0.60

280

Methotrexate

788

0.75

1.45

4.3

5.5

350.26

367.28

umol/l

0.44

700

Congenital deformities of hip, including avohilmo

117

1.72

1.45

7.3

6.4

450.15

396.39

umol/l

0.91

108

Other abnormal uterine and vaginal bleeding

162

971

1.20

1.45

5.3

5.7

354.00

377.36

umol/l

1.15

141

851

Adenocarcinoma of pancreas

152

0.46

1.44

7.3

4.8

261.86

343.37

umol/l

—

135

Keratitis

292

2564

1.14

1.43

5.2

5.7

351.24

365.51

umol/l

0.99

253

2243

Other (seronegative) rheumatoid arthritis, wide

1012

0.78

1.43

3.8

5.3

355.61

356.75

umol/l

0.02

885

Impacted teeth

131

1363

0.82

1.43

5.7

6.1

384.01

375.16

umol/l

0.27

117

1205

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

109

879

1.24

1.43

4.6

5.3

347.49

354.65

umol/l

0.18

762

Malignant melanoma of skin, including Hilmo

852

0.76

1.41

4.1

4.8

338.05

349.15

umol/l

0.27

731

All dysplastic lesions of the cervix uteri

175

1457

1.18

1.41

5.3

5.8

379.83

376.34

umol/l

0.12

156

1275

Disorders of conjunctiva

755

5395

1.08

1.40

5.4

5.6

363.78

369.81

umol/l

0.53

651

4767

Disorders of vitreous body and globe

307

3281

0.88

1.39

4.6

5.3

343.48

362.17

umol/l

1.56

268

2862

Impotence

364

1.38

1.39

4.4

5.5

374.54

349.28

umol/l

0.48

311

Malignant melanoma of skin

713

0.74

1.38

4.3

4.9

325.16

352.20

umol/l

0.69

614

Other and unspecified corneal deformities and disorders

190

1.54

1.38

5.1

6.5

334.38

367.73

umol/l

0.67

173

Atypical virus infections of central nervous system

2.23

1.38

3.3

4.4

318.56

371.14

umol/l

—

Perioral dermatitis

121

0.41

1.38

4.8

6.4

315.80

376.29

umol/l

—

110

Disorders of synovium and tendon

363

3444

0.89

1.37

4.7

5.6

344.70

369.69

umol/l

2.95

312

3038

Polyarthropathies

510

3603

0.91

1.36

5.0

5.8

342.83

370.47

umol/l

4.35

439

3170

Malignant neoplasm of small intestine, including Hilmo

164

0.48

1.36

2.0

5.1

316.38

351.27

umol/l

—

147

Other and unspecified abdominal hernia

207

1.51

1.35

3.4

5.4

315.23

355.59

umol/l

0.68

183

Glomerulonephritis

574

1.29

1.35

5.1

5.5

334.34

362.90

umol/l

1.11

514

Atypical virus infections of central nervous system, including avohilmo

2.17

1.34

3.3

4.4

318.56

372.11

umol/l

—

Malignant neoplasm of bronchus and lung

931

0.80

1.33

4.7

4.4

387.51

338.88

umol/l

2.17

792

Congenital malformations of the circulatory system

123

985

1.22

1.32

4.3

5.8

368.18

380.58

umol/l

0.45

114

888

Other keratitis

745

1.25

1.32

4.9

5.9

367.63

363.02

umol/l

0.11

660

Retinal vascular occlusion

594

1.28

1.31

3.6

4.6

334.60

342.61

umol/l

0.16

509

Psoriatic and enteropathic arthropathies

740

0.75

1.31

4.1

5.8

335.60

375.84

umol/l

1.17

652

Malignant neoplasm of breast, ER-negative, including Hilmo

100

1152

0.81

1.31

4.4

5.2

372.54

367.56

umol/l

0.13

1000

Anterior Iridocyclitis

149

1253

1.19

1.31

4.7

5.6

362.38

361.89

umol/l

0.01

132

1104

Other contact dermatitis

446

1.33

1.30

4.3

5.6

338.29

369.43

umol/l

0.74

390

Other diseases of stomach and duodenum

343

1.38

1.30

5.2

5.1

361.74

347.64

umol/l

0.30

299

Gonarthrosis [arthrosis of knee](FG)

661

3498

1.09

1.29

5.0

5.5

341.89

368.16

umol/l

5.04

577

3070

HSIL lesion of the cervix uteri, vagina or vulva

132

1099

1.20

1.29

5.2

5.9

363.35

374.45

umol/l

0.38

123

947

Other skin changes

139

1163

1.20

1.29

4.6

5.0

331.60

355.70

umol/l

1.10

120

1002

Ménière disease

485

0.70

1.29

3.7

5.2

379.41

352.79

umol/l

0.52

431

Adjustment and management of implanted device

113

927

1.22

1.29

3.6

4.2

321.32

333.76

umol/l

0.44

101

771

Left bundle-branch block

361

1.36

1.28

5.6

5.1

343.35

347.52

umol/l

0.06

319

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

114

1.67

1.26

4.3

6.0

394.37

405.31

umol/l

0.11

104

Other bursitis of hip

107

1.70

1.26

5.1

5.7

331.23

349.11

umol/l

0.15

Sequelae of infectious and parasitic diseases

440

1.32

1.26

5.2

5.8

364.43

357.55

umol/l

0.16

384

Malignant neoplasm of respiratory system and intrathoracic organs

105

1062

0.82

1.25

4.4

4.5

367.24

340.99

umol/l

0.96

901

Coronary atherosclerosis

425

2959

0.90

1.25

4.6

5.4

341.06

360.02

umol/l

2.08

375

2561

Benign neoplasm of mouth and pharynx

599

1.27

1.25

5.6

5.8

338.75

358.04

umol/l

0.60

535

Malignant neoplasm of small intestine

119

0.42

1.25

2.2

5.1

308.80

351.97

umol/l

—

107

Bitten or struck by other mammals

715

1.25

1.24

5.2

6.0

331.82

371.22

umol/l

1.74

633

Foreign body on external eye

1099

0.81

1.22

5.4

6.1

342.61

367.03

umol/l

1.14

970

Familial hypercholesterolemia, with ischemic heart disease

486

1.30

1.22

3.8

4.2

341.94

335.21

umol/l

0.16

410

Degenerative macular diseases

601

1.27

1.22

4.4

4.8

312.03

341.08

umol/l

0.87

520

Artrosis, including avohilmo

766

3891

1.08

1.22

5.2

5.7

346.88

368.94

umol/l

4.30

663

3407

Spondylopathies

653

3562

1.08

1.21

4.6

5.6

341.28

366.27

umol/l

4.24

570

3118

Cervicobrachial syndrome

163

1393

1.17

1.21

4.6

6.0

341.53

375.48

umol/l

2.14

145

1219

Brachial plexus disorders

540

1.28

1.21

3.9

6.1

370.81

371.04

umol/l

0.00

474

Other congenital malformations of tongue, mouth and pharynx

1.73

1.20

3.6

5.8

405.94

401.46

umol/l

0.04

Papulosquamous disorders

302

2695

1.12

1.20

5.0

5.6

347.87

365.84

umol/l

1.29

256

2364

Dentofacial anomalies [including malocclusion]

622

4491

1.08

1.19

5.5

5.9

372.20

373.55

umol/l

0.09

549

3989

Glaucoma suspect

250

2205

1.13

1.19

5.5

4.8

369.69

353.23

umol/l

0.94

226

1907

Acute and subacute iridocyclitis

142

1202

1.18

1.19

4.8

5.6

363.50

363.59

umol/l

0.00

126

1058

Gout

220

1651

1.15

1.18

5.4

5.0

335.54

352.12

umol/l

1.09

188

1417

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

410

1.32

1.18

5.5

346.58

359.51

umol/l

0.25

362

Retinal vascular disorders

604

1.26

1.18

3.6

4.6

334.60

342.71

umol/l

0.16

517

Abnormality of white blood cells, not elsewhere classified

2.03

1.17

7.4

5.1

404.10

363.36

umol/l

—

Injury of muscle and tendon at hip and thigh level

624

0.75

1.17

3.8

5.9

355.54

368.24

umol/l

0.27

559

Deviated nasal septum

221

2511

0.88

1.16

5.0

5.8

343.94

365.77

umol/l

1.52

194

2211

Chronic diseases of tonsils and adenoids

628

4279

0.92

1.16

5.6

5.9

366.90

376.22

umol/l

0.88

551

3816

Abnormal spermatozoa

691

0.76

1.16

5.8

4.6

351.84

340.15

umol/l

0.25

593

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

0.00

1.16

0.0

4.3

—

357.79

—

Adenomyosis (Endometriosis of uterus)

723

0.77

1.15

5.2

5.8

342.48

377.42

umol/l

1.15

637

Sequelae of infectious and parasitic diseases, including avohilmo

447

1.30

1.15

5.2

5.9

364.43

356.66

umol/l

0.19

391

Foreign body or object entering through skin

421

1.31

1.15

5.8

6.2

341.30

365.20

umol/l

0.58

381

Diabetic retinopathy, strict definition

114

1210

0.83

1.15

5.8

6.1

339.21

357.95

umol/l

0.75

1081

Squamous cell neoplasms and carcinomas of the skin

553

0.74

1.14

4.5

3.7

337.37

327.55

umol/l

0.18

463

Arthropathies

882

4167

1.07

1.14

5.2

5.8

355.99

374.18

umol/l

3.22

770

3672

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

682

0.77

1.14

4.8

3.8

334.62

330.79

umol/l

0.07

573

Finngen Rheumatological endpoints

892

4738

1.07

1.14

5.2

5.7

347.83

370.32

umol/l

4.88

765

4177

Primary_lymphoid and hematopoietic malignant neoplasms

121

1437

0.84

1.13

5.2

4.9

342.99

351.22

umol/l

0.26

106

1241

Thyroiditis, ILD-related definition

626

1.25

1.12

5.9

5.7

367.69

371.38

umol/l

0.08

557

Acute mastoiditis

2.02

1.12

7.0

5.2

428.25

332.09

umol/l

—

Injury of muscle and tendon at wrist and hand level

108

898

1.21

1.12

6.0

6.1

344.48

368.70

umol/l

0.99

786

Other intervertebral disc disorders

705

3906

1.08

1.11

4.6

5.6

343.92

367.05

umol/l

4.26

614

3431

Injury of muscle and tendon at forearm level

104

1.65

1.10

5.5

6.6

306.47

371.09

umol/l

1.01

Shoulder lesions

550

3570

0.92

1.09

4.1

5.6

347.76

366.50

umol/l

2.21

466

3151

Oral lichen planus, including avohilmo , including avohilmo

387

0.69

1.09

3.4

5.8

346.17

364.46

umol/l

0.25

341

LSIL lesion of the cervix uteri

575

1.26

1.09

4.8

5.9

387.63

373.09

umol/l

0.35

500

Residual foreign body in soft tissue

312

1.35

1.08

7.0

6.0

381.58

374.63

umol/l

0.13

272

Viral warts, including avohilmo

174

1511

1.15

1.08

5.8

5.7

387.31

367.60

umol/l

1.05

151

1325

Chronic suppurative otitis media, including avohilmo

487

1.28

1.08

4.5

5.5

393.05

368.82

umol/l

0.75

437

Hydronephrosis

558

1.26

1.08

7.9

4.7

358.42

347.84

umol/l

0.26

475

Ovarian cyst

240

1212

1.13

1.08

5.4

357.82

377.01

umol/l

1.36

212

1054

Overexertion and strenuous or repetitive movements

657

1.24

1.08

4.7

6.1

342.13

370.85

umol/l

1.11

579

Infections of breast associated with childbirth

166

0.54

1.08

3.9

6.7

402.44

384.31

umol/l

—

146

Other abnormalities of plasma proteins

1.77

1.07

5.5

5.1

329.92

360.37

umol/l

0.26

Sudden idiopathic hearing loss

535

0.75

1.07

4.3

5.3

345.74

353.01

umol/l

0.11

468

Hypertrophic cardiomyopathy

217

0.60

1.06

3.2

5.6

322.98

360.51

umol/l

0.75

197

Burn and corrosion of ankle and foot

1.73

1.06

7.4

6.3

427.64

370.04

umol/l

0.52

Urethral stricture

279

1.37

1.05

4.7

4.9

323.87

337.70

umol/l

0.29

246

Ethmoidectomy

814

0.80

1.05

4.8

5.8

338.84

367.52

umol/l

0.95

716

Use of rasagiline

124

0.48

1.05

3.0

5.4

395.33

356.25

umol/l

—

114

Benign lipomatous neoplasm of other sites/unspecified

453

0.73

1.05

6.1

5.4

331.35

352.26

umol/l

0.29

398

Calculus of kidney and ureter

168

1929

0.87

1.04

4.8

5.2

331.69

354.62

umol/l

1.23

142

1668

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

395

0.71

1.04

5.4

5.9

368.00

376.58

umol/l

0.09

344

Perforation of tympanic membrane

570

1.25

1.04

5.0

5.5

384.75

359.78

umol/l

0.72

502

Clubfoot

1.86

1.04

5.8

437.55

377.30

umol/l

1.18

HSIL lesion of the cervix uteri

118

998

1.18

1.03

5.4

6.0

373.04

374.47

umol/l

0.03

109

860

Hodgkin lymphoma, hilmo

151

0.53

1.03

9.1

6.2

441.00

364.13

umol/l

—

136

Malignant neoplasm of bronchus and lung, including Hilmo

106

1052

0.84

1.03

4.9

4.5

388.04

339.61

umol/l

2.52

893

Actinic keratosis

190

1965

0.88

1.02

3.7

4.2

319.63

336.63

umol/l

1.06

166

1665

Gonarthrosis, primary, with knee surgery

355

3035

0.91

1.02

4.6

5.0

337.24

355.36

umol/l

1.73

302

2632

Spondylosis

430

3080

1.09

1.02

4.5

5.5

328.69

365.69

umol/l

5.86

369

2695

Vertical strabismus

188

1.44

1.02

3.9

5.9

406.41

356.12

umol/l

0.94

171

Crohn disease

865

0.81

1.01

7.0

5.9

346.81

371.25

umol/l

0.78

764

Type 1 diabetes, strict (exclude DM2)

663

0.78

1.01

3.7

6.1

360.73

385.51

umol/l

0.52

600

Diabetic retinopathy, excluding more controls

176

1128

0.87

1.01

5.8

6.1

354.19

366.34

umol/l

0.53

153

1001

Skin changes due to chronic exposure to nonionizing radiation

198

2030

0.88

1.01

3.7

4.3

320.11

336.08

umol/l

0.95

172

1722

Systemic atrophies primarily affecting the central nervous system

222

1.40

1.01

4.9

5.6

368.86

353.50

umol/l

0.21

202

Lichen simplex chronicus and prurigo

325

1.33

1.00

5.0

5.6

311.71

360.96

umol/l

1.06

287

Malignant neoplasm of urinary organs

574

0.76

1.00

3.7

4.6

314.35

343.85

umol/l

0.89

494

Non-rheumatic valve diseases

284

2249

0.90

1.00

4.2

5.3

350.02

360.43

umol/l

0.68

254

1938

Motorcycle rider injured in other and unspecified transport accidents

431

1.28

1.00

4.3

6.5

341.49

369.54

umol/l

0.67

389

172

1.45

1.00

6.8

5.0

433.46

439.11

umol/l

0.06

161

Other specified/unspecified soft tissue disorders

248

1.38

0.99

4.3

5.7

346.70

355.73

umol/l

0.09

217

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

584

0.77

0.99

3.8

4.6

309.16

343.87

umol/l

0.96

506

Chloasma

0.00

0.98

0.0

6.2

—

383.38

—

LSIL lesion of the cervix uteri, vagina or vulva

720

1.21

0.98

4.5

6.0

380.90

374.00

umol/l

0.16

626

Arterial embolism and thrombosis

266

1.36

0.97

2.7

4.7

354.88

345.94

umol/l

0.04

235

Status post-ami

142

1245

0.86

0.97

3.9

4.5

350.43

333.83

umol/l

0.82

124

1044

Ovarian dysfunction

371

1.30

0.97

5.4

6.0

338.97

369.59

umol/l

0.60

319

Benign neoplasm: Small intestine

207

1.41

0.97

5.6

5.1

378.42

350.88

umol/l

0.41

187

Type 1 diabetes, definitions combined

669

0.79

0.96

3.7

6.1

359.18

385.66

umol/l

0.58

606

Benign neoplasm of urinary organs

241

1.38

0.96

4.5

5.1

327.21

347.67

umol/l

0.32

217

Coeliac disease

650

1.22

0.95

6.5

5.7

385.26

367.27

umol/l

0.53

579

Pregnancy with abortive outcome

390

2217

0.92

0.94

4.9

5.5

358.24

371.75

umol/l

1.13

335

1947

Degeneration of macula and posterior pole

325

2280

1.10

0.94

4.1

4.6

332.07

341.94

umol/l

0.57

270

1955

Varicose veins of other sites

432

0.74

0.94

4.1

5.8

364.69

368.59

umol/l

0.06

381

Tonsillectomy and adenotomy

446

3360

0.92

0.94

5.5

6.1

368.03

378.93

umol/l

0.81

382

3015

conjunctival haemorrhage

409

1.28

0.93

5.2

5.6

331.00

356.08

umol/l

0.61

362

Delayed puberty

1.84

0.93

5.8

6.1

359.90

408.90

umol/l

—

Iridocyclitis

166

1457

1.14

0.93

4.6

5.6

361.45

363.06

umol/l

0.05

148

1276

Pulmonary oedema

1.83

0.92

18.6

3.7

401.50

327.69

umol/l

—

Malignant neoplasm of kidney, except renal pelvis

521

0.77

0.92

3.8

4.7

303.12

344.29

umol/l

1.31

455

Major coronary heart disease event

626

4002

0.93

0.92

4.9

5.6

352.75

366.83

umol/l

1.68

548

3521

Haemorrhage in early pregnancy

146

1625

0.87

0.92

4.8

6.0

358.30

382.15

umol/l

1.08

128

1429

Valvular heart disease excluding rheumatic fever

288

2267

0.91

4.2

5.4

350.33

361.32

umol/l

0.75

258

1954

Achalasia of cardia

1.64

0.91

6.6

4.9

372.14

340.72

umol/l

0.51

Spondyloarthritis

1157

0.85

0.91

4.8

5.5

347.56

362.88

umol/l

0.57

1016

Other and unspecified mononeuropathies of upper limb

176

1.43

0.91

6.8

6.2

349.52

354.98

umol/l

0.08

154

Preterm labour and delivery

137

1575

0.87

0.91

4.9

6.3

378.55

384.71

umol/l

0.19

119

1402

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

125

1191

0.86

0.90

4.8

4.7

367.96

342.93

umol/l

1.04

108

1012

Pre-eclampsia or eclampsia

101

1188

0.85

0.90

5.5

6.0

368.34

379.10

umol/l

0.34

1034

Diverticular disease of intestine

530

3067

1.08

0.90

4.8

5.2

340.21

362.58

umol/l

3.18

472

2647

Non-Hodgkin lymphoma, all, including Hilmo

785

0.81

0.89

4.9

316.05

352.22

umol/l

1.20

679

Other and unspecified vascular occlusions

447

1.26

0.89

3.7

4.5

315.25

342.44

umol/l

0.69

388

Exposure to other and unspecified man-made environmental factors

119

1.52

0.88

3.3

7.1

403.69

382.90

umol/l

0.20

109

HSIL lesion of the vulva

1.62

0.88

4.4

6.4

296.64

377.27

umol/l

1.87

Lumbar disc prolapse

536

3699

1.07

0.88

4.8

5.7

341.03

369.40

umol/l

4.87

465

3259

Pre-eclampsia

1086

0.85

0.86

5.7

6.1

365.85

378.49

umol/l

0.38

946

Herpesviral [herpes simplex] infections, including avohilmo

186

1655

1.13

0.86

5.0

5.8

364.86

366.67

umol/l

0.05

163

1456

Postpartum haemorrhage due to anatomy

379

0.74

0.85

5.5

339.70

368.80

umol/l

0.42

326

Conductive hearing loss, unspecified

469

1.24

0.84

5.2

5.8

367.60

363.34

umol/l

0.07

416

Carbimazole or st.post thyroidectomy, condition for graves disease

103

1200

0.86

0.83

6.2

5.7

362.86

366.49

umol/l

0.11

1056

Vitamin B12 deficiency anaemia

515

1.23

0.83

3.0

4.7

313.25

344.33

umol/l

0.98

449

Patellar tendinitis

115

0.52

0.83

8.3

6.5

471.17

394.03

umol/l

—

103

All dysplastic lesions of the vagina

141

0.56

0.83

3.6

6.7

310.37

371.75

umol/l

—

124

Exfoliative dermatitis

1.75

0.83

4.7

4.8

322.75

325.19

umol/l

—

Inguinal hernia

459

3277

0.93

0.82

4.9

5.5

345.90

362.25

umol/l

1.74

398

2875

Other retinal disorders

496

3515

1.07

0.81

4.6

5.2

340.84

355.80

umol/l

1.40

423

3055

Dysplasia of cervi uteri

162

1007

1.13

0.81

5.2

5.7

388.03

383.11

umol/l

0.16

143

885

Neovascular glaucoma

215

1.35

0.80

2.0

5.6

279.17

353.68

umol/l

2.32

193

Dislocation, sprain and strain of joints and ligaments of knee

501

4231

1.07

0.80

5.2

5.8

345.06

374.15

umol/l

5.21

433

3752

159

1.41

0.80

6.7

4.9

434.22

444.62

umol/l

0.10

149

Benign neoplasm of major salivary glands

509

1.22

0.80

4.9

5.4

338.29

349.23

umol/l

0.27

450

Other and unspecified nerve root and plexus disorders, also in other diseases

153

1355

1.13

0.78

4.2

5.8

342.50

365.05

umol/l

1.14

130

1171

Other necrotizing vasculopathies (FG)

295

1.29

0.78

4.1

5.3

306.03

363.13

umol/l

1.26

267

Radiculopathy

105

906

1.16

0.78

5.2

5.4

336.02

359.61

umol/l

0.93

780

Other specific arthropathies, wide

123

0.57

0.78

3.7

5.6

282.86

371.08

umol/l

—

112

FESS (DNB20)

782

0.83

0.78

4.8

5.8

338.84

366.37

umol/l

0.89

688

Hypertrophic disorders of skin

322

1.28

0.77

7.2

6.0

375.34

375.05

umol/l

0.01

282

Disorders of sclera, cornea, iris and ciliary body

451

4209

1.07

0.77

5.0

5.7

357.03

366.87

umol/l

0.81

397

3693

Acute poliomyelitis

1.71

0.76

2.8

4.9

329.40

359.98

umol/l

—

Chronic suppurative otitis media

395

1.24

0.75

4.3

5.6

396.73

362.27

umol/l

1.03

354

Glaucoma secondary to other eye disorders

218

1.34

0.75

2.0

5.3

279.17

352.43

umol/l

2.27

196

Traumatic amputation of wrist and hand

232

0.69

0.75

4.7

5.8

388.19

363.44

umol/l

0.39

212

Malignant neoplasm of urinary organs, including Hilmo

669

0.82

0.75

3.9

4.6

315.17

343.81

umol/l

0.90

571

219

2167

0.91

0.73

3.8

4.4

323.95

337.20

umol/l

0.76

188

1842

Other/unspecified enthesopathies of lower limb, excluding foot

424

1.23

0.73

4.0

6.2

339.83

382.73

umol/l

1.31

371

Vasomotor rhinitis (mode)

397

1.24

0.73

3.6

5.9

340.76

363.73

umol/l

0.50

347

Normotensive glaucoma

397

1.24

0.73

6.2

4.5

336.17

340.31

umol/l

0.08

347

Cleft palate

1.68

0.72

2.3

5.5

366.30

371.70

umol/l

—

Acute poliomyelitis, including avohilmo

1.68

0.72

2.8

5.0

329.40

361.56

umol/l

—

Haemorrhoids and perianal venous thrombosis

232

2101

1.10

0.71

4.8

5.0

349.92

359.08

umol/l

0.49

203

1799

5-aminosalicylic acid

138

1553

0.89

0.71

5.1

6.0

355.50

368.87

umol/l

0.52

121

1369

Bell's palsy

673

1.18

0.71

5.3

5.6

377.55

360.75

umol/l

0.48

583

Other peripheral vertigo

462

1.22

0.71

5.6

5.4

340.78

355.79

umol/l

0.34

409

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

443

3999

1.07

0.70

5.6

5.8

355.16

370.97

umol/l

1.52

385

3552

Endometriosis of fallopian tube

1.72

0.70

8.1

5.9

382.57

352.76

umol/l

—

Arthrosis

644

3336

1.06

0.70

5.0

5.8

340.90

369.78

umol/l

5.80

556

2931

Myocardial infarction, strict

294

2254

0.92

0.69

4.7

5.1

346.28

348.31

umol/l

0.09

254

1933

Malignant neoplasm of bladder, including Hilmo

654

0.83

0.69

3.7

4.1

319.09

332.46

umol/l

0.40

546

Retinal detachments and breaks

204

2243

0.91

0.69

4.0

5.1

334.53

352.44

umol/l

0.99

176

1933

Non-follicular lymphoma

498

0.80

0.69

3.9

5.1

313.15

347.34

umol/l

0.84

435

In situ neoplasms

220

2410

0.91

0.69

4.7

4.9

340.25

352.48

umol/l

0.69

203

2059

Uterine polyps

157

1025

0.89

0.69

5.2

5.7

344.25

378.66

umol/l

2.23

142

901

Necrobiosis lipoidica, not elsewhere classified

1.87

0.69

6.4

4.3

328.90

339.36

umol/l

—

Iliotibial band syndrome

1.54

0.68

2.8

6.5

345.00

393.72

umol/l

—

Endocarditis

187

1.34

0.68

4.5

5.2

303.06

337.89

umol/l

0.49

166

Oxicams

175

1103

0.90

0.68

4.1

6.2

339.58

372.53

umol/l

2.27

150

991

Unspecified jaundice

250

0.72

0.68

5.7

5.0

369.50

354.34

umol/l

0.17

227

483

1.20

0.68

4.4

5.0

345.79

346.70

umol/l

0.02

423

Hydrocele

760

1.16

0.68

5.9

4.8

350.90

347.39

umol/l

0.08

646

Other acquired deformities of musculoskeletal system and connective tissue

240

1.30

0.67

5.2

6.4

392.12

365.12

umol/l

0.45

218

Congenital malformations of anterior segment of eye

1.64

0.67

5.0

5.5

426.43

372.03

umol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.53

0.67

6.0

4.8

385.60

361.04

umol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

285

1.27

0.66

4.1

5.9

367.70

364.41

umol/l

0.05

249

Inflammatory bowel disease

211

2310

0.91

0.66

5.8

5.9

354.09

366.70

umol/l

0.62

186

2033

Fibrosis and cirrhosis of liver

406

0.79

0.66

4.4

5.3

333.56

349.70

umol/l

0.34

364

Glucosamine medication

296

2186

1.08

0.65

4.7

4.6

325.32

350.99

umol/l

2.73

250

1880

Other hammer toe(s) (acquired)

114

914

1.14

0.65

4.0

5.2

357.29

359.95

umol/l

0.06

793

Nerve, nerve root and plexus disorders

922

5296

1.05

0.65

4.7

5.6

354.83

362.97

umol/l

0.87

810

4638

Hypertrophy of breast in women and men

123

1091

1.13

0.65

5.9

5.8

353.60

374.19

umol/l

1.07

103

963

Benign thyroid growths and nodules

187

1577

1.10

0.65

5.2

4.7

353.26

356.20

umol/l

0.11

163

1373

Budesonide

104

913

1.14

0.65

4.3

5.9

324.64

366.86

umol/l

2.52

804

Spirochaetal infections, other/unspecified

493

0.81

0.64

3.7

5.6

335.67

355.23

umol/l

0.31

434

Mucosal proctocolitis

882

0.86

0.64

5.9

6.1

326.80

367.66

umol/l

1.69

788

Other disorders of eyelid

301

2638

1.08

0.62

4.3

5.0

330.04

357.13

umol/l

2.86

255

2277

Acute nasopharyngitis (common cold)

863

1.14

0.62

5.8

6.3

399.74

375.99

umol/l

1.03

765

Juvenile Open Angle Glaucoma

1.68

0.62

12.4

5.3

288.00

340.12

umol/l

—

Metatarsalgia

507

1.19

0.62

4.5

5.8

346.12

372.77

umol/l

0.87

447

Lichen sclerosus et atrophicus

599

0.83

0.61

4.0

5.7

332.10

370.65

umol/l

0.89

524

Endometriosis ASRM stages 1,2

104

918

1.13

0.61

4.7

6.0

352.16

377.29

umol/l

1.09

795

Oral corticosteroids

945

5313

1.04

0.61

4.6

5.6

347.46

366.53

umol/l

3.63

798

4688

Carcinoma in situ of prostate

0.00

0.61

0.0

5.5

—

299.20

—

Corneal ulcer

137

1231

1.11

0.60

5.1

5.6

342.72

364.53

umol/l

1.05

117

1076

Benign neoplasm of other and ill-defined parts of digestive system

108

957

1.13

0.60

5.8

5.2

354.83

354.71

umol/l

0.00

833

Pre-eclampsia or poor fetal growth

159

1743

0.91

0.59

4.9

5.8

363.56

377.36

umol/l

0.65

138

1527

Contact with and exposure to communicable diseases

246

2265

1.08

0.59

6.6

5.8

374.78

377.66

umol/l

0.12

223

2003

Hallux valgus (acquired)

239

1577

1.08

0.58

5.3

5.5

366.76

371.04

umol/l

0.17

205

1379

Acute lymphadenitis

336

1.22

0.58

4.8

6.2

362.67

371.95

umol/l

0.20

300

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

112

0.62

0.58

5.3

6.2

403.29

359.17

umol/l

—

103

Other interstitial pulmonary diseases

842

0.87

0.58

4.5

4.6

317.24

344.25

umol/l

0.84

724

Malignant neoplasm, without specification of site

150

0.66

0.58

5.5

4.3

326.20

340.87

umol/l

—

129

Calculus of lower urinary tract

255

1.26

0.58

3.6

5.1

305.96

340.34

umol/l

0.77

228

Calcific aortic valvular stenosis

182

1601

1.09

0.58

3.9

4.2

330.11

330.42

umol/l

0.01

164

1335

Calcific aortic valvular stenosis, operated

182

1601

1.09

0.58

3.9

4.2

330.11

330.42

umol/l

0.01

164

1335

Other disorders of prostate

149

1.35

0.58

4.9

5.0

350.60

323.86

umol/l

0.29

130

Interstitial lung disease

841

0.87

0.57

4.5

4.6

317.24

344.12

umol/l

0.83

723

Interstitial lung disease endpoints

841

0.87

0.57

4.5

4.6

317.24

344.12

umol/l

0.83

723

Varicella [chickenpox], including avohilmo

373

1.21

0.57

4.9

6.4

420.95

375.86

umol/l

1.08

335

Myocardial infarction, with ST-elevation

979

0.88

0.57

3.3

4.6

325.23

338.30

umol/l

0.38

829

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

132

1.37

0.57

4.0

6.4

345.08

383.86

umol/l

0.43

115

Other disorders of conjunctiva

773

1.14

0.57

4.7

5.2

336.16

354.39

umol/l

0.55

678

Hypertrophic scar

301

1.23

0.57

6.5

6.2

374.55

375.12

umol/l

0.01

267

Macular hole

283

1.24

0.56

3.5

5.0

325.37

356.56

umol/l

0.50

252

Fibroblastic disorders

154

1399

1.10

0.56

4.2

5.2

337.83

360.06

umol/l

1.11

131

1201

Malignant neoplasm of other and unspecified female genital organs

0.56

12.8

5.0

378.20

355.41

umol/l

—

Benign neoplasm: Bronchus and lung

1.46

0.56

8.1

5.7

362.13

342.43

umol/l

—

MS-disease / Multiple Sclerosis

411

1.20

0.56

4.7

6.4

379.96

370.90

umol/l

0.14

365

Other appendicitis

494

1.18

0.56

5.7

6.1

383.98

362.17

umol/l

0.62

440

Other or ill-defined heart diseases

330

1.22

0.54

6.3

5.8

350.80

354.30

umol/l

0.05

293

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

127

1110

1.11

0.54

4.4

5.7

358.24

377.52

umol/l

0.90

114

991

Autoimmune diseases excluding thyroid diseases

871

4534

1.04

0.54

4.8

5.3

351.93

365.55

umol/l

1.90

736

3985

Muscle strain

195

1.29

0.54

7.6

6.0

384.40

368.92

umol/l

0.26

170

Urolithiasis

193

2094

0.92

0.54

4.6

5.1

325.73

353.93

umol/l

1.91

160

1810

Operations 2 for CAVS

181

1599

1.09

0.53

3.9

4.1

330.81

330.23

umol/l

0.02

163

1333

Calcific aortic valvular stenosis, diagnosis (helper)

181

1599

1.09

0.53

3.9

4.1

330.81

330.23

umol/l

0.02

163

1333

Allergic rhinitis

214

2282

0.92

0.53

5.3

5.9

372.95

380.86

umol/l

0.37

187

2036

Other arrhythmias

506

3589

1.05

0.53

4.6

5.7

350.83

367.90

umol/l

1.65

445

3132

Disorders of breast

326

2693

1.07

0.53

5.6

5.5

359.22

372.98

umol/l

0.99

275

2384

Sarcoidosis

781

0.87

0.53

4.7

5.6

340.92

360.30

umol/l

0.54

693

Personal history of allergy to drugs, medicaments and biological substances

1.53

0.53

6.6

346.40

352.09

umol/l

—

Contact with nonpowered hand tool

277

1.23

0.53

4.0

6.3

305.90

370.73

umol/l

1.47

255

Type 1 diabetes, wide definition, subgroup 1

153

1395

1.10

0.52

5.1

5.7

340.99

372.28

umol/l

1.87

134

1223

Loose body in joint

135

0.66

0.52

3.6

6.5

299.44

372.82

umol/l

—

120

Bullous disorders

305

1.22

0.51

3.9

5.4

336.07

353.44

umol/l

0.20

272

Benign neoplasm: Skin of lip

1.41

0.51

7.4

6.2

355.11

348.47

umol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

181

1602

1.09

0.51

3.9

4.2

330.81

329.98

umol/l

0.03

163

1336

Other aneurysm

260

1.23

0.51

5.8

4.8

353.81

348.69

umol/l

0.07

235

Hypertrophy of breast

100

894

1.12

0.51

5.2

5.8

345.45

379.90

umol/l

1.95

783

Oter anti-inflammatory and antirheumatic agents, non-steroids

188

950

1.09

0.51

4.4

5.9

351.70

366.59

umol/l

0.77

161

847

Malignant neoplasm of bladder

357

0.81

0.50

3.7

3.9

353.57

327.34

umol/l

0.51

299

Tooth agenesis EXCLUDE clefts and syndromes

246

0.77

0.50

4.5

6.2

390.00

391.45

umol/l

0.02

219

Coxibs

229

1292

0.93

0.49

4.9

6.2

346.58

376.66

umol/l

2.77

203

1165

Thyrotoxicosis with diffuse goitre

659

0.86

0.49

5.9

5.2

367.97

363.45

umol/l

0.09

579

Other inflammation of eyelid, including avohilmo

321

3404

0.94

0.49

5.1

5.8

366.52

372.31

umol/l

0.30

274

3010

Spinal stenosis

363

2527

1.06

0.49

4.0

5.2

329.22

358.46

umol/l

3.55

309

2186

Maxillary retrognathism

110

0.63

0.48

3.0

5.8

366.43

388.58

umol/l

—

102

Arterial embolism and thrombosis of lower extremity artery

154

1.30

0.48

2.7

4.4

268.23

347.29

umol/l

0.99

140

Glaucoma, exfoliation

502

1.16

0.48

4.3

4.1

327.68

333.17

umol/l

0.11

423

Other superficial mycoses

137

1.32

0.47

4.5

6.7

348.05

364.93

umol/l

0.16

124

Thoracic aortic aneurysm

868

0.89

0.47

4.8

5.0

326.57

352.45

umol/l

1.03

742

Malignant neoplasm of head and neck, including Hilmo

591

0.86

0.47

4.2

5.2

298.81

346.66

umol/l

1.94

505

Benign neoplasm: Skin of other and unspecified parts of face

559

0.86

0.47

5.8

5.3

361.65

355.37

umol/l

0.11

492

Major coronary heart disease event excluding revascularizations

457

2871

1.05

0.46

4.8

5.2

342.75

353.88

umol/l

0.99

397

2485

Other necrotizing vasculopathies

374

1.18

0.46

4.1

5.3

315.97

357.70

umol/l

0.94

331

Amiodarone users

494

0.85

0.46

3.7

4.7

394.41

341.52

umol/l

1.58

427

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

131

1162

1.10

0.46

4.4

5.6

359.59

377.32

umol/l

0.79

117

1035

Other congenital malformations of peripheral vascular system

0.61

0.46

8.0

6.3

375.40

370.88

umol/l

—

Nonischemic cardiomyopathy

617

1.14

0.46

5.6

5.4

351.25

354.03

umol/l

0.06

535

Other specified/unspecified inflammatory spondylopathies

265

0.79

0.45

5.2

6.5

327.24

386.75

umol/l

1.18

236

Other and unspecified disorders of skin and subcutaneous tissue

338

1.19

0.45

6.3

5.6

327.42

363.10

umol/l

0.69

297

ILD, hospital admissions

822

0.89

0.45

4.5

4.7

317.24

344.69

umol/l

0.86

708

Benign neoplasm: Skin of eyelid, including canthus

808

1.12

0.45

5.3

5.2

339.32

352.14

umol/l

0.38

708

Polypectomy (DHB20)

395

0.83

0.44

7.3

5.9

385.04

354.99

umol/l

0.53

358

Zoster [herpes zoster], including avohilmo

341

3468

0.95

0.44

4.9

5.3

369.54

356.60

umol/l

0.82

291

3010

Use of antiglaucoma preparations and miotics

376

1.17

0.44

2.9

4.4

340.91

340.04

umol/l

0.01

322

Motorcycle rider injured in noncollision transport accidents

220

1.23

0.44

5.2

6.6

355.27

367.45

umol/l

0.18

201

Excessive vomiting in pregnancy

414

1.16

0.43

5.6

6.2

370.05

379.04

umol/l

0.17

356

Sequelae of poliomyelitis

1.62

0.43

2.6

4.3

425.20

347.58

umol/l

—

Aortic aneurysm

128

1367

0.92

0.43

4.1

4.5

326.26

338.78

umol/l

0.51

117

1148

Diabetic neuropathy

750

1.12

0.43

5.2

5.8

321.73

348.69

umol/l

0.95

665

Congenital malformations of breast, including avohilmo

0.65

0.42

2.5

6.7

309.17

377.25

umol/l

—

Other sexually transmitted chlamydial diseases

443

1.15

0.42

6.7

6.2

323.89

378.25

umol/l

1.82

385

Myocardial infarction, unclassifiable

129

1057

1.09

0.42

4.0

335.68

329.88

umol/l

0.16

105

874

Other secondary gonarthrosis

276

1.20

0.42

3.9

5.8

355.79

365.47

umol/l

0.14

243

Vasomotor and allergic rhinitis

285

2944

0.94

0.42

4.9

6.0

364.94

379.79

umol/l

1.04

248

2638

Pityriasis rubra pilaris

0.00

0.41

0.0

4.4

—

324.00

—

Syndactyly

0.00

0.41

0.0

4.8

—

307.56

—

Sequelae of poliomyelitis, including avohilmo

1.52

0.41

2.6

4.3

425.20

353.25

umol/l

—

Membranous nephropathy

0.00

0.41

0.0

5.5

—

287.40

—

Spontaneous rupture of synovium and tendon

444

1.15

0.41

4.5

5.5

353.02

360.36

umol/l

0.14

392

Maternal care for other conditions predominantly related to pregnancy

137

1231

1.09

0.41

5.7

6.0

369.68

382.90

umol/l

0.47

121

1075

Other and unspecified neuropathies

0.00

0.41

0.0

5.5

—

343.29

—

First line medication for Crohn's disease

1008

5261

1.03

0.40

4.7

5.8

357.10

369.95

umol/l

1.94

859

4658

Other/unspecified synovitis and tenosynovitis

662

1.12

0.40

4.9

5.7

341.98

370.38

umol/l

0.92

584

Nonhereditary hypogammaglobulinemia

1.34

0.40

8.5

6.2

328.38

348.98

umol/l

—

Neoplasms

709

3851

0.96

0.40

5.8

5.9

363.75

374.48

umol/l

1.25

628

3415

Cyst of Bartholin Gland

186

1.24

0.40

1.9

6.2

323.13

370.83

umol/l

0.76

167

Other abnormal immunological findings in serum

103

0.68

0.39

4.4

6.4

401.30

370.94

umol/l

—

Tinnitus

140

1512

0.93

0.39

5.3

5.4

337.35

362.03

umol/l

1.17

117

1317

Benign neoplasm: salivary glands, exclude unknown (D119)

465

1.14

0.39

4.7

5.6

336.49

351.53

umol/l

0.36

410

Mandibular retrognathia

388

0.85

0.39

4.8

6.2

399.29

385.61

umol/l

0.17

348

Abdominal aortic aneurysm (AAA)

481

0.86

0.39

2.6

3.7

308.58

320.78

umol/l

0.22

401

Abnormal findings in secretions and smears from cervix uteri vagina vulva

327

2288

1.05

0.38

5.6

5.8

371.23

379.46

umol/l

0.45

286

2020

Isolated proteinuria

151

1.26

0.38

6.4

362.68

370.06

umol/l

0.09

136

Bacterial sepsis of newborn

1.40

0.38

3.4

4.5

474.40

423.22

umol/l

—

ILD, hospital admissions 1, main diag only

727

0.89

0.38

4.7

4.8

316.57

346.10

umol/l

0.83

627

Endometriosis of ovary

921

0.91

0.38

4.2

5.8

350.06

382.59

umol/l

1.53

807

Spermatocele

462

0.86

0.37

4.0

5.2

354.48

346.35

umol/l

0.14

392

Benign neoplasm: Ascending colon

734

1.10

0.36

5.2

5.0

370.22

348.43

umol/l

0.74

645

Early lumbar disc prolapse, operated

658

1.11

0.36

5.6

6.9

328.22

379.06

umol/l

2.91

586

Other systemic involvement of connective tissue

165

1543

1.07

0.36

4.4

5.2

343.60

357.64

umol/l

0.63

136

1336

Benign lipomatous neoplasm

171

1825

0.94

0.36

4.8

5.5

354.81

362.00

umol/l

0.25

150

1579

Deep bite

682

0.90

0.36

4.5

5.8

382.08

385.88

umol/l

0.08

618

Granuloma annulare

1.27

0.36

5.4

6.7

337.56

379.91

umol/l

—

Marginal zone B-cell lymphoma, including Hilmo

0.66

0.36

4.2

5.0

274.80

358.64

umol/l

—

Other bacterial agents as the cause of diseases classified to other chapters

1.44

0.35

16.8

5.1

404.17

354.42

umol/l

—

Type 1 diabetes, wide definition

158

1476

1.07

0.35

5.1

5.6

342.60

373.51

umol/l

1.91

139

1293

Chronic rhinitis, nasopharyngitis and pharyngitis

251

2381

1.05

0.35

4.8

5.9

342.91

375.23

umol/l

3.35

215

2124

Pemphigoid

126

1.27

0.35

3.9

5.0

292.45

357.68

umol/l

0.76

114

Blepharospasm

1.40

0.35

6.5

6.6

376.67

364.97

umol/l

—

Non-allergic asthma

479

1.13

0.35

4.2

5.6

349.80

370.62

umol/l

0.52

428

Autoimmune diseases related-to ILD

724

5861

1.03

0.35

5.3

5.5

352.12

366.24

umol/l

1.81

617

5161

Ventricular septal defect, a heart condition

153

1.24

0.35

3.9

5.2

398.74

406.45

umol/l

0.09

145

Insulin, fast-acting (human)

106

977

1.09

0.34

5.2

6.1

342.54

366.75

umol/l

1.00

873

Cirrhosis of liver, NAS

287

0.83

0.34

3.5

5.2

347.53

348.22

umol/l

0.01

260

Propionic acid derivatives

283

1353

1.05

0.34

5.1

6.1

352.71

378.33

umol/l

2.52

257

1223

Hypoparathyroidism

181

1.22

0.34

8.6

5.3

345.56

356.23

umol/l

0.09

163

Benign paroxysmal vertigo

186

1751

1.06

0.34

5.8

5.2

361.12

356.74

umol/l

0.16

151

1522

Slow fetal growth and fetal malnutrition

1.36

0.34

3.7

5.1

455.83

453.82

umol/l

—

ILD medications: prednisolone, methylprednisolone, prednisone

976

5280

1.03

0.34

4.6

5.7

349.24

369.29

umol/l

4.04

817

4675

Dilated cardiomyopathy

679

0.90

0.34

4.5

5.3

333.05

348.55

umol/l

0.39

587

Respiratory tuberculosis, confirmed

1.35

0.34

5.7

4.7

351.09

339.93

umol/l

0.13

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

144

0.76

0.33

4.5

5.0

364.91

333.12

umol/l

0.53

125

Chronic lymphocytic leukaemia, helper endpoint

144

0.76

0.33

4.5

5.0

364.91

333.12

umol/l

0.53

125

Chronic lymphocytic leukaemia

144

0.76

0.33

4.5

5.0

364.91

333.12

umol/l

0.53

125

Pneumoconiosis due to asbestos and other mineral fibres

0.70

0.33

7.3

3.5

310.17

325.80

umol/l

—

Disorders of vestibular function (Vertigo)

323

3011

1.04

0.32

5.2

5.1

357.91

358.39

umol/l

0.02

271

2611

Achilles tendinitis

624

0.90

0.32

5.0

5.9

364.16

375.84

umol/l

0.21

541

Other peripheral vascular diseases

413

0.87

0.32

4.5

5.7

416.00

368.49

umol/l

0.34

360

Malignant neoplasm of cervix uteri, including Hilmo

132

0.76

0.32

7.2

5.8

423.00

358.71

umol/l

—

113

Respiratory tuberculosis, confirmed, including avohilmo

1.33

0.32

5.7

4.6

351.09

338.84

umol/l

0.15

Bullous pemphigoid

1.31

0.32

3.1

5.0

253.43

351.96

umol/l

—

Endometriosis ASRM stages 3,4

111

1195

0.93

0.31

4.1

5.7

354.03

370.27

umol/l

0.66

102

1045

Ischaemic heart disease, wide definition

587

3497

1.03

0.31

5.1

5.5

349.12

363.60

umol/l

1.69

515

3045

Other benign neoplasms of skin

224

2355

0.95

0.31

5.7

5.2

354.25

360.25

umol/l

0.27

199

2029

Pyogenic granuloma

0.72

0.31

2.9

6.0

290.14

379.90

umol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

705

0.91

0.31

4.7

5.9

341.07

369.32

umol/l

0.98

635

Endocrine disorders, other/unspecified

100

0.70

0.30

6.0

449.00

362.54

umol/l

—

Postmenopausal bleeding

177

873

1.06

0.30

6.3

5.6

376.60

378.21

umol/l

0.05

159

768

Angina pectoris

382

2632

0.96

0.30

4.4

5.1

338.03

353.69

umol/l

1.34

343

2265

Injury of muscle and tendon at ankle and foot level

138

1.24

0.30

2.9

6.6

283.92

372.47

umol/l

1.98

124

Presence of other functional implants

395

2806

0.96

0.30

4.9

5.1

349.34

356.47

umol/l

0.42

333

2441

Other/unspecified rheumatoid arthritis

610

0.90

0.30

3.9

5.2

338.93

350.53

umol/l

0.24

545

Disorders of synovium and tendon in diseases classified elsewhere

120

1.25

0.30

7.9

5.9

299.00

368.50

umol/l

1.29

106

Adhesive capsulitis of shoulder

964

0.92

0.30

4.7

5.6

345.51

370.43

umol/l

0.84

839

Other acute skin changes due to ultraviolet radiation

175

1.20

0.30

5.4

5.9

366.63

356.26

umol/l

0.11

159

Inguinal or femoral hernia, bilateral

648

1.10

0.30

3.8

5.0

305.72

350.97

umol/l

2.18

570

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.28

0.30

8.4

7.1

306.71

366.45

umol/l

—

Pulmonary eosinophilia, not elsewhere classified

1.25

0.29

6.9

6.5

411.14

357.67

umol/l

—

Benign neoplasm of bone and articular cartilage

487

1.11

0.29

4.8

5.7

388.94

361.76

umol/l

0.76

435

Cervical disc disorders

253

2419

1.05

0.29

4.3

5.7

341.58

369.93

umol/l

2.70

220

2120

Rosacea

691

0.91

0.28

4.0

5.5

350.80

369.04

umol/l

0.45

609

Other deformities of toe(s)

184

0.81

0.28

3.8

6.0

356.67

375.57

umol/l

0.25

162

Endometriosis of pelvic peritoneum

100

845

1.08

0.28

4.4

6.1

349.24

388.38

umol/l

2.05

747

Sub-endpoint used in defining T1D endpoints

222

2083

1.05

0.28

5.2

5.6

340.04

364.53

umol/l

1.74

196

1814

Malignant neoplasm of head and neck

481

0.89

0.28

4.0

5.1

282.26

349.19

umol/l

2.63

411

Guillain-Barre syndrome

1.32

0.28

7.6

5.2

406.60

354.27

umol/l

—

Other hearing loss

175

1607

1.06

0.28

4.7

4.6

335.51

339.18

umol/l

0.11

148

1361

Other puerperal infections

384

1.12

0.27

6.7

6.0

330.74

370.60

umol/l

0.93

331

Polymyalgia rheumatica

658

0.91

0.27

3.7

4.8

338.15

340.44

umol/l

0.04

571

Retinal haemorrhage

117

0.77

0.27

1.7

5.6

312.44

358.86

umol/l

—

108

Myeloproliferative diseases (CML excluded)

395

0.88

0.26

3.0

5.2

333.23

347.33

umol/l

0.24

347

Noninflammatory disorders of female genital tract

264

1269

1.04

0.26

5.6

5.4

371.03

378.35

umol/l

0.33

227

1104

Anomalies of dental arch relationship, including avohilmo

145

1239

1.06

0.26

5.4

5.7

363.74

376.48

umol/l

0.55

136

1091

Acute appendicitis, no complications

452

4356

1.03

0.26

5.8

364.85

370.20

umol/l

0.34

402

3842

Other protozoal intestinal diseases

0.68

0.26

4.4

5.3

293.20

371.40

umol/l

—

Other specified disorders of kidney and ureter

169

1.19

0.26

4.5

5.4

355.93

354.30

umol/l

0.01

152

Nontoxic goitre/thyroid nodule

152

1603

0.95

0.25

5.5

5.2

355.45

358.98

umol/l

0.13

136

1405

Diabetic nephropathy

106

1115

0.94

0.25

5.3

5.8

312.82

347.82

umol/l

1.80

977

Presbyopia

435

1.10

0.25

6.7

6.2

382.31

365.44

umol/l

0.39

391

Unspecified lump in breast

772

1.08

0.25

5.3

5.5

348.14

372.09

umol/l

0.83

675

Other diseases of blood and blood-forming organs

382

0.89

0.24

7.6

5.9

376.97

356.47

umol/l

0.39

340

Other noninflammatory disorders of uterus, except cervix

121

856

0.94

0.24

5.6

5.5

349.00

376.15

umol/l

1.46

105

753

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.27

0.24

5.7

4.9

351.09

339.47

umol/l

0.14

Hypersensitivity pneumonitis due to organic dust

1.17

0.24

10.7

5.9

374.78

356.97

umol/l

—

Lateral epicondylitis

802

1.07

0.24

4.0

6.0

349.14

377.83

umol/l

1.12

703

Malignant neoplasm of eye and adnexa, including Hilmo

0.74

0.24

3.2

4.5

242.17

354.41

umol/l

—

Congenital malformations of breast

0.72

0.24

2.5

6.4

309.17

376.06

umol/l

—

Plantar fascial fibromatosis

532

1.09

0.24

4.6

5.9

383.94

375.69

umol/l

0.19

471

Inguinal hernia, bilateral

638

1.08

0.24

3.6

5.0

302.65

350.75

umol/l

2.35

562

Fistulae involving female genital tract

0.70

0.24

5.3

6.2

335.67

383.14

umol/l

—

Colectomy operation

941

0.93

0.24

6.4

5.0

354.76

352.75

umol/l

0.05

813

Acute peritonitis

341

1.12

0.23

6.2

5.4

317.03

350.66

umol/l

0.73

307

Benign neoplasm: Stomach

475

1.10

0.23

4.8

5.3

350.74

354.87

umol/l

0.08

419

Benign neoplasm: Choroid

349

0.89

0.23

3.4

5.3

347.42

352.42

umol/l

0.05

307

Benign neoplasms

867

4814

0.98

0.23

5.6

5.5

361.48

366.73

umol/l

0.50

753

4213

Umbilical hernia

195

1867

1.05

0.23

5.0

5.5

334.00

363.59

umol/l

2.28

174

1627

Pollen allergy

130

1352

0.95

0.23

5.6

6.1

374.07

383.93

umol/l

0.37

118

1207

Systemic connective tissue disorders

221

2122

1.04

0.23

4.2

5.2

341.75

359.89

umol/l

1.11

182

1842

Melanoma of uvea

1.32

0.23

3.4

4.4

264.40

347.64

umol/l

—

Benign neoplasm: Parotid gland

428

1.10

0.23

4.9

5.7

342.54

353.14

umol/l

0.24

379

Abnormal serum enzyme levels

192

1933

0.96

0.23

4.4

5.0

332.47

347.67

umol/l

0.87

170

1654

Cardiomyopathy, Hypertrophic obstructive

0.77

0.22

3.0

5.9

292.43

376.21

umol/l

—

Allergic contact dermatitis

722

0.93

0.22

4.3

5.9

340.57

370.98

umol/l

0.90

631

Conotruncal defects

0.73

0.22

2.6

5.6

382.00

397.80

umol/l

—

Distal bite

236

1.14

0.22

3.5

5.8

417.19

401.36

umol/l

0.20

217

Leukaemia of unspecified cell type

1.22

0.22

5.6

5.0

242.80

340.83

umol/l

—

Other disorders of the genitourinary system

607

0.92

0.22

4.5

5.2

312.69

354.79

umol/l

1.78

536

Birth injury to skeleton

0.00

0.21

0.0

4.1

—

429.90

—

Aortic hypoplasia

0.00

0.21

0.0

4.0

—

447.91

—

Traumatic subcutaneous emphysema

0.00

0.21

0.0

4.1

—

304.00

—

Other porphyria

0.00

0.21

0.0

3.1

—

319.20

—

Tuberculosis of other organs, strict, including avohilmo

107

1.22

0.21

6.8

5.0

370.85

345.32

umol/l

0.35

Calcinosis cutis

0.00

0.21

0.0

4.5

—

328.55

—

Chylothorax

0.00

0.21

0.0

4.6

—

344.00

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.21

0.0

4.6

—

318.73

—

Puerperal sepsis

613

1.08

0.21

5.3

5.9

332.93

378.67

umol/l

2.01

540

Occlusion and stenosis of arteries, not leading to stroke

1.19

0.21

2.0

4.6

356.20

322.83

umol/l

—

General- and plastic-surgery devices associated with adverse incidents

0.00

0.21

0.0

6.3

—

399.50

—

Autoimmune diseases excluding thyroid diseases, strict definition

828

4414

1.02

0.21

4.8

5.2

350.89

364.99

umol/l

1.92

702

3878

Ulcerative colitis, NAS

915

1.06

0.21

4.9

5.9

351.13

367.33

umol/l

0.54

809

Thyroiditis

373

1.10

0.21

5.0

5.8

343.82

364.61

umol/l

0.43

329

Need for immunization against other single infectious diseases

0.00

0.20

0.0

5.3

—

332.29

—

Care involving dialysis

412

1.09

0.20

5.3

5.5

293.10

350.13

umol/l

1.56

357

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.20

0.0

4.6

—

362.43

—

Other enthesopathy of foot (+metatarsalgia)

567

1.08

0.20

4.5

5.8

340.40

375.95

umol/l

1.27

503

Postprocedural endocrine and metabolic disorders, not elsewhere classified

567

1.08

0.20

5.7

354.60

367.90

umol/l

0.33

500

Retinoschisis and retinal cysts

115

0.78

0.20

5.4

5.6

327.67

354.45

umol/l

—

106

Other/unspecified enthesopathies, not elsewhere classified

448

0.91

0.19

3.8

5.4

331.85

360.56

umol/l

0.53

394

Scarlet fever, including avohilmo

1.18

0.19

3.3

5.6

297.33

381.30

umol/l

—

Central retinal artery occlusion

1.23

0.19

2.7

5.0

376.09

361.50

umol/l

0.08

Other protozoal intestinal diseases, including avohilmo

122

0.82

0.19

4.1

6.2

337.20

386.57

umol/l

—

110

Maternal care for cervical incompetence

184

1.14

0.19

3.3

5.9

346.19

376.40

umol/l

0.38

157

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.13

0.18

16.8

5.4

404.17

364.50

umol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

311

0.90

0.18

5.4

5.6

368.00

367.80

umol/l

0.00

266

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

394

0.91

0.18

5.9

5.7

348.87

370.64

umol/l

0.46

348

Follow-up examination after treatment for malignant neoplasms

394

0.91

0.18

4.3

4.4

400.04

344.75

umol/l

1.48

335

Glomerular disorders in diseases classified elsewhere

716

1.06

0.18

5.3

298.90

355.68

umol/l

3.00

621

Ulcerative colitis

178

1715

1.04

0.18

5.8

5.6

355.72

366.40

umol/l

0.44

158

1506

Prepatellar bursitis

279

0.89

0.18

6.3

6.0

380.35

362.62

umol/l

0.31

242

Carcinoma in situ of cervix uteri

493

1.08

0.18

5.2

6.0

360.44

370.78

umol/l

0.17

422

Other metabolic disorders

629

1.07

0.17

5.5

352.19

367.66

umol/l

0.40

550

Use of cabergoline

1.15

0.17

7.1

5.6

345.86

352.29

umol/l

—

Atrophic disorders of skin

893

1.05

0.17

4.3

5.5

339.37

371.08

umol/l

1.14

785

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

755

5972

0.98

0.17

5.2

5.5

375.93

365.33

umol/l

1.14

661

5256

Contusion of toe(s) with damage to nail

0.74

0.17

3.4

5.4

297.40

370.36

umol/l

—

Sicca syndrome [Sjögren]

407

1.08

0.17

4.9

5.6

341.29

365.08

umol/l

0.54

363

Malignant neoplasm of vulva, including Hilmo

0.72

0.17

2.0

5.0

223.40

350.36

umol/l

—

Carcinoma in situ of cervix uteri, endocervix

1.18

0.16

9.4

7.4

305.00

374.37

umol/l

—

Other disorders of breast

670

1.06

0.16

6.5

5.4

368.26

373.07

umol/l

0.09

584

ILD medications

989

5404

0.99

0.16

4.7

5.7

353.00

370.17

umol/l

3.19

829

4791

Migraine without aura, drug-induced

1.15

0.16

4.4

6.9

383.38

365.02

umol/l

—

Retinal detachment with retinal break

729

1.06

0.16

4.2

5.4

333.06

353.30

umol/l

0.66

634

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.14

0.16

6.9

6.4

345.25

373.23

umol/l

—

Rubella [German measles], including avohilmo

204

0.88

0.16

4.8

6.0

349.94

359.88

umol/l

0.14

179

Polyarthrosis

122

1145

0.96

0.16

4.4

5.2

353.29

365.45

umol/l

0.47

102

990

Stenosis and insufficiency of lacrimal passages

484

0.93

0.16

5.3

5.6

388.39

359.19

umol/l

0.60

429

Unstable angina pectoris

231

1868

0.97

0.16

3.6

4.8

324.44

341.07

umol/l

1.01

198

1590

Haemorrhagic and haematological disorders of fetus and newborn

142

1.15

0.16

6.0

5.1

438.35

445.76

umol/l

0.07

135

Rubella [German measles]

203

0.89

0.15

4.8

6.0

349.94

360.03

umol/l

0.14

178

Benign neoplasm: Spinal cord

1.13

0.15

7.8

6.5

413.44

376.88

umol/l

—

Immunodeficiency with predominantly antibody defects

159

1.13

0.15

5.2

6.3

351.11

367.12

umol/l

0.19

147

Oral lichen planus

140

1.15

0.15

3.7

5.8

332.55

366.76

umol/l

0.48

126

Gonarthrosis,primary

683

4051

1.02

0.15

5.0

5.3

343.36

361.29

umol/l

2.76

593

3533

Other systemic involvement of connective tissue (FG)

161

1528

1.03

0.15

4.5

5.1

343.25

363.53

umol/l

1.13

132

1328

Other specified and unspecified disorders of eyelid

1.09

0.14

4.9

5.9

347.33

362.70

umol/l

—

Crushing injury of wrist and hand

0.81

0.14

5.4

6.3

323.29

357.79

umol/l

—

Myeloproliferative diseases

430

0.93

0.14

3.0

5.3

343.87

347.83

umol/l

0.06

378

Follow-up care involving plastic surgery

169

1.13

0.14

5.5

6.1

395.86

362.26

umol/l

0.54

148

Venous complications and haemorrhoids in pregnancy

1.19

0.14

3.2

6.9

368.18

384.61

umol/l

0.12

Duodenal ulcer

576

1.06

0.14

5.3

4.7

338.30

347.61

umol/l

0.20

487

Presbycusis

695

1.05

0.14

4.3

3.8

317.55

320.85

umol/l

0.06

572

Tuberculosis of other organs, strict

103

1.17

0.13

5.8

5.0

367.08

344.69

umol/l

0.27

Migraine, single triptan purchase ok & required. ICD-code if available is included

617

4241

0.98

0.13

4.4

6.1

347.74

378.49

umol/l

6.06

530

3781

Triptan medication for migraine, single purchase ok

617

4241

0.98

0.13

4.4

6.1

347.74

378.49

umol/l

6.06

530

3781

Certain disorders involving the immune mechanism

115

1193

0.96

0.13

4.7

5.5

345.81

364.32

umol/l

0.72

104

1047

Disorders of choroid and retina

610

4332

0.98

0.13

4.7

5.4

344.15

361.08

umol/l

2.02

523

3789

Ectopic pregnancy

922

1.04

0.13

5.7

6.3

366.38

383.37

umol/l

0.60

821

Peritonsillar abscess

158

1533

1.03

0.13

5.0

6.2

355.48

370.33

umol/l

0.64

136

1365

Other arthritis (FG)

220

2146

1.03

0.12

4.5

5.5

346.37

367.76

umol/l

1.41

192

1876

Cardiomyopathies, Primary/intrinsic

712

0.95

0.12

4.5

5.1

324.70

346.98

umol/l

0.70

607

Arthropod-borne viral fevers and viral haemorrhagic fevers

571

1.05

0.12

5.3

6.0

354.81

364.26

umol/l

0.24

514

Calcific tendinitis of shoulder

317

1.07

0.12

5.1

5.7

409.39

365.17

umol/l

1.25

279

Diseases of inner ear

366

3562

0.98

0.12

5.0

5.2

361.39

357.90

umol/l

0.18

309

3100

Congenital malformations of heart and great arteries

897

1.04

0.11

4.3

5.8

364.03

382.94

umol/l

0.76

807

Primary gonarthrosis, bilateral

352

2893

1.02

0.11

4.8

5.0

337.05

356.53

umol/l

2.03

309

2505

Other osteochondropathies

435

0.94

0.11

5.6

6.0

392.11

368.52

umol/l

0.50

387

Aortic valve malfunction, age under 60 years

639

0.95

0.11

4.4

6.0

340.52

364.65

umol/l

0.73

576

Other and unspecified mononeuropathies, also in other diseases

153

1.11

0.11

4.5

5.6

360.53

350.85

umol/l

0.13

133

Vitreous haemorrhage

592

1.05

0.11

4.1

5.4

324.55

353.39

umol/l

0.81

522

Tuberculosis of other organs

1.16

0.11

6.5

5.0

352.30

346.94

umol/l

—

Hallux rigidus

801

0.96

0.11

4.3

5.5

328.81

365.24

umol/l

1.76

694

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

104

1.14

0.10

6.1

5.3

470.33

443.21

umol/l

0.21

Spondylolisthesis/Spondylolysis

113

1095

1.03

0.10

4.9

5.8

352.07

370.63

umol/l

0.67

102

954

Anti-inflammatory and antirheumatic products, non-steroids

264

1354

0.98

0.10

5.6

6.1

359.75

378.59

umol/l

1.48

238

1224

Ganglion

127

1306

0.97

0.10

4.4

5.8

352.88

374.26

umol/l

1.01

105

1150

Macular pucker

839

0.97

0.09

4.9

4.6

347.66

347.09

umol/l

0.01

732

Other respiratory diseases principally affecting the interstitium

1011

0.97

0.09

6.2

4.8

340.28

345.19

umol/l

0.12

870

Adhesive middle ear disease

1.15

0.09

6.1

6.5

415.60

375.21

umol/l

—

Obstructed labour due to maternal pelvic abnormality

828

0.97

0.09

4.7

6.3

386.16

385.50

umol/l

0.01

736

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

773

1.04

0.09

4.2

5.7

350.21

363.99

umol/l

0.33

682

Testicular dysfunction

321

1.06

0.09

7.7

6.2

355.41

365.08

umol/l

0.15

287

Carcinoma in situ of skin, other sites/unspecified

1.07

0.08

5.0

3.8

270.83

334.88

umol/l

—

Myocardial infarction

338

2395

0.99

0.08

4.8

5.2

348.33

349.55

umol/l

0.06

293

2054

Benign neoplasm: Vulva

107

1.12

0.08

4.2

6.0

325.17

371.06

umol/l

0.56

Giant cell arteritis with polymyalgia rheumatica

175

0.91

0.08

3.2

5.0

264.64

350.74

umol/l

1.42

155

Benign leiomyoma with endometriosis

745

0.97

0.08

4.7

5.3

342.58

367.04

umol/l

0.78

649

Benign mammary dysplasia

674

0.96

0.08

4.5

5.2

365.98

365.12

umol/l

0.02

585

Lumbosacral root disorders, not elsewhere classified

0.80

0.08

2.4

7.0

312.20

350.79

umol/l

—

Other specified/unspecified arthritis

194

1904

1.02

0.08

4.4

5.6

343.64

369.30

umol/l

1.68

169

1654

Other sexually transmitted chlamydial diseases, including avohilmo

716

1.03

0.08

6.3

6.2

340.33

373.38

umol/l

1.19

629

Intussusception

117

1.11

0.08

4.7

6.3

342.77

363.23

umol/l

0.28

106

Internal derangement of knee

300

2927

1.01

0.08

4.8

5.8

340.56

370.70

umol/l

3.24

257

2576

Other diseases of gallbladder

236

0.93

0.08

5.9

5.1

337.64

349.01

umol/l

0.17

209

Valvular operations

845

0.97

0.08

4.0

4.9

335.71

344.06

umol/l

0.26

714

Early lumbar disc prolapse operation

754

0.97

0.08

5.6

6.5

328.22

376.41

umol/l

2.70

666

Chronic hepatitis NAS

1.05

0.08

5.1

5.3

361.29

350.34

umol/l

—

Colorectal neuroendocrine tumor and carcinoma

1.05

0.08

2.6

5.1

347.86

364.43

umol/l

—

Viral warts

628

1.04

0.07

5.2

5.8

389.66

366.22

umol/l

0.80

559

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.83

0.07

3.2

5.5

396.50

344.67

umol/l

—

Wet age-related macular degeneration

843

0.97

0.07

3.9

3.8

312.82

325.76

umol/l

0.36

697

Malignant neoplasm of tongue, including Hilmo

137

1.10

0.07

2.3

5.4

299.30

359.35

umol/l

—

118

Other and unspecified immunodeficiencies with predominantly antibody defects

1.04

0.07

2.1

5.8

325.63

368.93

umol/l

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

108

1.11

0.07

2.6

5.8

265.71

361.97

umol/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

1.03

0.07

5.8

5.1

253.63

337.12

umol/l

—

Other congenital malformations of skin

235

1.06

0.07

4.7

6.6

369.74

383.47

umol/l

0.15

213

conjunctival degenerations and deposits

112

0.89

0.07

4.4

5.9

291.40

369.86

umol/l

—

101

Other enthesopathies

195

1982

0.98

0.07

4.3

5.9

341.68

374.99

umol/l

2.58

171

1753

Mandibular prognathia

1.13

0.07

7.8

6.0

445.60

378.65

umol/l

—

Malignant neoplasm of cervix uteri

0.85

0.06

7.8

6.6

433.00

371.77

umol/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

285

1.05

0.06

4.1

5.6

367.56

360.86

umol/l

0.09

248

Extracorporeal dialysis

356

0.95

0.06

5.0

5.6

271.86

354.82

umol/l

2.07

321

Malignant neoplasm of oral cavity

177

1.07

0.06

2.5

5.2

301.77

351.87

umol/l

0.73

155

Malignant neoplasm of stomach, including Hilmo

315

0.95

0.06

4.1

4.4

355.56

334.68

umol/l

0.28

266

Granulomatous disorders of skin and subcutaneous tissue

148

1.08

0.06

5.7

6.0

336.78

366.59

umol/l

0.39

131

Congenital malformations of the urinary system

355

1.04

0.06

4.8

6.3

356.19

365.87

umol/l

0.17

322

Poor fetal growth

618

0.97

0.06

3.8

6.0

357.27

372.89

umol/l

0.43

532

Ascites

355

1.04

0.06

5.9

4.9

318.41

350.78

umol/l

0.98

315

Eustachian salpingitis and obstruction

553

1.03

0.05

6.1

7.1

377.14

377.16

umol/l

0.00

496

Nontoxic multinodular goitre

890

0.98

0.05

5.7

4.6

348.66

352.19

umol/l

0.10

787

Inflammatory bowel disease treatment related agents

994

5537

1.00

0.05

4.7

5.7

350.36

369.15

umol/l

3.74

842

4891

Injury of muscle and tendon at lower leg level

958

0.98

0.04

4.8

5.8

355.08

366.01

umol/l

0.32

825

Other diseases of pancreas

444

0.97

0.04

4.5

5.3

328.91

355.40

umol/l

0.58

390

Benign neoplasm of eye and adnexa

555

1.03

0.04

3.8

5.5

363.13

354.82

umol/l

0.14

494

Other congenital malformations of skin, including avohilmo

474

0.97

0.04

5.2

6.0

362.54

373.78

umol/l

0.21

425

Testicular hypofunction

292

0.96

0.04

7.6

6.3

354.87

368.64

umol/l

0.20

261

Radial styloid tenosynovitis [de Quervain]

292

0.96

0.04

5.4

6.0

339.04

371.85

umol/l

0.67

256

Other specified/unspecified systemic involvement of connective tissue

298

1.04

0.04

3.9

5.9

349.08

361.81

umol/l

0.21

262

Enthesopathies of lower limb, excluding foot

153

1510

1.01

0.04

4.6

6.1

356.17

376.33

umol/l

0.94

132

1327

Cardiomyopathy (excluding other)

735

0.98

0.04

4.6

5.1

334.04

347.82

umol/l

0.36

628

Temporal arteritis

170

0.94

0.04

3.2

5.1

264.64

347.64

umol/l

1.35

152

Other, unspecified and serous retinal detachments

170

1.06

0.04

5.8

5.7

329.72

358.87

umol/l

0.57

158

Impacted maxillary molar

382

0.97

0.04

5.4

6.0

363.06

364.07

umol/l

0.02

339

Embedded and impacted teeth

212

1737

0.99

0.04

5.9

6.0

394.94

374.96

umol/l

1.16

190

1539

Allergic conjunctivitis

445

4261

1.00

0.02

5.4

5.8

358.24

374.07

umol/l

1.39

383

3783

Myocardial infarction, without ST-elevation

248

2223

1.01

0.02

4.5

4.6

341.01

335.62

umol/l

0.24

212

1891

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

419

4028

1.00

0.02

5.4

5.8

356.38

373.64

umol/l

1.51

359

3580

Essential (haemorrhagic) thrombocythaemia

202

1.04

0.02

3.2

5.2

321.56

354.92

umol/l

0.50

176

Ischemic heart diseases

657

3919

1.00

0.01

5.2

5.7

355.77

368.01

umol/l

1.43

581

3446

Cardiomyopathy

103

1038

0.99

0.01

4.9

5.1

349.90

348.04

umol/l

0.05

876

Childhood allergy (age < 16)

116

949

1.01

0.01

5.3

5.6

378.70

391.06

umol/l

0.42

101

846

Other disorders of patella

113

1138

0.99

0.01

4.5

6.3

349.46

380.35

umol/l

1.39

991

Diabetic maculopathy, excluding more controls

613

1.01

0.01

5.1

5.3

302.80

359.52

umol/l

2.55

527

Crowding of teeth, including avohilmo

549

1.01

0.00

4.0

6.1

398.36

397.71

umol/l

0.01

498

Complications predominantly related to the puerperium

143

1423

1.00

0.00

5.6

5.9

349.22

381.07

umol/l

2.02

124

1241

Endometriosis

206

1193

1.00

0.00

4.6

5.5

358.90

376.00

umol/l

0.98

181

1040

Other and unspecified rosacea

484

1.01

0.00

4.2

5.8

335.44

367.46

umol/l

0.80

428

Palmar fascial fibromatosis [Dupuytren]

846

0.99

0.00

4.2

4.5

319.65

349.16

umol/l

1.01

720

Other diseases of upper respiratory tract

947

4935

1.00

0.00

5.1

5.6

349.63

367.64

umol/l

3.23

820

4347

Heart failure and coronary heart disease

281

1971

1.00

0.00

3.9

4.8

326.12

342.75

umol/l

1.35

241

1687

Benign neoplasm of ovary

817

1.00

0.00

6.4

5.3

350.55

370.12

umol/l

0.57

713

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

392

3046

1.00

0.00

5.8

5.5

370.68

370.93

umol/l

0.01

335

2674

Acetic acid derivatives and related substances

245

1269

1.00

0.00

4.9

6.2

326.64

376.75

umol/l

6.32

210

1145

Bronchiectasis

345

0.99

0.00

3.4

4.9

320.22

352.79

umol/l

0.60

302

Malignant neoplasm of oral cavity, including Hilmo

246

1.02

0.00

2.9

5.1

309.61

347.08

umol/l

0.66

217

Thyrotoxicosis with toxic multinodular goitre

299

1.00

0.00

5.9

5.3

352.08

355.17

umol/l

0.05

265

Patent foramen ovale

144

0.97

0.00

3.9

5.8

343.14

378.22

umol/l

0.50

131

Diabetic nephropathy, excluding more controls

106

860

1.00

0.00

5.3

6.0

312.82

361.63

umol/l

2.99

756

Cutaneous lupus erythematosus

118

1.02

0.00

4.4

5.6

406.23

363.38

umol/l

—

104

Inguinal hernia, unilateral

138

1.01

0.00

5.2

5.4

355.43

363.03

umol/l

0.09

124

Inguinal of femoral hernia, unilateral

138

1.01

0.00

5.2

5.4

355.43

363.03

umol/l

0.09

124

Femoral hernia, unilateral

138

1.01

0.00

5.2

5.4

355.43

363.03

umol/l

0.09

124

Giant cell arteritis

192

0.99

0.00

2.8

5.1

276.62

349.46

umol/l

1.25

170

Laparoscopic right hemicolectomy

282

0.99

0.00

4.0

4.8

345.48

344.42

umol/l

0.01

249

Chronic sinusitis

321

3201

1.00

0.00

4.8

5.9

337.89

372.67

umol/l

4.68

275

2836

Sequelae of injuries of upper limb

623

1.00

0.00

5.2

6.0

359.12

365.52

umol/l

0.13

547

Benign neoplasm of male genital organs

109

1.01

0.00

5.4

5.9

342.73

345.44

umol/l

0.03

101

Congenital malformations of the urinary system, including avohilmo

375

0.99

0.00

4.8

6.1

356.19

364.26

umol/l

0.14

339

Benign neoplasm: Skin of ear and external auricular canal

203

0.99

0.00

5.4

5.6

345.20

354.01

umol/l

0.15

185

Scissor bite

175

1.02

0.00

5.1

5.2

452.44

400.45

umol/l

0.90

159

Cyst of kidney

363

0.99

0.00

4.3

5.2

363.89

345.62

umol/l

0.30

321

Other disorders of male genital organs

303

0.99

0.00

5.8

5.9

376.24

360.71

umol/l

0.31

271

Other diseases of arteries and capillaries

477

1.01

0.00

4.8

5.5

369.76

352.64

umol/l

0.37

416

Left hemicolectomy

105

0.95

0.00

4.9

304.00

354.11

umol/l

—

Carcinoma in situ of skin of trunk

145

0.97

0.00

5.9

4.1

341.36

334.87

umol/l

0.06

130

Benign neoplasm: Conjunctiva

175

1.03

0.00

3.7

5.9

397.00

359.22

umol/l

0.37

158

Ascorbic acid deficiency

0.00

0.0

4.7

—

390.71

—

Albinism

0.00

0.0

4.8

—

320.67

—

Carcinoma in situ of oesophagus

0.00

0.0

5.4

—

320.29

—

Reduction defects of unspecified limb, including avohilmo

0.00

0.0

4.3

—

276.00

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

5.8

—

326.83

—

HSIL lesion of the vagina

0.97

0.00

3.9

7.9

312.71

389.84

umol/l

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

5.6

—

450.71

—

Malignant neoplasm of pyriform sinus

0.00

0.0

3.0

—

262.80

—

Carcinoma in situ of stomach

0.00

0.0

3.4

—

276.20

—

Otitis media in diseases classified elsewhere

0.00

0.0

2.6

—

360.00

—

Pemphigus foliaceus

0.00

0.0

3.6

—

277.00

—

Benign lipomatous neoplasm of spermatic cord

0.00

0.0

5.3

—

347.50

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

0.0

5.9

—

267.29

—

Unspecified drowning and submersion

0.00

-0.00

0.0

5.7

—

362.17

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

3.0

—

295.80

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

-0.00

0.0

3.8

—

254.67

—

Mature T/NK-cell lymphomas, hilmo

0.89

-0.00

2.4

5.5

322.80

350.84

umol/l

—

Other retinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

4.0

—

295.12

—

Drug-induced autoimmune haemolytic anaemia

0.00

-0.00

0.0

3.6

—

254.29

—

Myiasis, including avohilmo

0.00

-0.00

0.0

5.6

—

316.43

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

4.4

—

249.60

—

Myiasis

0.00

-0.00

0.0

5.8

—

356.40

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

4.6

—

181.20

—

Acquired ichthyosis

0.00

-0.00

0.0

2.2

—

259.20

—

Other accidental hanging and strangulation

0.00

-0.00

0.0

6.6

—

288.71

—

Pseudohypoparathyroidism

0.00

-0.00

0.0

4.6

—

396.29

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

3.3

—

342.67

—

Measles

1.01

-0.00

7.7

6.5

413.71

364.53

umol/l

—

Measles, including avohilmo

1.01

-0.00

7.7

6.5

413.71

364.53

umol/l

—

Ophthalmic devices associated with adverse incidents

0.00

-0.00

0.0

3.3

—

279.67

—

Environmental-pollution-related condition

0.00

-0.00

0.0

6.8

—

322.20

—

Leprosy [Hansen's disease]

0.00

-0.00

0.0

3.8

—

300.40

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

5.9

—

458.67

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

4.1

—

307.88

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.01

-0.00

4.9

5.2

341.05

399.86

umol/l

—

Leprosy [Hansen's disease], including avohilmo

0.00

-0.00

0.0

3.8

—

300.40

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

3.4

—

235.43

—

Accident to powered aircraft causing injury to occupant

0.00

-0.00

0.0

3.4

—

218.00

—

Alpha thalassaemia

0.00

-0.00

0.0

4.7

—

364.00

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

4.7

—

421.37

—

Corneal degeneration

0.95

-0.00

5.2

5.4

369.33

358.78

umol/l

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

5.0

—

296.80

—

Cystic fibrosis with intestinal manifestations

0.00

-0.00

0.0

5.3

—

428.86

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

4.1

—

400.00

—

Coarctation of the aorta

0.97

-0.00

7.1

4.6

321.86

386.09

umol/l

—

Impacted maxillary canine

1.02

-0.00

10.8

4.7

441.40

393.05

umol/l

—

Ascariasis, including avohilmo

0.00

-0.00

0.0

4.9

—

293.88

—

Carcinoma in situ, eye

0.00

-0.00

0.0

4.5

—

274.33

—

Hyperchylomicronaemia

0.00

-0.00

0.0

4.0

—

304.00

—

Carcinoma in situ of oral cavity and pharynx

0.00

-0.00

0.0

5.8

—

295.60

—

Carcinoma in situ of skin of lower limb, including hip

1.01

-0.00

4.3

4.7

335.56

345.22

umol/l

—

Placental disorders

0.86

-0.00

7.6

6.0

402.00

407.48

umol/l

—

Selective deficiency of immunoglobulin M [IgM]

0.00

-0.00

0.0

5.6

—

319.00

—

Malignant neoplasm of vulva

0.98

-0.00

2.0

5.2

223.40

363.82

umol/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

-0.00

0.0

4.8

—

312.00

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.00

-0.00

5.1

5.4

304.63

393.38

umol/l

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

-0.00

0.0

5.1

—

301.14

—

Ebstein's anomaly

0.00

-0.00

0.0

4.9

—

406.29

—

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

0.00

-0.00

0.0

3.3

—

375.67

—

Tympanosclerosis

0.00

-0.00

0.0

5.3

—

337.38

—

Knuckle pads

0.00

-0.00

0.0

2.8

—

334.20

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

6.1

—

417.43

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

2.2

—

322.20

—

Congenital absence of the uterus

0.00

-0.00

0.0

7.0

—

406.00

—

Noonan syndrome

0.00

-0.00

0.0

6.9

—

382.25

—

Personal history of medical treatment

0.89

-0.00

2.2

5.6

350.60

346.48

umol/l

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

4.6

—

340.38

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

5.3

—

451.83

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

4.0

—

199.33

—

Lumbosacral spina bifida and hydrocephalus

0.00

-0.00

0.0

3.2

—

312.60

—

Malignant neoplasm of oropharyng

0.00

-0.00

0.0

3.4

—

329.40

—

Certain zoonotic bacterial diseases, including avohilmo

160

1.00

-0.00

4.8

6.3

292.82

364.59

umol/l

0.90

145

Spotted fever [tick-borne rickettsioses], including avohilmo

0.00

-0.00

0.0

6.0

—

262.63

—

Spotted fever [tick-borne rickettsioses]

0.00

-0.00

0.0

5.8

—

226.50

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

3.6

—

326.50

—

Abnormal findings on diagnostic imaging of breast

0.87

-0.00

5.2

6.1

362.83

380.00

umol/l

—

Polyneuropathy due to other toxic agents

0.00

-0.00

0.0

3.0

—

187.00

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

3.2

—

311.20

—

Isolated proteinuria with specified morphological lesion

0.86

-0.00

1.2

5.3

269.20

356.17

umol/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Valproate [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS